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Abstract 
 
In eukaryotes, secretory and membrane proteins are targeted to the endoplasmic 
reticulum (ER) membrane for cotranslational translocation. This requires the specific 
interaction of the signal recognition particle (SRP), a ribonucleoprotein, with its 
receptor (SR). The eukaryotic SR is a heterodimeric protein consisting of SRα and 
SRβ which is anchored to the ER membrane. In all three kingdoms of life the 
conserved GTPases in SRP and SR (in eukaryotes SRP54 and SRα, respectively) 
enable the formation of the docking complex in a GTP dependent manner.  
SRβ is the third and least understood GTPase participating in cotranslational 
targeting in eukaryotes. Therefore a more detailed view on the GTPase cycle of SRβ 
and functionally relevant SRβ effector interactions should be obtained. X-ray structure 
analysis was used to determine the structure of a soluble form of SRβ (SRβΔTM) in 
its GTP bound state in complex with a fragment of SRα. The structure allows to 
precisely define the minimal SRβ binding domain of SRα (SRX). The homology to 
other small GTPases and the underlying principles of regulation together with 
previous biochemical data allow to attribute a functional role to SRX in the activation 
of the SRβ GTPase. 
An immobilised peptide library was used in order to examine the interaction of 
SR with the translocon. Evidence is presented that the apo- and likely the GDP 
bound form of SRβΔTM (SRβΔTM-apo/GDP) bind to cytosolic loops of the translocon 
in contrast to SRβΔTM-GTP in complex with SRXHis or SRαHis. These experiments 
suggest that the SRX binding surface of SRβ-GTP, as observed in the 
SRXHis:βΔTMGTP X-ray structure, is the same as engaged in SRβΔTM-apo/GDP 
binding to the translocon. SRβΔTM-apo binds to peptides of several cytosolic loop 
regions of the translocon. Mapping of these regions on the available structure of the 
homologous translocon from Methanococcus jannaschii suggests that SRβΔTM-
apo/GDP blocks the translocation pore. 
Based on the molecular structure of the SRXHis:βΔTM-GTP SRX belongs to 
the SNARE-like superfamily with the common fold of the longin domains (LDs). The 
common principles of the LD family are analysed by a comparison of surface 
hydropathicity and structure based sequence alignment with structurally known LDs. 
Putative LDs are considered according to secondary structure prediction and primary 
sequence alignment. The interaction of small GTPases with LDs is suggested to be 
important for the assembly of large complexes at or targeting of vesicles to the 
endomembrane system. 
Important structural information on the mammalian SRP:SR complex are still 
missing, including the arrangement of the individual protein subunits and the 
positioning of the SRP RNA. Extensive purification and assembly of a pentameric 
SRP:SR complex, consisting of SRα:βΔTM, SRP54, SRP19 and a 104 base pair long 
SRP RNA, was set up in order to establish the basis for further structural studies on 
this macromolecular complex. 
 
 
 
 
 
 
 
 
 III
Zusammenfassung 
 
In eukaryotischen Zellen werden sekretorische und Membranproteine cotranslational 
zum Endoplasmatischen Retikulum (ER) transportiert. Dies erfordert die Interaktion 
des Signalerkennungspartikels (Signal Recognition Particle, SRP), einem 
Ribonukleoprotein, mit seinem Rezeptor (SR). Der eukaryotische SR ist ein 
Heterodimer, der aus SRα und dem membranverankerten SRβ aufgebaut ist. In allen 
drei Königreichen des Lebens vermittelt die GTP-abhängige Wechselwirkung 
zwischen den in SR und SRP konservierten GTPasen die Bildung des Docking-
Komplexes. SRβ ist die dritte, am wenigsten verstandene GTPase, die an der co-
translationalen Translokation beteiligt ist. 
Der GTPase-Zyklus von SRβ wurde weiter aufgeklärt und funktionell relevante 
Schnittstellen zwischen SRβ und seinen Effektoren untersucht. Mit Hilfe von 
Röntgenstrukturanalyse wurde die Struktur einer löslichen Form von SRβ (SRβΔTM) 
im GTP-Zustand mit einem Fragment von SRα bestimmt. Mit Hilfe dieser Struktur 
wurde die minimale SRβ-Bindungsdomäne von SRα präzise definiert. Durch einen 
detailierten Vergleich mit den Strukturen von anderen kleinen GTPasen und deren 
Effektorkomplexen, sowie bekannten biochemischen Daten, konnte der SRX-
Domäne eine funktionelle Rolle bei der Aktivierung der GTPase SRβ abgeleitet 
werden. 
Eine immobilisierte Peptidbibliothek wurde benutzt, um die Interaktion des 
Translokons mit dem SR zu untersuchen. Es wird gezeigt, dass SRβΔTM in der Apo- 
und wahrscheinlich auch in der GDP-gebundenen Form (SRβΔTM-apo/GDP) an 
zytosolische Loopregionen des Translokons bindet, aber nicht in der GTP-Form im 
Komplex mit SRXHis oder SRαHis. Für die Bindung des Translokons wird von SRβ 
offenbar die selbe Oberfläche benutzt wie zur Bindung der SRX-Domäne. SRβΔTM-
apo bindet an zahlreiche zytosolische Loopregionen des Translokons. Durch 
Veranschaulichung dieser Regionen anhand der Struktur des homologen 
Translokons von Methanococcus jannaschii kann vorschlagen werden, dass 
SRβΔTM-apo/GDP die Translokationspore blockiert. 
Basierend auf der Röntgenstruktur des SRXHis:βΔTM-GTP-Komplexes kann 
gezeigt werden, dass SRX zur Familie der SNARE-ähnlichen Proteine gehört mit 
dem allgemeinen Faltungsmuster der Longin-Domänen (LDs). Die grundsätzlichen 
Prinzipien der LD-Familie werden anhand von LDs mit bekannter Struktur analysiert, 
durch Vergleich der Oberflächenhydropathizität und der Prmärsequenz. Die 
Interaktion von kleinen GTPasen mit LDs ist daher wichtig für den Aufbau von 
grossen Komplexen oder Vesikeln an und den Transport von Vesikeln in 
Endomembran-Systeme.  
Wichtige molekulare Informationen über den Säugetier-SRP:SR-Komplex 
fehlen immer noch. Die aufwendige Aufreinigungsmethode und Rekonstitution eines 
pentameren SRP:SR-Komplexes bestehend aus SRα:βΔTM, SRP54, SRP19 und 
einer 104 Basenpaare langen SRP-RNA wurde etabliert, als Basis für weitere 
strukturelle Studien an diesem makromolekularen Komplex. 
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Introduction 
 1
1 Introduction 
1.1 Protein Targeting in the Eukaryotic Cell 
In eukaryotic cells different membrane enclosed compartments form an elaborate 
endomembrane system (Figs. 1, 2). Therefore, proteins must be sorted according to 
their site of action which in general is directed by a signal sequence. Proteins without 
a special targeting signal remain in the cytosol.  
 
Newly synthesised secretory and membrane proteins (MPs) are transported to 
the endoplasmic reticulum (ER) which is very important for protein folding and 
modification as well as lipid synthesis. The membranous network of the Golgi 
apparatus is responsible for further maturation and sorting of secretory and 
membrane proteins.  
The main mode for proteins to enter the ER is cotranslational translocation 
where the translating ribosome is targeted to the ER membrane and the nascent 
chain is inserted into the protein conducting channel (PCC, translocon). The signal 
recognition particle (SRP) and its receptor (SR) at the ER membrane are key players 
in this targeting step (Fig. 2). Alternatively, proteins can be translated completely in 
the cytosol, stabilised by the interaction with chaperones and then access the ER 
 
 
Figure 1 Schematic drawing of a eukaryotic cell, features are labelled and combined with 
micrographs (image from (Voet and Voet, 1995)). 
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lumen through the translocon (post-translational translocation). The ER is a check 
point for correct protein folding and also the compartment in which proteins can be 
modified by N-linked glycans. 
 
 
1.2 The SRP Cycle  
In eukaryotes, the 80S ribosome and the newly synthesised protein assemble to the 
so called ribosome nascent chain complex (RNC). RNCs of translated secretory and 
membrane proteins are targeted in a GTP dependent process to the ER termed 
cotranslational translocation. Cotranslational translocation requires recognition of a 
hydrophobic N-terminal signal peptide by the ribonucleoprotein SRP and targeting of 
the RNC to the ER membrane.  
The SRP cycle (Fig. 3) is initiated when SRP recognises the hydrophobic 
signal sequence at the ribosomal polypeptide exit site. Signal sequence binding 
pauses translation (elongation arrest (Walter and Blobel, 1981)) by SRP interacting 
 
Figure 2 From DNA to protein – cartoon of important steps. mRNA (labelled) can be either 
translated by free ribosomes (black dots) for cytosolic proteins or the initiated translation is paused 
by SRP (green) for lysosomal, secretory and membrane proteins. The ribosome-nascent 
chain:SRP complex is targeted to the ER (green arrow) by the interaction of SRP and SR (green). 
At the ER translation resumes (small red box and blow up). Consequently, proteins are 
transported into the Golgi apparatus (magenta arrow) and maturated inside (blue arrows). Finally, 
proteins are sorted for lysosomes, secretion or membrane protein localisation. 
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with the site of protein synthesis between the ribosomal subunits. The matching size 
(250 Å (Halic et al., 2004)) and elongated shape of SRP (Halic et al., 2004) allows 
communicating between the site of protein synthesis and the ribosomal polypeptide 
exit site (Fig. 4A) which are located 100 Å apart (Beckmann et al., 2001). 
The RNC is targeted in eukaryotes to the ER (in prokaryotes to the plasma 
membrane) by a GTP-dependent process, in which SRP interacts with its cognate 
receptor (SR) enabling the formation of the docking complex (Fig. 3, see below) (for 
review, see (Halic and Beckmann, 2005; Keenan et al., 2001; Luirink and Sinning, 
2004)). In eukaryotes, the SR is a hetero-dimer consisting of SRα and SRβ (Tajima 
et al., 1986)). The nascent chain is transferred to the Sec61 translocon, the 
elongation arrest is released and SR and SRP dissociate (Fig. 3). In Fig. 4B a cryo 
electron microscopy (cryo-EM) structure is shown of the ribosome in complex with 
the translocon. After dissociation from SR, SRP is available for a new round of 
targeting. The exact sequence of events during nascent chain transfer is poorly 
understood.  
In principle, SRP cycles in eukaryotic and prokaryotic cells share the 
conserved four steps of the SRP cycle as shown in Fig. 3.  
 
 
Figure 3: Overview of the SRP cycle (modified from (Luirink and Sinning, 2004)). SRP samples 
the nascent chain for signal peptides, binds to the ribosome and promotes an elongation arrest 
indicated by ‘Stop’ (1.). Binding of the RNC to the ER is arranged by the GTP-dependent 
interaction of SR and SRP (2.). Successively, the ribosome is transferred to the translocon, the 
elongation arrest is released and translation resumes (3.). Finally, SRP and SR dissociate under 
GTP hydrolysis (4.). 
Introduction 
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1.3 The Signal Recognition Particle (SRP) 
Eukaryotic SRP is a ribonucleoprotein consisting of six proteins (SRP9, 14, 19, 54, 
68, 72, called according to their molecular weight) and a scaffolding 7SL RNA (Fig. 5) 
consisting of 300 nucleotides. The RNA is organised in two domains: The Alu domain 
is named according to the homologous Alu domains of small repetitive sequences 
and the small cytoplasmic Alu RNAs (Chang et al., 1996; Weiner, 1980) with a 
conserved three way junction of stems (Andersen et al., 2006; Strub et al., 1991). 
The 150 bp S domain appears as an insertion in the Alu domain sequence 
(Gundelfinger et al., 1983).  
Figure 4 The signal recognition particle interacting with the elongation arrested ribosome and the 
ribosome in complex with the Sec61 translocon (modified from (Halic and Beckmann, 2005)). A
The SRP is highlighted in red, the 40S subunit of the ribosome in yellow, the 60S subunit in blue, 
tRNA in green. B Colour code as in A but the translocon is indicated in red. 
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The Alu domain is complexed to SRP9 and 14 and initiates the elongation 
arrest by binding in between the ribosomal subunits (Fig. 4A) (Halic et al., 2004). The 
elongation arrest is not required for cotranslational translocation (Siegel and Walter, 
1985). The S domain binds to the remaining four SRP proteins (SRP19, 54, 68, 72; 
reviewed in (Halic and Beckmann, 2005; Keenan et al., 2001; Luirink and Sinning, 
2004; Wild et al., 2004)) (Fig. 5) including the conserved SRP54 which is important 
for signal peptide and SR binding (see below).  
 In archea, chloroplasts and bacteria, SRP is less complex (Table 1). SRP54 
and its homologues (fifty four homologue, Ffh) represent the conserved core of the 
SRP and fulfil all functions required for cotranslational targeting (RNA-, signal 
sequence- and SR binding). Archeal SRP comprises homologues of SRP54 and 
SRP19, and 7S RNA. Bacterial SRP consists of a 48 kD Ffh (P48) and the 4.5 S 
RNA (reviewed in (Keenan et al., 2001; Luirink and Sinning, 2004).  
 
 
 
 
 
 
 
 
Figure 5 SRP electron density determined from the ribosome:SRP complex. Proteins and RNA 
models are fitted (if available) according to density (modified from (Halic et al., 2004)). SRP68/72 
positions are considered to fill unexplained electron density. RNA is highlighted in red and yellow 
with Alu and S domain labelled. All SRP proteins are indicated as well as the position of the signal 
peptide (green). SRP54 consists of three domains (N, G and M domains). NG and M domains are 
differentiated. 
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Eukaryotes Archea Eubacteria Chloroplast 
 Mammals Yeast    
SRP54 SRP54p SRP54 Ffh (48 kD) cpSRP54 
SRP19 Sec65p SRP19 - - 
SRP72 SRP72p - - - 
Proteins 
belonging to 
S Domain 
SRP68 SRP68p - - - 
SRP14 SRP14p - - - 
Proteins 
belonging to 
Alu Domain 
SRP9 
SRP21p 
(SRP9 
related) 
- - - 
- 
- - - - cpSRP43 
RNA 
7 SL SRP 
RNA 
7 SL SRP 
RNA 
(ScR1) 
7 SL SRP 
RNA 
4.5 S RNA - 
Table 1 Table of SRP proteins and their homologues in the three domains of life and chloroplasts. 
Table adapted from (Schunemann, 2004), archeal SRP reviewed in (Zwieb and Eichler, 2002), for 
yeast SRP see (Brown et al., 1994; Van Nues and Brown, 2004), cpSRP is reviewed in (Schunemann, 
2004). 
 
1.4 The Translocon 
The translocon is an essential component in cotranslational translocation because it 
binds the RNC and allows the translocation of the nascent chain into the ER and 
coordinates the insertion of membrane proteins into the ER membrane (for review 
see (Matlack et al., 1998)).  
The translocon in eukaryotes has been named protein conducting channel 
(PCC), Sec61 complex, Sec61p complex and Sec61αβγ complex, according to its 
subunits. The prokaryotic homologue of the Sec61 complex was termed SecY 
complex or SecYEG, according to its subunits (for more information, see (Corsi and 
Schekman, 1996; Rapoport et al., 1996; Wickner and Leonard, 1996). SecY forms 
the channel pore (Fig. 6) and is homologous to Sec61α in mammals (termed Sec61p 
and Ssh1p in yeast). One of the two smaller subunits associating to the central pore 
is in prokaryotes SecE which is homologous to Sec61γ in mammals and Sss1p in 
yeast. The third subunit in the translocon is in prokaryotes SecG with homology to 
Sec61β in mammals (termed Sbh1p and Sbh2p in yeast). The degree of 
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conservation can be demonstrated by the high degree of sequence identity between 
the Homo sapiens Sec61α and the Methanococcus jannaschii SecY which is 33.8 %.  
Recently, the X-ray structure of the translocation pore from Methanococcus 
jannaschii has been determined (Van den Berg et al., 2004) (Fig. 6). SecY appears 
as a bundle of ten transmembrane helices (TMs) with a cytoplasmic funnel-like cavity 
formed by the loops between the TMs. A front and a back side have been proposed 
for the translocation pore with the two smaller subunits SecE and SecG forming the 
‘back’. SecG contains only one TM and the N-terminus is exposed to the cytosol. The 
third subunit, SecE shows two helices which bind to SecY like a clamp. The N-
terminal helix of SecE anchors to the cytosolic side of the ER membrane, while the 
C-terminal helix is inserted into the membrane.  
The three translocon subunits are involved in co- and posttranslational 
translocation (see below). Recently complementation assays performed with a yeast 
strain deficient in the Sec61α homologue Sec61p have shown that the cytosolic 
loops L6 and L8 of Sec61p play an important role in protein translocation (Cheng et 
al., 2005). Mutations within loop L8 but not L6 influence the Sec61p-ribosome 
interaction. Loop L6 has been found to affect a different step in co-translational 
translocation, possibly the interaction with the SR.  
 
 
 
 
Figure 6 X-ray structure of the hetero-trimeric prokaryotic translocon (SecYEG, PDB accession 
code 1RHZ, (Van den Berg et al., 2004)). The ten helix bundle SecY is coloured in rainbow from 
blue (N terminus) to red (C-terminus) (mammalian homologue: Sec61α). SecE (in mammals 
Sec61γ) is indicated in dark grey and SecG (homologous to Sec61β) in light grey. Loop 6 (L6) and 
8 (L8) are labelled. In the left panel, the translocon is oriented with the upper moiety facing the 
cytosol. In the right panel, the translocon is turned 90° with the cytosolic site towards the observer.  
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1.5 Small GTPases: Structural and Functional Characteristics 
 
GTPases represent molecular switches featuring two functional states. In the active 
state, they bind guanosin-tri-phosphate (GTP) as substrate and catalyse its 
hydrolysis, Consequently, they reach the inactive, gunosin-di-phosphate (GDP) 
bound state (Fig. 7, (Bourne et al., 1990; Vetter and Wittinghofer, 2001)).  
Small GTPases feature a common structural core characterised by the 
Rossmann fold (Rossmann et al., 1974) also known as nucleotide-binding fold with a 
three layer architecture (α/β/α). The central β-sheet spans six anti-parallel β-strands. 
Characteristically, small GTPases contain five conserved consensus elements, 
termed G-elements (G1-G5), which are important for nucleotide binding (Bourne et 
al., 1991; Sprang, 1997; Vetter and Wittinghofer, 2001) (Tables 2, 3; Fig. 8A). The 
loops including the G-elements G2 and G3 change their conformation upon GTP 
hydrolysis, these flexible regions are therefore called switch I and switch II, 
respectively.  
Small Ras-like GTPases are a large group of small GTPases sharing structural 
and functional characteristics with Ras Small Ras-like GTPases comprise a 
conserved structural fold, a characteristically ~30 % sequence identity (Corbett and 
Alber, 2001), a slow intrinsic hydrolysis rate and a relatively high affinity for 
nucleotide (Luirink and Sinning, 2004; Sprang, 1997). The low hydrolysis rate of 
small Ras-like GTPases is increased by GTPase activating proteins (GAPs). 
 
 
 
Figure 7 Schematic overview of the GTPase cycle of small GTPases. GTP hydrolysis of a 
GTPase in the active state is stimulated by a GTPase activating protein (GAP). In this reaction the 
inactive state of the GTPase in the GDP state is generated as well as an inorganic phosphate (Pi). 
The guanine-nucleotide exchange factor (GEF) again facilitates the release of GDP and allows the 
binding of GTP (modified from (Alberts et al., 2002)) 
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Guanyl nucleotide exchange factors (GEFs) facilitate the release of GDP and 
stabilise the nucleotide-free state (Vetter and Wittinghofer, 2001). Binding of GTP is 
favoured by the excess of GTP versus GDP inside the cell. In the SRP system, SRβ 
is the only Ras-like GTPase. 
In contrast to classical small Ras-like GTPases, SRP54, SRα and their 
respective homologues in different species form a special class of small GTPases 
called SRP GTPases  (Bourne et al., 1990). The flagellum protein FlhF shares the 
common fold of SRP GTPase but is dispensible for protein secretion (Zanen et al., 
2004).  
SRP GTPases are characterised by a much lower affinity for nucleotides 
compared to regular Ras-like GTPases (KD = 2 - 80 pM for Ras and Ran, and 2 – 10 
µM for SRP GTPases) (Jagath et al., 1998; Moser et al., 1997) and are stable even 
in the empty form (Rapiejko and Gilmore, 1997). The SR/FtsY and SRP54/Ffh form 
this special subclass of SRP GTPases (see below). 
SRP GTPases differ structurally from classical small Ras-like GTPases by an 
α/β/α insertion (Montoya et al., 1997; Moser et al., 1997) named I box, which is 
located between G2 (Switch I) and G3 (switch II) (Fig. 8B). The I box is proposed to 
function as a build-in GEF (Montoya et al., 1997; Moser et al., 1997). It is suggested 
that SRP GTPases are relatively stable in the empty form (Rapiejko and Gilmore, 
1997). This is also supported by X-ray structures of SRP GTPases and their 
conserved NG domain core in the nucleotide-free state (Freymann et al., 1997; 
Montoya et al., 1997; Montoya et al., 2000; Ramirez et al., 2002; Rosendal et al., 
2003).  
For general reviews on GTPase protein folds and their mechanism, see 
(Sprang, 1997; Vetter and Wittinghofer, 2001). 
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 Consensus 
sequence 
Function 
G1 (P Loop) GxxxxGK(S/T)
 
Contacts α- and β-phosphate, Mg2+ is 
bound via serine/threonine 
G2 (in switch I) Includes one 
conserved T, 
that can be 
replaced by S 
 
Mg2+ coordination in the GTP bound form; 
topology in SRP GTPases is here 
different due to the insertion of the I box 
featuring a αβα-fold. 
G3 (in switch II) DxxG 
 
Mg2+ coordination (for the conserved 
aspartate via an water molecule) and γ-
phosphate binding; includes the catalytic 
residue which is important for positioning 
the nucleophile water for hydrolysis 
(His119 in SRβ); 
G4 (N/T)(K/Q)xD 
 
Nucleotide specificity; the conserved 
aspartate recognises N1 and N2 of the 
guanosin base, altering this aspartate to 
an asparagine changes substrate 
specificity to XTP (Xanthosin-
triphosphate) (for SRβ this was shown by 
(Legate et al., 2000)). 
G5 (closing loop) -  Nucleotide coordination (via backbone 
contact of Ala246 for SRβ)  
Table 2: Consensus elements of GTP binding proteins. The five G elements are shown with their 
consensus sequence (there is no for G5) and the respective sequence in SRβ as well as their function. 
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 G1 G2 G3 
Consensus GxxxxGK(S/T) S/T  DxxG 
SRβ (mouse) 69GLCDSGKT76 90TQTSITDSS98 115DLPGHE120 
SRβ (human) 69GLCDSGKT76 90TQTSITDSC98 115DLPGHE120 
SRβy (SRP102p) 45GPQNSGKT52 66TVVSQEPLS74 87DFPGHV92 
Sar1 (human) 32GLDNAGKT39 53HVPTLHPTS61 75DLGGHE80 
Arf1 (human) 24GLDAAGKT31 45TIPTIGFNV53 67DVGGQD72 
Ras (human) 10GAGGVGKS17 32YDPTIEDSY40 57DTAGQE62 
    
 G4 G5  
Consensus (N/T)(K/Q)xD -  
SRβ (mouse) 178NKQDIA183 245SAK247  
SRβ (human) 178NKQDIA183 245SAK247  
SRβy (SRP102p) 154NKSELF159 227SIN229  
Sar1 (human) 134NKIDRT139 179SVL181  
Arf1 (human) 126NKQDLP131 159CAT161  
Ras (human) 116NKCDLA121 145SAK147  
Table 3 Conservation of GTP binding elements of SRβ and its homologues. Residues conserved all 
through the proteins used here for comparisons are in red, strongly similar residues are in green. The 
residue following the conserved G in G3 represents the residue crucial for positioning the catalytic 
water molecule. Numbers of the first and last residue of each G-element sequence are given. Primary 
sequence alignment was done with ClustalW (Thompson et al., 1994) and corrected according to 
determined structures for G2 and G5 (accession codes: mouse SRβ: 2FH5, yeast SRβ: 1NRJ, yeast 
Sar1: 1M2O chain B (not included in this figure), human Arf1: 1J2J chain A, human Ras: 1CLU). 
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1.6 GTPases in the SRP cycle 
1.6.1 SRP54 
SRP54 is a multi-domain protein comprising an N-terminal (N), a central GTPase (G) 
and a C-terminal methionine-rich (M) domain (Fig. 9). SRP54 covers all features of 
SRP required to function in cotranslational translocation and is the only SRP subunit 
which is conserved in all three kingdoms of life (Table 1). Essential SRP features are 
RNA and signal peptide binding (with the SRP54M domain) and GTP dependent 
binding to the SR (with the SRP54G domain). Unusually, the chloroplast SRP system 
possesses no RNA. Accordingly, chloroplast SRP54 does not contact RNA but it 
binds with its C-terminus the unique SRP43 protein (Groves et al., 2001). In general, 
the SRP54M domain (22 kD) samples and binds nascent chains emerging from the 
ribosome for signal peptides in order to select proteins for cotranslational 
translocation (Lutcke et al., 1992; Romisch et al., 1990; Zopf et al., 1990).  
The NG domains (35 kD) represent the catalytic core of SRP54 (and SRα, see 
below) and are therefore often noted together as NG domain. The N-terminal N 
domain forms a four-helix bundle and packs tightly against the G domain which is the 
 
Figure 8 The GTP binding pocket in three dimensions taken from human Ras and superimposed 
with FtsY from E.coli . Ras (PDB accession code 121P (Krengel, 1991)) is in cartoon 
representation, coloured in magenta. A Conserved G-elements are highlighted in yellow and 
labelled, a non-hydrolysable GTP analogue is in sticks and Mg2+ is shown as cyan sphere. B I Box 
as a characteristical feature of GTPses. Ras with the colour code, magnification and view point as 
in A, superimposed with FtsY from E. coli (PDB accession code 1FTS (Montoya et al., 1997)). 
FtsY is in grey and it’s I box in blue.  
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GTPase domain of the SRP. The C-terminal M domain has been structurally 
determined and includes a hydrophobic groove responsible for signal peptide binding 
(Clemons et al., 1999; Keenan et al., 1998).  
The M domain of SRP54 has also been determined in atomic detail either in 
complex with RNA (Batey et al., 2000), bound to the S domain and SRP19 
(Kuglstatter et al., 2002), and in context with the NG domain with and without RNA 
(Rosendal et al., 2003). 
 
 
 
 
Figure 9 Structure of SRP54 and SRP54 domain architecture. Colour codes for the domains in A 
and B correspond. A: In this structure of Sulfolobus solfataricus SRP54 (Rosendal et al., 2003) not 
only N and G but also a major part of the C-terminal M domain is present. B: Domain architecture 
comparison of full length SRP54 from Homo sapiens and Sulfolobus solfataricus. Domain sizes 
are drawn to scale. 
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1.6.2 The Signal Recognition Particle Receptor 
In eukaryotes, the signal recognition particle receptor is a heterodimer consisting of 
the two subunits SRα (70 kD) and SRβ (30 kD) (Tajima et al., 1986).  
SRα consists of the N-terminal A domain, the central N and the C-terminal G 
domain (Fig. 10). The GTPases SRα and SRβ differ in their GTPase characteristics. 
SRβ is more related to the ‘classical’ small GTPases. In contrast, SRα and SRP54 
form the special subclass of SRP GTPases (see below). It was found that the N-
terminal 176 amino acids of human SRα (SRX2) include the minimal domain required 
for SRβ binding (Fig. 10) (Young et al., 1995). From proteinase K digestion of human 
SRα translated in vitro in rough reticulocyte lysate, it was estimated that the minimal 
SRβ binding domain of SRα would comprise approximately 140 amino acids (Young 
et al., 1995). During this work, the minimal domain required for SRβ binding was 
defined in yeast and termed SRX domain (Schwartz and Blobel, 2003).  
SRX has been described as effector for SRβ and only binds to the GTP-bound 
form of the GTPase (Legate et al., 2000). The SRX domain belongs to the SNARE-
like superfamily including the N-terminal domains of non-syntaxin SNAREs, also 
known as longin domains (Filippini et al., 2001). Longin domains have been 
proposed to regulate a variety of membrane trafficking processes (Rossi et al., 2004). 
Members of this superfamily with known 3D structures include the SNAREs Sec22b 
(Gonzalez et al., 2001) and Ykt6 (Tochio et al., 2001), the component SEDL of the 
transport protein particle (TRAPP) (Jang et al., 2002), and the clathrin adaptor 
proteins AP-σ and AP-Nµ (Collins et al., 2002; Heldwein et al., 2004). 
SRβ is a classical small Ras-GTPase most similar to Arf (ADP-ribosylation 
factor) and Sar1 (Secretion-associated and Ras-related 1) with an accordingly low KD 
of ~30 nM for GTP (Bacher et al., 1999; Miller et al., 1995). Phylogenetically, SRβ 
together with Arf and Sar1 separated from other small Ras-GTPases already in the 
earliest branching event indicating the functional importance of an ancestral SRβ in 
eukaryotic evolution (Jekely, 2003). A special feature of SRβ is its predicted 
membrane spanning helix, which is dispensable for SR function (Ogg et al., 1998). In 
comparison, proteins of the Arf and Sar1 family have an extra N-terminal helix that is 
preceded by an N-terminal hydrophobic patch in Sar1 (Huang et al., 2001) and 
becomes myristoylated in Arf (Chavrier and Goud, 1999). The GTPases are 
anchored in the GTP-bound state to their target membrane.  
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The functional homologues of the mammalian SRα subunit are in yeast 
SRP101p (Ogg et al., 1998) and in prokaryotes FtsY (Bernstein et al., 1989; Luirink 
et al., 1994; Miller et al., 1994). The protein homologous to SRβ in yeast is named 
SRP102p (Ogg et al., 1998), in prokaryotes there is no such homologue (Luirink and 
Sinning, 2004). Accordingly, FtsY is N-terminally shorter when compared to SRα (Gill 
et al., 1986) and does consequently not contain a domain homologous to the SRβ 
binding domain (Young et al., 1995). In prokaryots, FtsY binds directly to the 
cytoplasmic membrane (Luirink et al., 1994) due to an affinity to phospholipids (de 
Leeuw et al., 2000; Millman et al., 2001). The lack of SRβ in prokaryotic cells may be 
explained by the fact that SRP is not required to be targeted to a specific organelle 
such as the ER in eukaryotes. In prokaryotes, unspecific membrane affinity (Millman 
et al., 2001) and the ability to bind directly to the prokaryotic translocon (Angelini et 
al., 2005) allow FtsY to be functional in cotranslational translocation. SRβ and the 
SRX domain of SRα can be regarded as molecular adaptions of the SRP system to 
the complex eukaryotic endomembrane system.  
 
Figure 10 Domain architecture of the two subunits of the mammalian SRP receptor. SRα
comprises three domains: the acidic N-terminal A-domain, the central N-domain and the C-
terminal G-domain which includes the GTPase fold. It was found that an N-terminal fragment of 
SRα consisting of 176 amino acids (SRX2) contains the minimal SRβ binding domain which was 
assumed to contain approximately the N-terminal 140 amino acids of SRα (Young et al., 1995). 
The minimal SRβ binding domain of SRα was later named X-domain (Schwartz and Blobel, 2003). 
Numbers shown for SRα are the first amino acid and the last amino acids of each domain. For 
SRβ, numbers of the first and last amino acids as well as the first amino acid of the GTPase 
domain are given.  
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1.7 GTPases Regulate the SRP Cycle 
In eukaryotic cells, three small GTPases are involved in the regulation of the SRP 
cycle: the SRP GTPases SRP54 and SRα, and the small Ras-like GTPase SRβ. 
SRα and SRβ form the SR. 
 In the first step SRP binds to the ribosome. SRP54 scans the nascent chain 
emerging from the ribosomal exit tunnel for the signal peptide (Fig. 11). Once a 
nascent chain is bound to SRP54, the affinity of SRP54 for GTP is increased (Bacher 
et al., 1996). The RNC acts as a nucleotide loading factor for SRP54. GTP affinity for 
SRP54 is also increased by the SR and GTP hydrolysis in SRP54 is inhibited by 
signal peptide binding (Miller et al., 1993). The concomitant elongation arrest is 
mediated by the Alu domain of the SRP (Siegel and Walter, 1986).  
In the second step the SRP:SR complex is formed. SRP54 is the SRP protein 
targeting the SRP:RNC complex to the ER membrane (Bacher et al., 1996) due to its 
interaction with the SR in a GTP dependent manner (Connolly and Gilmore, 1993). It 
was shown that the functional GTP binding site in SRα is crucial for protein 
translocation across the ER membrane (Rapiejko and Gilmore, 1992). Insights in the 
SRP:SR docking state were recently shown by the determination of the X-ray 
structures of the FtsY and Ffh NG domains from Thermus aquaticus  (Egea et al., 
2004; Focia et al., 2004) (Fig. 12) and Sulfolobus solfataricus (Sinning group, 
unpublished results). Due to the high degree of homology these structures can serve 
as general models of the SRP:SR interaction. The complexes were formed in 
presence of a non-hydrolysable GTP analogue. Two of these substrate molecules 
contribute to the interface in a uniquely twinned manner with each ribose contacting 
the γ-phosphate of the other substrate (Fig. 13). The SR:SRP54 complex is formed 
by cooperative binding of GTP. Dissociation requires mutual GTP hydrolysis 
(Rapiejko and Gilmore, 1997) following molecular mechanisms that are not yet 
understood.  
SRβ is suggested to co-ordinate the presence of the RNC:SRP:SR complex 
with the proximity of the translocon (Fulga et al., 2001) which is crucial for the third 
step in the cycle, the transfer of the signal peptide from SRP to the translocon.  
 SRβ alone does not hydrolyse GTP (Legate and Andrews, 2003; Mandon et 
al., 2003). It is also not activated in complex with either SRα or SRX (Bacher et al., 
1999). Like for other small Ras-GTPases, a GTPase-activating protein (GAP) and a 
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guanine nucleotide exchange factor (GEF) are necessary to drive the GTPase cycle 
(Bourne et al., 1990; Vetter and Wittinghofer, 2001).  
 
 
RNCs interact with SRβ in its GTP-bound state (Bacher et al., 1999). GTP 
binding to SRβ is stimulated by the translocon and is suggested to be required to 
release the nascent chain from the SRP-SR complex (Fulga et al., 2001). The GAP 
function for trypsin-digested SR heterodimers that retain SRβ and the N-terminal 
fragment of SRα (including SRX) has been attributed to the RNC complex (Bacher et 
al., 1999). In contrast, GAP function of the RNC for the isolated SRβ could not be 
found (Legate and Andrews, 2003; Mandon et al., 2003).  
In the yeast system, the GEF activity for SRβ has been assigned to the two 
orthologues (Sbh1p, Sbh2p) of the Sec61β subunit of the translocon (Helmers et al., 
2003) and point mutations in the cytoplasmic loops of the yeast translocon severely 
affect the co-translational translocation pathway (Cheng et al., 2005). However, the 
molecular details for the initiation of GTP hydrolysis and the subsequent GDP release 
from SRβ remain so far unclear. 
Figure 11 Schematic drawing of the SRP cycle connected with a GTPase cycle (modified from 
(Luirink and Sinning, 2004)). The nucleotide-free state is indicated by an “O”, the GTP-loaded 
state by an asterisk and a question mark denotes when the nucleotide-loading state is unclear. 
The three GTPases are denoted, the ribosome is in yellow (40S subunit) and light grey (60S 
subunit), the signal peptide in green and the translocon in dark gray. 1. SRP binds to the ribosome 
allowing SRP54 to bind the signal peptide and causes the elongation arrest (highlighted with 
“STOP”). In the presence of the ribosome SRP54 is loaded with GTP. The RNC is formed. 2. The 
RNC:SRP complex and the SR facilitate mutual GTP binding and in the proximity of the 
translocon. 3. Once all three GTPases are complexed to GTP, the RNC is transferred to the 
translocon. 4. Nucleotide hydrolysis in SRα and SRP54 resolves the SRP:SR interaction and the 
elongation resumes. Still, it is not known whether after these four steps SRβ hydrolyses GTP 
leading possibly to the dissociation of the SR. 
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 All three GTPases involved in the SRP cycle have to be in the active GTP 
state to allow the transfer of the signal peptide (Fulga et al., 2001) (Fig. 11). Release 
of the signal peptide might enable the inhibited SRP54. SRP54 and SR act as mutual 
GAPs. GTP hydrolysis in both SRP GTPases leads to the dissociation of the SRP:SR 
complex (Connolly et al., 1991; Rapiejko and Gilmore, 1997)  in the fourth step of the 
SRP cycle (Fig. 11). GDP can easily dissociate from SRP54 and SRα due to the low 
nucleotide affinity for SRP GTPases, and also relatively stable nucleotide-free forms 
of SRα and SRP54 can occur (Rapiejko and Gilmore, 1997). Finally, SRP is available 
for another round of targeting. For reviews see (Keenan et al., 2001; Luirink and 
Sinning, 2004; Wild et al., 2004). 
It is not known whether GTP hydrolysis of SRβ occurs in each SRP cycle.  
 
 
 
 
 
 
Figure 12 X-ray structure of the Thermus aquaticus FtsY Ffh NG NG complex (PDB accession 
code 1OKK). NG domains are in cartoon representation, the non-hydrolysable GTP analogue 
GMPPCP is in sticks, Mg2+ is depicted as magenta spheres. 
 
Figure 13 Close-up of the nucleotides in the FtsY Ffh NG NG complex. P loops (cartoon 
representation), Mg2+ (magenta spheres) and nucleotides (sticks). The ribose of each nucleotide 
is interacting with the γ-phosphate (γ-P) of the other substrate. 
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1.8 Aim of this Work 
In the SRP cycle the roles of the two SRP GTPases SRP54 and SRα, and their 
respective homologues from other species, are rather well characterised. The 
intimate contact of the two NG domains allows the formation of the SRP:SR complex 
at the membrane. In eukaryotes, a third GTPase is present with SRβ which is poorly 
understood. It was suggested that the translocon acts as a GEF for SRβ and that the 
RNC might act as a GAP for SRβ. Molecular details of the GTPase cycle of SRβ were 
however not known. Therefore, this work focuses on the structural and functional 
analysis of SRβ in the context of the SRP:SR complex.  
 
In particular, these were the aims: 
 
− Understanding the role of SRβ in the SRP cycle by X-ray structure 
determination of relevant subcomplexes of SRα:β. 
 
− Investigating the SRP:SR interaction by complex formation studies of a 
trimeric complex composed of SRα:βΔTM and SRP54, and a pentameric 
complex consisting of SRα:βΔTM, SRP54, SRP19 and RNA104. 
 
− Characterisation of the SR-translocon interactions.  
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2 Results 
2.1 Expression and Purification of SR and SRP proteins 
Proteins of the mammalian SRP system were cloned, expressed and purified in order 
to understand molecular mechanisms of the interaction of SRP with its receptor and 
the interaction of SRβ with external regulators using mainly X-ray crystallography. Of 
particular interest were functionally relevant interfaces of SRβ which anchors SRα to 
the ER membrane and was suggested to interact with the translocon. The second 
focus was the interface between SRα and SRP54 which allows the binding of the 
RNC:SRP complex to the SR. In order to examine the conformational arrangements 
of SRP when bound to its receptor, a complex of the SR and SRP54 was 
reconstituted (SRαHis:βΔTM:SRP54DHis) and SRP RNA and SRP19 were added to 
bind to the SRP54 subunit forming a pentameric complex 
(SRαHis:βΔTM:SRP54DHis:SRP19:RNA104) from purified components.  
The schematic overview from Figure 14 is introduced in order to highlight SRP 
proteins presented in this chapter in context with their binding partners. The scheme 
will be shown in the beginning of each subsection to highlight the proteins of interest.  
 
 
Figure 14 Schematic overview of the SR:SRP complex in the GTP bound state at the ER 
membrane. RNA is indicated by a thick black line connecting the SRP proteins and separated into 
Alu- and S domains by a dashed line. Proteins which were included in this work are highlighted in 
magenta (SRβ), green (SRP19), orange-red (SRα), blue (SRP54) containing the names of their 
respective domains. The image is adapted from (Wild et al., 2004b). 
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2.1.1 SRαHis:βΔTM 
The mammalian SRP receptor is a heterodimeric 
complex consisting of the two GTPases SRα and 
SRβ (Tajima et al., 1986). The SR lacking the 
transmembrane region (SRα:βΔTM) complex has been shown to be functional in vitro 
(Abell et al., 2004; Fulga et al., 2001; Ogg et al., 1998).   
The SR subunits were co-expressed from a bicistronic plasmid generating a 
stable complex (SRαHis:βΔTM) (Fulga, 2001). The preparation involves four 
purification steps and is based on (Fulga, 2001). Firstly, the N-terminal hexa-His tag 
of SRα  in the SRαHis:βΔTM complex was used for Ni2+-affinity purification. 
Secondly, anion exchange chromatography is applied. Here, the pH is 
adjusted in a way that SRαHis:βΔTM is positively charged and does not bind. The 
protein is therefore found in the flow-through. Minor contaminations and DNA are 
removed from the sample. Subsequently, in cation exchange chromatography the 
protein is bound to the resin, contaminations and minor amounts of SRαHis:βΔTM are 
found in the flow-through.  
Finally, the protein is purified via size-exclusion chromatography (Superdex 
200 (26/60)) and appears as a single peak at elution volume (VE) 155 ml with a 
calculated molecular mass of ~ 200 kD (Fig. 15). This molecular weight correlates to 
approximately the double molecular mass of SRαHis:βΔTM and may be explained by 
an elongated shape caused by the polypeptide linking the SRX and NG domains 
since both subdomains do not show an elution volume correlating to a 
disproportionately high molecular weight (see below). 
By sedimentation equilibrium centrifugation it has been shown before that 
SRαHis:βΔTM appears as a ‘monomer’ (Fulga, 2001). Equilibrium centrifugation 
experiments performed by Karsten Rippe and Jacek Mazurkiewicz (Kirchhoff Institut 
für Physik, Heidelberg) supported this result but experiment could not be evaluated 
accurately because the protein aggregated partially during the equilibrium ultra-
centrifugation run. Static light scattering experiments showed a molecular weight 
slightly elevated from the ‘monomeric’ complex, verifying its ‘monomeric’ state (not 
shown). 
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2.1.2 SRX2His:βΔTM 
The SRX2His:βΔTM construct contains SRβΔTM and the 
N-terminal 176 amino acids of SRα including the 
minimal SRβ-binding domain (Young et al., 1995) 
(SRX) with an N-terminal hexa-His tag. 
The heterodimeric complex was expressed and purified based on the method 
used for SRαHis:βΔTM. Buffers were adjusted from previously published recipes 
(Fulga, 2001) in order to optimise the purification. The protein after Ni2+-affinity 
purification is shown in Fig. 16 and appears to be in a pure and ‘monomeric’ state 
after size exclusion chromatography (Fig. 17). SRX2His:βΔTM elutes at 146 ml from a 
Superdex 75 (26/60) column. The ‘monomeric’ state was also verified by analytical 
ultra-centrifugation experiments performed by Karsten Rippe and Jacek 
Mazurkiewicz (Kirchhoff Institut für Physik, Heidelberg (see below). The protein 
showed a slight tendency to form dimers (KD = 270 µM).  
 
Figure 15 SRαHis:βΔTM after size exclusion chromatography. SRαHis:βΔTM and SRβΔTM are 
labelled. Fractions analysed by SDS-PAGE and stained with Coomassie Brilliant Blue are labelled 
(10, 11, 12, 14, 16, 19). 
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2.1.3 Seleno-L-Methionine Substituted SRX2His:βΔTM 
 
Seleno-L-methionine substituted protein was expressed 
for crystallisation and the determination of phase 
information by a successive SAD experiment. 
Additional phase information was required in order to 
improve the model achieved from the Srax3-2 data set 
(see below). The protein expressed and purified as described here led to crystals 
subjected to a SAD experiment at beamline ID 14-4 (ESRF, Grenoble). Phase 
information obtained from this experiment was not included in the bootstrapping 
 
Figure 16: SRX2His:βΔTM after Ni2+ affinity purification. SRX2His and SRβΔTM are labelled. Load 
and protein from the eluted peak were analysed by SDS-PAGE followed by staining with Coomassie 
Brilliant Blue. 
 
Figure 17: Size exclusion chromatography purification of SRX2His:βΔTM (Superdex 75 (26/60). The 
elution volume is given. SRX2 and SRβΔTM are labelled. Protein from the eluted peak (left panel) 
was analysed by SDS-PAGE with successive Coomassie Brilliant Blue staining.  
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process for the final model due to the low phasing power of the seleno-L-methionine 
substituted crystals. 
Expression of seleno-L-methionine substituted SRX2His:βΔTM was performed 
in methionine auxotroph cells and in a medium including all amino acids but not 
methionine which was replaced by seleno-L-methionine. Otherwise, conditions of 
expression and purification were kept as described for SRX2His:βΔTM (see above). 
The course of purification is illustrated in Fig. 18.  
 
 
 
2.1.4 SRαNGHis (SRαNΔ314-NHis) 
In order to understand the function of the catalytic 
core of SRα its C-terminally located NG domain 
(residues 315 to 638) was cloned and expressed for 
crystallisation. It was assumed that the NG domain 
would be a rigid protein suitable for crystallisation since homologues prokaryotic and 
archeal NG domains have been crystallised before (Egea et al., 2004; Focia et al., 
Figure 18: Purification of seleno-L-methionine substituted SRX2:SRβΔTM. Protein samples from 
the purification steps were analysed by SDS-PAGE followed by staining with Coomassie Brilliant 
Blue. SRX2His and SRβΔTM are labelled. A Ni2+ affinity purification of SRX2His:βΔTMSeMet. B Cation 
exchange chromatography of SRX2His:βΔTMSeMet. SRX2His:βΔTMSeMet does not bind; eluted 
impurities are shown in the right lane. C Anion exchange chromatography of SRX2His:βΔTMSeMet. 
Contaminations do not bind, eluted SRX2His:βΔTMSeMet is shown in the lanes right to the molecular 
weight marker. D Size exclusion chromatography (Superdex 75 (26/60)) of SRX2His:βΔTMSeMet.  
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2004; Freymann et al., 1997; Montoya et al., 1997; Montoya et al., 1999; 
Padmanabhan and Freymann, 2001; Ramirez et al., 2002).  
Cloning of SRαNGHis into pET16b resulted in a construct that could be easily 
expressed. Test-expressions are summarised in Table 4 and Fig. 19 shows the Ni2+-
affinity tag purified protein. The purified protein easily precipitated. Protein 
precipitation could be prevented for more than 24 h by using protein concentrations 
below 2 mg/ml and including minimal 10% of glycerol into the buffer. The protein 
seemed to precipitate less at room temperature than at 4°C. Presumably, the 
conformation of SRαNGHis needs to be stabilised by a part of SRα not included in the 
construct.  
N-terminal extension of SRαNG might stabilise the protein. Constructs which 
could be considered are the SRα degradation fragment described by Claudio Moser 
(SRαΔ285) (Moser, 1998) or the SRα elastase fragment (Andrews et al., 1989; 
Young et al., 1995) which was also characterised by Claudio Moser (Moser, 1998). 
These constructs were not examined in this work. 
 
 
 
Cells used for expression Remarks 
BL21 (DE3) Expression works, gives not most but purest 
protein after Ni2+-affinity purification 
Rosetta (DE3) Weak expression 
BL21 (DE3) pLysS Weak expression 
C43 (DE3) Protein seems to degrade mainly to a 28.9 kD 
species  
Rosetta (DE3) pLysS Highest expression rate, more impurities after 
Ni2+-affinity purification compared to BL21 (DE3) 
expressed protein  
Table 4: Test-expression results of SRαNGHis expressed ON at 16°C, induced with 0.5 mM 
IPTG and purified by Ni2+-affinity chromatography. 
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2.1.5 SRβΔTMHis 
SRβΔTMHis was expressed in order to analyse the 
interaction of the mammalian SR with cytosolic loops of 
the human translocon by an immobilised peptide library 
scan. Expression and purification were reproduced according the procedure 
described in (Fulga, 2001). Protein bound to the Ni2+- saturated Fast Flow chelating 
resin was eluted in two steps (100 and 300mM imidazole). This led to two SRβΔTMHis 
fractions, a nucleotide-free (300mM imidazole) and a mostly GTP containing fraction 
(100 mM imidazole) as observed before (Fulga, 2001). The nucleotide-free fraction is 
called here SRβHis-apo. The purity of the protein after size exclusion chromatography 
is shown in Fig. 20. 
  
 
Figure 19 Ni2+-affinity purification of SRαNGHis. Protein fractions are analysed by SDS-PAGE 
and subjected to Coomassie Brilliant Blue staining. Fractions of the Ni2+-affinity purification are 
labelled (FT: flow through). 
 
Figure 20 SRβΔTM purified by Ni2+-affinity and size exclusion chromatography. The protein 
shown here was first purified via Ni2+-affinity chromatography and then subjected to size exclusion 
chromatography using a Superdex 200 (10/30) column. SRβΔTM eluted at VE = 16.7 ml. The peak 
fraction was analysed by SDS-PAGE with successive Coomassie Brilliant Blue staining. 
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2.1.6 SRP54DHis (SRP54CtermΔ68-His) 
SRP54 and its archeal and prokaryotic homologues 
represent the conserved core of the SRP including the 
catalytic NG domain and the C-terminal M-domain 
which binds signal sequences (High and Dobberstein, 
1991; Zopf et al., 1990) and SRP RNA (Romisch et al., 1990). SRP54 interacts with 
the SR (Connolly and Gilmore, 1993) and a functional GTP binding site in SRα is 
crucial for protein translocation across the ER membrane (Rapiejko and Gilmore, 
1992). SRP54 and SRα allow the GTP dependent formation of the docking complex 
including the RNC and the SR at the ER membrane.  
In order to understand the GTPase function of SRP54 alone or in complex with 
interacting proteins, SRP54 constructs with a hexa-His tag were cloned, expressed 
and purified containing the NG domain and 140 of the 208 residues of the C-terminal 
M-domain (SRP54DHis). SRP54D with a C-terminal hexa-His tag was named 
accordingly SRP54DCHis and with a N-terminal hexa-His SRP54DNHis. The C-terminus 
of the M-domain was defined according to the X-ray structure of the E. coli 
RNA:SRP54M domain complex and the respective sequence alignment of SRP54M 
domains from Doudna and co-workers (Batey et al., 2000). The C-terminal truncation 
was aimed to express a SRP54 construct with a rigid C-terminus suitable for 
crystallisation. 
 
 
 
 
 
 
 
Cells used for expression Remarks 
BL21 (DE3) pLysS Weak over-expression 
Rosetta (DE3) pLysS Over-expression level significantly higher than in 
BL21 (DE3), but weaker than in C43 (DE3) 
C43 (DE3) Best over-expression, used for all further 
expressions 
Table 5 Results from SRP54 test expression experiments.  
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SRP54DHis was routinely expressed in C43 (DE3) cells (Table 5, Fig. 21). The 
protein was purified using Ni2+-affinity chromatography (Fig. 21). Size-exclusion 
chromatography using Superdex 75 (16/60) (Fig. 22) revealed that a part of the 
protein appeared as a dimer (VE (dimer) = 134 ml) with a majority of the protein still in 
monomeric form (VE = 155 ml).  
SRP54DHis and SRP54NGHis (see below) expressed in E. coli showed a 
tendency to form homodimers. Both SRP54 constructs contained the SRP54NG 
domain. A homodimeric interface is likely formed similar to the one existing between 
the SRP54NG domain homologue (Ffh) from Thermus aquaticus and its respective 
SR NG domain homologue (FtsY) (Egea et al., 2004; Focia et al., 2004) and 
Sulfolobus solfataricus (Sinning group, unpublished results).  
After successive complex reconstitution steps with SRαHis:βΔTM and 
SRP19His:RNA104, a ‘monomeric’ macromolecular complex could be obtained. In this 
complex, the SRP54NG surface used for homodimerisation is possibly occupied by 
the NG domain of SRα (Egea et al., 2004; Focia et al., 2004).  
Homodimerisation of hexa-His tagged SRP54D could not be observed using 
protein expressed by Mark Brooks (EMBL Grenoble, Cusack group) in insect cells. 
Possibly, differences caused by the expression system are responsible for this 
behaviour. 
 
 
Figure 21: Ni2+-affinity chromatography of SRP54DNHis over-expressed in C43 
(DE3) cells. Protein fractions are analysed by SDS-PAGE and subjected to 
Coomassie Brilliant Blue staining. Fractions of the purification are labelled (FT: 
flow through). 
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2.1.7 SRP54NGHis (SRP54CtermΔ208) 
In order to examine structure and function of 
the human SRP54 GTPase, a construct of the human 
NG domain of SRP54 (SRP54NG) was cloned, 
expressed and purified. The expressed protein was 
named SRP54NGHis and over-expressed in C43 (DE3) cells (Table 6, Fig. 23).  
 
 
 
 
 
 
Cells used for expression Remarks 
BL21 (DE3) Arg Weak expression 
Rosetta (DE3) Weak expression 
BL21 (DE3) pLysS Expressed, but not as good yield as from C43 
(DE3) or Rosetta (DE3) pLysS expression 
C43 (DE3) Nice expression, protein looks quite pure already 
after Ni2+-affinity purification 
Rosetta (DE3) pLysS Highest expression rate, little more impurities after 
Ni2+-affinity purification compared to C43 (DE3) 
expressed protein  
Table 6: Results from SRP54NGHis test expression experiments.  
Figure 22: Size exclusion chromatography of SRP54DNHis via Superdex 75 (26/60). Elution 
volumes of the two major peaks are labelled (left panel). Protein fractions are analysed by SDS-
PAGE and subjected to Coomassie Brilliant Blue staining (right Panel).  
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After Ni2+-affinity chromatography, SRP54NGHis was subjected to size-exclusion 
chromatography and migrated as a symmetric peak (VE = 170 ml on a Superdex 200 
(26/60)), corresponding to the calculated molecular mass of a monomer, and a 
protein species with an elution volume of 136 ml, corresponding to the molecular 
mass of a dimer, when using a buffer with 5% glycerol and 350 mM NaCl (Fig. 24).  
In high salt buffer lacking glycerol (600 mM NaCl), the monomer peak appears 
to be not homogeneous. A third protein species within the monomer peak can be 
seen (VE = 160 ml). In order to examine whether the inhomogeneity in the monomeric 
protein peak might be caused by different nucleotide loading states, the SRP54NGHis 
was incubated ON at RT with 2 mM GDP or 1 mM EDTA supplemented buffer. The 
addition of GDP was intended to highlight the nucleotide loaded subfraction of the 
protein. In contrast, EDTA as a chelating agent for divalent cations removes Mg2+ 
from the GTP-binding site reducing concomitantly the nucleotide affinity of the 
GTPase. Therefore, EDTA was used often for nucleotide exchange experiments of 
small Ras-like GTPases such as SRβ (Legate and Andrews, 2003) and Rab3A 
(Burstein and Macara, 1992).  
Both monomeric protein species (VE = 160 ml and VE = 170 ml) were present 
after the incubation of SRP54NGHis with GDP but the species at 170 ml was more 
prominent (Fig. 25). In contrast, in the presence of 1mM EDTA SRP54NGHis, most of 
the protein precipitated over night, implying that the removal of Mg2+, and likely the 
bound nucleotide, from the active site led to a conformational destabilisation of 
SRP54NGHis. Analysis of the remaining soluble protein by size exclusion 
chromatography (Superdex 200 (26/60)) revealed the presence of only one protein 
 
Figure 23 Ni2+ affinity chromatography of SRP54NGCHis expressed in C43 (DE3) cells. Protein 
fractions are analysed by SDS-PAGE and subjected to Coomassie Brilliant Blue staining. 
Pellet from the ultra-centrifugation and the respective supernatant (Sup.), which was loaded 
on the column, flow through (FT) as well as wash and elution fractions are shown. 
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species which eluted at 160 ml, indicating that this might reflect SRP54NGHis in a 
nucleotide-free state.  
The data suggest that the difference in nucleotide load is correlated to different 
protein conformations detected by size exclusion chromatography. This idea is 
supported by the fact that size exclusion chromatography separates proteins 
according to their Stokes radii which are dependent on the molecular weight and the 
shape of the protein. The observation of different nucleotide loading states is 
supported by measurements of the ratio of 260 nm / 280 nm absorptions. The 
coefficient increased over the inhomogeneous monomer peak from 0.65 to 0.98. This 
correlates to a six fold increase in nucleic acid contents from 0.5% to 3.0% 
(http://www.bio.com/protocolstools/protocol.jhtml?id=p136) (Layne, 1957). In 
summary, these results suggest that the apo- and nucleotide loaded forms of 
SRP54NGHis occur in different conformations that can be partially separated by size 
exclusion chromatography. 
 The precipitation of SRP54NGHis was unexpected since SRP GTPases are 
relatively stable in the nucleotide-free form (Moser et al., 1997; Rapiejko and 
Gilmore, 1997; te Kaat, 1999) supported by X-ray structures of SRP GTPases or their 
conserved NG domain core in the nucleotide-free state (Freymann et al., 1997; 
Montoya et al., 1997; Montoya et al., 2000; Ramirez et al., 2002; Rosendal et al., 
2003). Future experiments have to elucidate these possibly species dependent 
differences in stability.   
 
Figure 24 Size exclusion chromatography of SRP54NGHis (Superdex 200 (26/60)) in a buffer 
containing 350 mM NaCl and 5% glycerol. The dimer peak occurs at 136 ml, the monomer peak at 
170 ml. Samples from the size-exclusion chromatography were analysed by SDS-PAGE and 
subjected to Coomassie Brilliant Blue staining. 
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2.2 Reconstitution of Different SR:SRP Complexes 
In order to establish the basis for the structural characterisation of the SR in complex 
with the complete SRP S domain, in vitro reconstitution and crystallisation trials of 
SR:SRP S domain subcomplexes were carried out. In vitro reconstitution of SR:SRP 
complexes was set up as a tool for the functional analysis of each SR and SRP 
component in the assembly process.  
In particular, the following complexes were reconstituted:  
(I) Trimeric complex of SRα (or the SRα(R524Q) mutant), SRβΔTM and 
SRP54D (SRαHis:βΔTM:SRP54DHis and SRαHis(R524Q):βΔTM:SRP54DHis 
respectively).  
(II) Pentameric complex of SRα, SRβΔTM, SRP54D, SRP19 and SRP RNA104 
(SRαHis:βΔTM:SRP54DHis:SRP19His:RNA104).   
2.2.1 Reconstitution of Trimeric SR:SRP Complexes 
The SRαHis:βΔTM:SRP54DHis Complex 
The trimeric SRαHis:βΔTM:SRP54DHis complex was reconstituted with the three 
proteins in the stoichiometry 1:1:1. SRP54DHis was incubated with SRαHis:βΔTM for 
one hour at 37°C in the presence of GMPPNP. The high incubation temperature was 
required for efficient reconstitution and made it possible to achieve the complex 
within a short time. A disadvantage of the high temperature was partial aggregation 
     
Figure 25 Size exclusion chromatography analysis of SRP54NGHis in the presence of nucleotide or 
a chelating reagent. Samples are loaded on a Superdex 200 (26/60) column. SRP54NGHis was 
incubated ON at RT in the presence of 2 mM GDP (left panel) and incubated ON at RT in the 
presence of 1 mM EDTA (right panel). It is important to note that protein at a much lower 
concentration was analysed in the right panel.  
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of the protein. The SRαHis:βΔTM:SRP54DHis complex could be isolated from the 
reconstitution setup using size exclusion chromatography (Fig. 26).  
  
 
Trimeric Complex Isolation by SRP54NGCHis pull-
down 
Purification of the SRαHis:βΔTM:SRP54NGHis complex 
using size exclusion chromatography includes the 
difficulty that SRαHis:βΔTM and the trimeric complex co-
purify in the same fractions due to similar molecular 
weight (94.5 kD and 128 kD, respectively). This difficulty could be overcome by 
setting up a complex reconstitution reaction with SRP54NG and SRα:βΔTM where 
only SRP54NG included a tag (SRP54NGCHis). SRα:βΔTM was pre-purified via cation 
exchange chromatography. After the complex reconstitution setup, the trimeric 
complex (SRα:βΔTM:54NGCHis) and unbound SRP54NGCHis were isolated by Ni2+-
affinity chromatography (Fig. 27). Free SRα:βΔTM could be found in the flow-
through. An excess of SRP54NGCHis could easily be separated from the trimeric 
complex by size exclusion chromatography (Fig. 28) because of its significantly lower 
molecular mass of 33 kD compared to the 128 kD for SRα:βΔTM:54NGCHis.   
 Since the complex reconstitution step did not require 37°C, possibly the 
54NGCHis homodimer is less stable than the SRP54DHis homodimer. This method 
overcomes the problem that SRαHis:βΔTM can not be separated by size exclusion 
chromatography from the SRαHis:βΔTM:SRP54NGHis complex. The same difficulty 
occurs in size-exclusion chromatography of a mixture of SRαHis:βΔTM and 
 
Figure 26 The purification of the trimeric SRαHis:βΔTM:SRP54DCHis complex. The complex eluted 
with a VE of 56.5 ml from the Superdex 200 (16/60) column (left panel). The peak with an elution 
volume of 45.3 ml represents aggregated trimeric complex. At 79 ml the excessive SRP54DCHis
elutes. A dimeric SRP54DCHis species elutes at 68 ml. SDS-PAGE of protein fractions from the 
purification step were subjected to Coomassie Brilliant Blue staining (right panel). 
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SRαHis:βΔTM:SRP54DHis and could be solved by using SRα:βΔTM and SRP54DHis in 
a similar approach. 
 
 
 
 
 
The SRαHis(R524Q):βΔTM:SRP54DHis Complex  
When a non-hydrolysable nucleotide is used for 
complex formation, an inhomogeneous nucleotide load 
in SRβ might occur when only a partial population of 
SRβ exchanges GTP as shown for free SRβΔTM 
(Legate and Andrews, 2003). The Arg524Gln mutation 
was introduced into SRα in order to express SR with the capability to bind nucleotide 
like the wild type receptor but lacking the ability of hydrolysis (Rapiejko and Gilmore, 
 
Figure 28 SDS-PAGE of size exclusion chromatography fractions of the SRα:βΔTM:SRP54NGCHis
complex. The complex isolated by Ni2+-affinity purification is subjected to size exclusion 
chromatography (Superdex 200 (26/60)). Protein fractions were analysed by SDS-PAGE and stained 
with Coomassie Brilliant Blue. 
 
Figure 27 Purification and assembly of the SRα:βΔTM:SRP54NGHis complex:  SRα:βΔTM is purified 
using SP-Sepharose as a cation exchanger: Load (1), flow through (2), wash (3), elution (4). 
SRP54NG after affinity tag purification is labelled with 5. SRα:βΔTM and SRP54NG are setup for 
complex formation and purified via Ni2+-affinity tag purification and the complex including an excess of 
SRP54NGHis is isolated: Load (6), wash (7a, 7b), elution (8). Protein fractions were analysed by SDS-
PAGE and stained with Coomassie Brilliant Blue. 
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1992). The mutated SRα Arg524 is located C-terminally of the DTAG consensus 
motif in the switch II region (DTAGR). Complex reconstitution with the mutant could be 
performed in presence of GTP instead of a non-hydrolysable GTP analogue leading 
to a trimeric complex with a homogenous nucleotide load. 
 In these experiments, SRP54DHis protein expressed in insect cells was used 
which was kindly provided by Mark Brooks (EMBL Grenoble, Cusack group).  
Although SRP54DHis expressed in E. coli (in house) and in insect cells shared the 
same sequence, insect-cell expressed SRP54DHis did not require the high 
reconstitution temperature of 37°C. SR:SRP complexes (SRαHis:βΔTM:SRP54DHis, 
SRαHis(R524Q):βΔTM:SRP54DHis) using SRP54DHis expressed in insect-cells could 
also be reconstituted ON at 4°C. Due to the lower temperature the time required for 
efficient reconstitution was prolonged but protein aggregation was avoided. It is not 
clear why efficient reconstitution of trimeric SR:SRP complexes using SRP54DHis 
expressed in E. coli or insect cells behave differently, but the dimerisation observed 
for E. coli expressed SRP54DHis (see 2.1.6) might be the reason for the reduced 
affinity for SRαHis:βΔTM, which was overcome at 37°C. Possibly the SRP54DHis 
homodimer interface occupies the surface that is required for SRαHis:βΔTM binding. 
Fig. 29 shows size exclusion chromatograms with SRαHis:βΔTM eluting at 11.9 
ml, SRP54DHis at 14.8 ml and the peak representing the trimeric complex at 11.2 ml. 
Complex reconstitution, as obtained for the SRαHis(R524Q):βΔTM:SRP54DHis mutant 
complex after five days, occurs for the SRαHis:βΔTM:SRP54DHis wild-type complex 
already after one day. The SRαHis(R524Q):βΔTM:SRP54DHis complex is reconstituted 
with an approximately five-fold reduced complex formation rate compared to 
SRαHis:βΔTM:SRP54DHis. 
From structural studies of the heterodimeric Thermus aquaticus NG domain 
complex from FtsY and Ffh (Egea et al., 2004; Focia et al., 2004) it can be observed, 
that the invariant and homologous residues Arg191 (FfhT.aq.), Arg195 (FtsYT.aq.), in 
the respective G3 regions, point away from the active side and are therefore in both 
atomic models not involved in the interface (Egea et al., 2004; Focia et al., 2004). 
Arg191 (FfhT.aq.) is located close to Glu284 (FtsYT.aq.), and Arg195 (FtsYT.aq.) is found 
in proximity to Glu274 (FfhT.aq.) (see Figure 30). 
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Therefore, it was assumed that by minor conformational changes the switch II 
region (G3) may be reoriented, suggesting the formation of a salt bridge meanwhile 
complex formation (Focia et al., 2004). According to primary sequence alignment 
(Chenna et al., 2003) Arg195 (FtsYT.Aq.) correlates to Arg524 in human SRα and 
Glu274 (FfhT.Aq.) to Glu280 in human SRP54 (Figs. 30, 31). The second salt bridge is 
not conserved from Thermus aquaticus to Homo sapiens and Sulfolobus Solfataricus 
(Archae) because the negative charged residue corresponding to Glu284 (FtsYT.aq.) 
is in the other two species occupied by a Gln that would only allow the formation of a 
weaker polar contact.  
Arg386 in E. coli FtsY is the residue homologous to Arg524 in human SRα. 
The Arg386Ala mutant of E. coli FtsY does not inhibit formation of the SR:SRP 
 
Figure 29 Reconstitution of SRαHis(R524Q):βΔTM. Samples were subjected to size exclusion 
chromatography (Superdex 200 (10/30)) under the same conditions. The same SR:SRP54DHis
stoichiometry was set up for complex reconstitution in order to generate Figs B – E. Samples from 
the same tube were taken for Figs. B – D. The two gels shown in A represent proteins after size 
exclusion chromatography, TCA precipitation, SDS-PAGE and Coomassie Brilliant Blue staining. 
Proteins examined and molecular weight markers are labelled. SRαHis(R524Q):βΔTM and 
SRαHis:βΔTM (not shown) migrate at 11.9 ml (F), the trimeric complex at 11.2 – 11.3 ml (B – E) 
and SRP54DHis at 14.8 – 14.9 ml (B – E).   
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complex in E. coli as observed from fluorescent spectroscopy experiments (Shan et 
al., 2004) but the Arg524Gln mutant of mammalian SRα slows down significantly 
reconstitution with SRP54D as shown here. The contradiction may be explained by 
species-dependent differences in SR:SRP complex formation which is reflected by 
the fact that not both in E. coli suggested salt bridges are conserved in Homo sapiens 
(Fig. 31). It is important to note that the formation of the SR:SRP complex, as shown 
in E. coli (Shan et al., 2004), is a complex process involving several different 
interactions.  
It could be shown using size exclusion chromatography for complex 
reconstitution analysis that the trimeric complex reconstitution rate of 
SRαHis(R524Q):βΔTM:SRP54DHis is approximately five-fold reduced compared to the 
wild-type complex. This implies that the suggested salt bridge could not be 
established during the reconstitution of the SRP:SR complex using 
SRαHis(R524Q):βΔTM, in contrast to SRαHis:βΔTM. A possible polar contact between 
Gln524 and Glu280 from SRα and SRP54DHis, respectively, could not stabilise the 
process of complex formation. The reduced binding strength between Gln524 
(human SRα) and Glu280 (human SRP54) compared to a salt bridge may therefore 
be the reason for the lower affinity. 
 
 
 
Figure 30 Interface of the Thermus Aquaticus FtsY-NG:Ffh-NG complex (Focia et al., 2004). The 
mutation introduced correlates according to primary structure alignments (ClustalW, (Chenna et 
al., 2003)) to R195Q for FtsY (T. aquaticus; black circle), E274 (Ffh, T. aquaticus) to E280 in 
SRP54 (H. sapiens). Accordingly, R191 (Ffh, T. aquaticus) corresponds to R194 (SRP54, H. 
sapiens) and E284 (FtsY, T. aquaticus) to Q618 (SRα, H. sapiens) (see also Fig. 31) 
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SRPRa_HUMAN_NG   -----GTLGGMFGMLKGLVGSKSLSREDMESVLDKMRDHLIAKNVAADIAVQLCESVANK 
FTSY_THEAQ_NG    MGFFDRLKAGLAKTRERLLKAIPWGG-NLEEVLEELEMALLAADVGLSATEEILQEVRAS 
SULSO_FtsY_NG    -----------------------------------MRYQLLESDVSFEVTEKILEDLKEN 
FtsYNG_EColi     -RSLLKTKENLGSGFISLFRGKKID----DDLFEELEEQLLIADVGVETTRKIITNLTEG 
SRP54_HUMAN_NG   -MVLADLGRKITSALRSLSNATIINEEVLNAMLKEVCTALLEADVNIKLVKQLRENVKSA 
THEAQ_Ffh_NG     --MFQQLSARLQEAIGRLRGRGRITEEDLKATLREIRRALMDADVNLEVARDFVERVREE 
SULSO_Ffh_NG     ------MLENIRDAVRKFLTGSTPYEKAVDEFIKDLQKSLISSDVNVKLVFSLTAKIKER 
SRP54NG_ECOLI    --MFDNLTDRLSRTLRNISGRGRLTEDNVKDTLREVRMALLEADVALPVVREFINRVKEK 
                                                    :   *:  :*    . .:   :    
                     
SRPRa_HUMAN_NG   LEGKVMGTFSTVTSTVKQALQESLVQILQPQRRVDMLRDIMDAQRRQRPYVVTFCGVNGV 
FTSY_THEAQ_NG    G-RKDLKEAV-KEKLVGMLEPDERRATLRKLGFNPQKPKPVEPKG----RVVLVVGVNGV 
SULSO_FtsY_NG    IIGKKVKRSDDLERIVKDSLKKSITEIITKNNAINVLEEIKKSPK---PYIIIFFGINGV 
FtsYNG_EColi     ASRKQLRDA---EALYGLLK-EEMGEILAKV---D-EPLNVEGKAP---FVILMVGVNGV 
SRP54_HUMAN_NG   IDLEEMASGLNKRKMIQHAVFKELVKLVDPG---V--KAWTPTKGK--QNVIMFVGLQGS 
THEAQ_Ffh_NG     ALGKQVLESLTPAEVILATVYEALKEALGGE---A--RLPVLKDR----NLWFLVGLQGS 
SULSO_Ffh_NG     LNKEKPPSVLERKEWFISIVYDELSKLFGGD---K--EPNVNPTKL--PFIIMLVGVQGS 
SRP54NG_ECOLI    AVGHEVNKSLTPGQEFVKIVRNELVAAMGEE---N--QTLNLAAQP--PAVVLMAGLQGA 
                    .                 .     .                      :  . *::*  
 
SRPRa_HUMAN_NG   GKSTNLAKISFWLLENGFS-VLIAACDTFRAGAVEQLRTHTRRLSALHPPEKHGGRTMVQ 
FTSY_THEAQ_NG    GKTTTIAKLGRYYQNLGKK-VMFCAGDTFRAAGGTQLSEWGK---RL----------SIP 
SULSO_FtsY_NG    GKTTTIAKFAYMLKKNGLS-CIISASDTFRAAAQEQLEVHSR---NL---E-------IP 
FtsYNG_EColi     GKTTTIGKLARQFEQQGKS-VMLAAGDTFRAAAVEQLQVWGQ---RN----------NIP 
SRP54_HUMAN_NG   GKTTTCSKLAYYYQRKGWK-TCLICADTFRAGAFDQLKQNAT---KAR----------IP 
THEAQ_Ffh_NG     GKTTTAAKLALYYKGKGRR-PLLVAADTQRPAAREQLRLLGE---KVG----------VP 
SULSO_Ffh_NG     GKTTTAGKLAYFYKKRGYK-VGLVAADVYRPAAYDQLLQLGN---QIG----------VQ 
SRP54NG_ECOLI    GKTTSVGKLGKFLREKHKKKVLVVSADVYRPAAIKQLETLAE---QVG----------VD 
                 **:*. .*:.            . . *. *...  **                     :  
 
SRPRa_HUMAN_NG   LFEKGYGKDAAGIAMEAIAFARNQGFDVVLVDTAGRMQ--DNAPLMTALAKLI------T 
FTSY_THEAQ_NG    VIQGPEGTDPAALAYDAVQAMKARGYDLLFVDTAGRLH--TKHNLMEELKKVKRAIAKAD 
SULSO_FtsY_NG    LIKGRYGGDPASVAFDAIRAAKSRGIDVVLIDTAGRMH--TDTDLVNELKRVV------N 
FtsYNG_EColi     VIAQHTGADSASVIFDAIQAAKARNIDVLIADTAGRLQ--NKSHLMEELKKIVRVMKKLD 
SRP54_HUMAN_NG   FYGSYTEMDPVIIASEGVEKFKNENFEIIIVDTSGRH--KQEDSLFEEMLQVA------N 
THEAQ_Ffh_NG     VLEVMDGESPESIRRRVEEKARLEARDLILVDTAGRL--QIDEPLMGELARLK------E 
SULSO_Ffh_NG     VYGEPNNQNPIEIAKKGVDIFVKNKMDIIIVDTAGRHGYGEETKLLEEMKEMY------D 
SRP54NG_ECOLI    FFPSDVGQKPVDIVNAALKEAKLKFYDVLLVDTAGRL--HVDEAMMDEIKQVH------A 
                 .       ..  :          .  :::: **:**     .  :.  : .:         
 
SRPRa_HUMAN_NG   VNTPDLVLFVGEALVGNEAVDQLVKFNRALADHSMAQTPRLIDGIVLTKFDTIDDKVGAA 
FTSY_THEAQ_NG    PEEPKEVWLVLDAVTGQNGLEQAKKF-----HEAVG-----LTGVIVTKLD-GTAKGGVL 
SULSO_FtsY_NG    IAKPNLKILVLDSLGGNDALEQAKYF-----ENNVG-----FDLVILTKVD-ADVKGGVI 
FtsYNG_EColi     VEAPHEVMLTIDASTGQNAVSQAKLF-----HEAVG-----LTGITLTKLD-GTAKGGVI 
SRP54_HUMAN_NG   AIQPDNIVYVMDASIGQACEAQAKAF-----KDKVD-----VASVIVTKLD-GHAKGGGA 
THEAQ_Ffh_NG     VLGPDEVLLVLDAMTGQEALSVARAF-----DEKVG-----VTGLVLTKLD-GDARGGAA 
SULSO_Ffh_NG     VLKPDDVILVIDASIGQKAYDLASRF-----HQASP-----IGSVIITKMD-GTAKGGGA 
SRP54NG_ECOLI    SINPVETLFVVDAMTGQDAANTAKAF-----NEALP-----LTGVVLTKVD-GDARGGAA 
                    *     . ::  *:        *     ..        .  : :**.*    : *   
 
SRPRa_HUMAN_NG   ISMTYITSKPIVFVGTGQTYCDLRSLNAKAVVAALMKA-- 
FTSY_THEAQ_NG    IPIVRTLKVPIKFVGVGEGPDDLQPFDPEAFVEALLED-- 
SULSO_FtsY_NG    LSLAYELNKPVGYLGIGQAYDDLIPFNAEWFIQRLFS--- 
FtsYNG_EColi     FSVADQFGIPIRYIGVGERIEDLRPFKADDFIEALFAR-- 
SRP54_HUMAN_NG   LSAVAATKSPIIFIGTGEHIDDFEPFKTQPFISKLLG--- 
THEAQ_Ffh_NG     LSARHVTGKPIYFAGVSEKPEGLEPFYPERLAGRILGMGD 
SULSO_Ffh_NG     LSAVVATGATIKFIGTGEKIDELETFNAKRFVSRILGMGD 
SRP54NG_ECOLI    LSIRHITGKPIKFLGVGEKTEALEPFHPDRIASRILGMGD 
                 :.       .: : * .:    : .: .. .   ::      
                                  
Figure 31 Primary sequence alignment of SR and SRP54 NG domain from Homo sapiens and 
FtsY and Ffh from Thermus aquaticus (Theaq) and Sulfolobus solfataricus (Sulso) according to 
ClustalW (Chenna et al., 2003). Hydrophobic residues are in red, polar residues green, positively 
charged pink and negatively charged blue. Conserved amino acids are labeled by an asterisk, 
similar ones by two spots and less similar ones by one spot. The conserved arginine is highlighted 
in yellow, the opposing residue in switch II (G3) is highlighted in cyan. 
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Figure 33 SDS-PAGE of the SRαHis:βΔTM:SRP54DCHis:SRP19His:RNA104 complex subjected to
silver staining. Components are labelled and RNA is visible as a small band close to SRβΔTM. 
2.2.2 Pentameric Complex Reconstitution: 
SRαHis:βΔTM:SRP54DHis:SRP19His:RNA104 
In order to form the pentameric complex, two sub-
complexes (SRαHis:βΔTM:SRP54DHis and 
SRP19:RNA104) were pre-formed. The heterotrimeric 
complex was subjected to size exclusion chromatography (Superdex 200 (26/60); 
see Fig. 26) and the heterodimer was purified via anion exchange chromatography 
by Klemens Wild (not shown). Both subcomplexes were mixed in a 1:1 ratio for the 
reconstitution of the pentameric complex which was purified using size exclusion 
chromatography (Superdex (26/60); Fig. 32). Size exclusion chromatography of the 
trimeric complex allowed removing excessive amounts of SRP54DHis which later 
could compete with SRαHis:βΔTM for SRP19His:RNA104. 
  Once the SRαHis:βΔTM:SRP54DHis complex was formed, it readily 
associated with SRP19His:RNA104 to a pentameric complex at 4°C (Figs. 32, 33) 
which could be isolated by size exclusion chromatography.   
 
 
 
Figure 32 Purification of the pentameric SRαHis:βΔTM:SRP54DCHis:SRP19His:RNA104 complex. 
The pentameric complex elutes from size exclusion chromatography via Superdex 200 (16/60)
with an elution volume of 58 ml (left panel). At 116 ml excessive GMPPNP elutes from the column. 
Fractions four to ten cover the main peak. SDS-PAGE of protein fractions from the purification 
step were subjected to Coomassie Brilliant Blue staining (right panel). The RNA is not stained but 
required include SRP19 into the complex. 
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2.2.3 Analysis of SR:SRP Complex 
Reconstitution  
Pull down experiments with Ffh, 4.5S SRP RNA and 
immobilised FtsY from E. coli suggested a stabilising 
function for 4,5S RNA in FtsY:Ffh complex formation 
(Miller et al., 1994). Further analysis by fluorescence 
spectroscopy showed that the association of E. coli Ffh 
to FtsY was increased by a factor of 200 to 400 in the 
presence 4.5S RNA compared to experiments without 
SRP RNA (Peluso et al., 2000; Peluso et al., 2001).  
Therefore these experiments were preformed to analyse the influence of SRP 
RNA and the RNA binding protein SRP19 on the formation of the SR:SRP complex in 
the mammalian system. Reconstitution of the pentameric 
(SRαHis:βΔTM:SRP54DCHis:SRP19His:RNA104) and the trimeric complex 
(SRαHis:βΔTM:SRP54DCHis) were compared by size exclusion chromatography. 
SRP54DHis expressed in insect cells (Mark Brooks, EMBL Grenoble, former Cusack 
group member) was used for these studies. 
Trimeric and pentameric complexes were setup in parallel from single purified 
components. SRαHis:βΔTM was already pre-formed. Samples were examined after 
approximately 1, 4 and 7h and analysed by size exclusion chromatography 
(Superdex 200 (10/30)) for complex reconstitution (Figs. 34, 35).  
In the time course shown in Fig. 34, the trimeric complex does not occur as an 
isolated peak because it could not be separated by size exclusion chromatography 
from SRαHis:βΔTM. Nevertheless, trimeric complex reconstitution can be followed by 
the decrease of the peak representing free SRP54DHis (VE = 14.9 ml) relative to the 
peak correlated to a mixture of SRα:βΔTM and trimeric complex at 11.8 ml.    
Pentameric complex reconstitution is easier to observe (Fig. 35) due to the 
presence of RNA104. The largest peak observed after 1 h 20 min correlates to the 
trimeric SRP54DHis:SRP19His:RNA104 complex (VE = 13.15 ml) which decreased by 
time until 10 h 30 min. During the time course of the experiment, the pentameric 
complex is formed (VE = 11 ml) and the correlating peak exceeds the 
SRP54DHis:SRP19His:RNA104 peak after 10 h 30 min. These experiments show that 
the trimeric complex from SRP components (SRP54DCHis:SRP19His:RNA104) is 
formed more rapidly than the SR:SRP complex, indicating that the affinity of 
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SRP54DHis is lower to SRαHis:βΔTM than to SRP19His:RNA104. This is in agreement 
with observations from the optimisation of the complex reconstitution protocols. Here, 
the SRαHis:βΔTM:SRP54DHis complex was assembled within 12 h at 4°C but 
SRP19:RNA104 bound to the pre-formed SRαHis:βΔTM:SRP54DHis complex within 1 h 
under the same conditions. This is reasonable considering the stability of the 
assembled SRP in contrast to the highly regulated SR:SRP interaction.  
Between 1 h 20 min and 4 h 30 min, the pentameric complex reconstitution 
increases by 42% (peak at 11 ml; Fig. 35, Table 7) which is more compared to the 
31% decrease of SRP54DHis (peak at 14.9 ml; Fig. 34, Table 7) between 1 h and 4 h 
in the trimeric SRαHis:βΔTM:SRP54DHis complex reconstitution experiment. It is 
suggestive that the affinity of SRP54DHis to SRαHis:βΔTM is enhanced with the 
formation of SRP54DHis:SRP19:RNA104 complex. Between 4 h 30 min and 7h 30 min, 
the pentameric complex is still formed (+10%) but there is no measurable change for 
the trimeric complex assembly between 4 h and 7 h, indicating that the pentameric 
complex might be more stable.  
Comparing the pentameric and trimeric complex reconstitution experiments, 
analysis were not performed in exactly the same time frame since the setup of the 
pentameric SRαHis:βΔTM:SRP54DHis:SRP19His:RNA104 complex was analysed 20 - 
30 min after the corresponding sample of the trimeric SRαHis:βΔTM:SRP54DHis 
complex. The numbers achieved for the pentameric complex were given from the 
Pharmacia Software UNICORNTM Version 4. They can not be considered to be 
precise since educts and products can not be separated by baseline. Values given 
here are only approximate numbers.  
In summary, reconstitution of the SRP54DHis:SRP19His:RNA104 complex is 
formed more rapidly than the SR:SRP complexes and SRP19/RNA104 seem to 
slightly facilitate the assembly of the SR:SRP complex. Additionally, the pentameric 
might be more stable than the trimeric complex since the reconstitution of the 
pentameric, but not the trimeric complex (SRαHis:βΔTM:SRP54DHis), can be observed 
after 4 h.  
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Figure 34 Time points in complex formation of the SRαHis:βΔTM:SRP54DHis complex analysed by 
size exclusion chromatography (Superdex 200 (10/30)). SRαHis:βΔTM and SRαHis:βΔTM:SRP54DHis
can not be separated via size exclusion chromatography. The decrease of the SRP54DCHis peak 
relative to the SRαHis:βΔTM / SRαHis:βTM:SRP54DHis peak can be observed. The sample examined 
for the time point 0 h was taken before the addition of GMPPNP to avoid the presence of trimeric 
complexes. The detected nucleotide (0 h) is derived from the protein preparation (intrinsic nt).  
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 Time SRαHis:βΔTM:SRP54DCHis SRαHis:βΔTM:SRP54DCHis:
SRP19:RNA104 
1 – 4 h  + ~31 %   Trimeric 
complex 
formed 
4 – 7 h Not measurable  
1h 20 min – 
4 h 30 min 
 + ~ 42 % Pentameric 
complex 
formed 4 h 30 min – 
7 h 30 min 
 + ~ 10 % 
Table 7 Comparison of trimeric and pentameric complex reconstitution. Results were calculated from 
values obtained from the size exclusion chromatography runs from Figs. 34 and 35. The areas of the 
peaks were determined by the Pharmacia UNICORN software. The total areas of peaks in diagrams 
were normalised before comparison in order to keep the total amounts of proteins constant. Numbers 
for the pentameric complex reconstitution are approximate numbers since the peak resembling this 
complex can not be baseline separated from others. Pentameric complex reconstitution is measured 
via the increase of the pentameric complex peak, the reconstitution of the trimeric complex is 
measured via the decrease of the SRP54DHis peak since SRαHis:βΔTM and the trimeric complex could 
not be separated by size exclusion chromatography. 
 
Figure 35 Time points of complex formation of the SRαHis:βΔTM:SRP54DHis:SRP19His:RNA104
complex analysed by size exclusion chromatography (Superdex 200 (10/30)). The complexes eluting 
as major peaks are labelled. The peak representing the eluting pentamer (11.00 ml) increases 
relative to the peak for the trimeric complex comprising here SRP54DHis, SRP19 and RNA104. 
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2.3 Structure Determination of SRXHis:βΔTM 
SRX2His:βΔTM was set up for crystallisation but the 
structure determined showed only residues homologous 
to yeast SRβΔTM and SRX not including the complete C-
terminus of SRX2. A result of the structural analysis was the definition of the minimal 
SRβ-binding domain of SRα (SRX) in mammals which was found to comprise the N-
terminal 130 amino acids SRX2 (176 amino acids).  
Initial phase information was achieved by molecular replacement from the data 
set Srax3-2. Model building and refinement led to a preliminary model with a high R-
factor (R-factor = 38.0%, free R-factor= 47.3%). In order to improve the phase 
information two methods were carried out: 
1. Crystallisation of L-selenomethionine substituted crystals for a SAD 
experiment. As a result crystals were obtained and the data set Peak 1_2 
(SAD data set) could be collected. The phasing power was too low to include 
phase information into the refinement and model building process 
2. Optimised Crystallisation trials in order to achieve higher diffracting crystals. 
Crystals were achieved diffracting to 2.45 Å (data set Sr2-1).  
The space group was determined in the Srax3-2, SAD- and Sr2-1 data sets to be 
I222. The lattice parameters in all crystals were very similar. The final model (R-factor 
= 19.3%, free R-factor = 23.2%) was mainly build and refined from the Sr2-1 data set 
but also from phase information of the preliminary model. 
The structure was determined by using the SRβΔTM subunit of the 
Saccharomyces cerevisiae SRX:βΔTM-GTP complex (Schwartz and Blobel, 2003) as 
a search model.   
2.3.1 Crystallisation  
SRXHis:βΔTM crystallised as leaf-shaped crystals with the space group I222 in 100 
mM sodium citrate pH 5.5, 2.0 M (NH4)2SO4 and in the presence of 100 mM 
guanidinium chloride (Fig. 36). Hexagonal and leaf-shaped crystals with the same 
space group were also grown from seleno-L-methionine substituted protein 
(SRXHis:βΔTMSeMet, Fig. 36) in the same condition.  
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2.3.2 Data Collection and Processing  
The Srax3-2 data set 
The Srax3-2 data set could be processed to 2.9 Å (I/σ = 2.0 and Rsym = 0.50). 
Reflections in the highest resolution shell (2.83 – 2.9 Å) were excluded due to weak 
signal (I/σ = 1.5) and high Rsym (0.64). Crystals belong to the space group I222 and 
one molecule was found per asymmetric unit. Data processing statistics are shown in 
Tables 8 and 9. From this data set the structure was solved and the first preliminary 
model was build. In Table 15 all relevant crystallographic data are summarised. 
 
  
 
 
 
 
Figure 36  Crystallisation of SRX2His:βΔTM SRXHis:βΔTM. Crystals diffracting to 2.45 Ǻ (left image; 
giving the Sr2-1 data set) and crystals obtained from SRX2His:βΔTMSeMet protein (right image).  
Shell Lower  Upper Average     Average     Norm.   Linear Square 
 limit    Angstrom       I   error   stat. Chi**2  R-fac  R-fac 
      30.00   6.95  6118.7   245.0    80.2  1.002  0.041  0.060 
       6.95   5.53  1776.3    98.2    42.5  1.000  0.052  0.051 
       5.53   4.83  2189.0   122.1    59.5  1.000  0.053  0.056 
       4.83   4.39  2515.6   127.8    53.7  1.000  0.052  0.055 
       4.39   4.08  1870.4   100.4    51.5  1.000  0.059  0.069 
       4.08   3.84  1129.6    82.7    47.7  1.000  0.075  0.071 
       3.84   3.65   960.0    99.0    51.8  1.000  0.095  0.093 
       3.65   3.49   723.5    76.4    48.5  1.000  0.111  0.095 
       3.49   3.35   483.0    67.4    47.2  1.000  0.151  0.139 
       3.35   3.24   377.1    64.4    47.8  1.000  0.195  0.174 
       3.24   3.14   265.7    58.7    46.0  0.999  0.259  0.232 
       3.14   3.05   202.5    63.1    49.7  1.000  0.364  0.335 
       3.05   2.97   153.2    65.0    50.1  0.996  0.495  0.445 
       2.97   2.90   119.4    59.8    48.1  1.000  0.568  0.504 
      (2.90   2.83    92.7    60.7    49.0  0.997  0.778  0.640) 
  All reflections   1297.5    93.7    51.7  1.000  0.077  0.064 
Table 8 Processing statistics of the Srax3-2 data set. Information is given about signal intensity (I, 
error) and reliability of the data (chi2, linear R-factor, square R-factor).  
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The SAD Data Set  
The SAD data set (termed also Peak1_2) was collected in order to determine 
additional phase information to improve the model build from the Srax3-2 data set.  
 Seleno-L-methionine substituted SRXHis:SRβΔTM-GTP protein was 
crystallised and successively subjected to a Single Anomalous Dispersion (SAD) 
experiment at beamline ID 14-4 (ESRF, Grenoble). The fluorescent scan showed a 
prominent absorbance peak from K-Shell electrons of Selenium at 12659 eV (Fig. 37, 
Table 10). Methionine was successfully substituted by seleno-L-methionine but the 
crystals showed only low phasing power. Therefore, the data set (Table 11) was not 
included in the refinement of the final model. 
The same day the SAD experiment was performed, also a higher resolution 
data set (Sr2-1) was collected. Refinement of the Sr2-1 data was successful to build 
an atomic model of high quality (see below).  
In order to obtain a signal sufficient for structure determination, there should 
be at least about one anomalous scatterer per 80 amino acids. The protein 
crystallised contained 6 methionine residues, corresponding to one seleno-L-
methionine per 67 residues. Due to disordered regions in the protein, only one 
methionine per 104 residues was observed in the final model. Therefore, the small 
number of ordered seleno-L-methionine residues might have been the reason for the 
weak phasing power.  
 
Shell            I/Sigma in resolution shells: 
  Lower Upper      % of reflections with I / Sigma less than 
  limit limit     0     1     2     3     5    10    20   >20  total 
  30.00  6.95   0.8   1.3   2.4   3.0   4.3   6.9  26.6  71.4   98.0 
   6.95  5.53   1.0   3.5   5.8   7.0  10.4  19.9  70.1  29.5   99.6 
   5.53  4.83   0.6   2.0   3.4   5.2   8.8  18.2  68.2  31.8  100.0 
   4.83  4.39   1.4   3.5   5.1   6.6   9.5  19.3  58.3  41.6   99.9 
   4.39  4.08   1.7   3.9   6.4   8.3  12.8  23.3  62.9  37.0   99.9 
   4.08  3.84   3.7   7.6  11.5  15.7  22.0  41.1  91.9   8.1  100.0 
   3.84  3.65   3.0   7.8  12.9  17.4  27.0  59.1 100.0   0.0  100.0 
   3.65  3.49   5.0  11.8  19.1  23.4  35.1  61.0  98.6   1.1   99.7 
   3.49  3.35   6.2  13.5  23.6  31.2  46.2  73.4 100.0   0.0  100.0 
   3.35  3.24   8.4  17.9  29.3  38.7  52.1  81.6  99.9   0.0   99.9 
   3.24  3.14  10.4  22.3  35.3  45.0  59.4  91.0  99.9   0.0   99.9 
   3.14  3.05  12.3  26.2  40.6  53.1  72.0  99.8 100.0   0.0  100.0 
   3.05  2.97  15.5  30.9  47.0  62.3  88.4  99.9  99.9   0.0   99.9 
   2.97  2.90  16.3  36.1  54.7  68.6  89.9  99.9  99.9   0.0   99.9 
  (2.90  2.83  20.6  40.7  61.3  79.9  98.0 100.0 100.0   0.0  100.0) 
 All hkl        7.0  15.0  23.6  30.6  41.8  58.9  84.5  15.2   99.8 
Table 9 Completeness of the Srax3-2 data set. Overall completeness is 99.8%, and completeness 
in the highest processed resolution shell is 99.9%. 
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Data Collection 
Wavelength (Å) 0.933                    
Resolution range (Å) 50 – 3.5 
Completeness (%)  94 (93) 
Rsym (%) 16.6 (56.7) 
<I/σ> 8 (2.5) 
Space group I222 
Cell parameters a = 67.9 Å, b = 120.0 Å, c = 118.1 Å  
Total reflections 6650 
Table 11 Crystallographic data from the SAD data set (Peak 1_2) of SRXHis:βΔTM summarised. 
Values in parentheses are for the highest resolution shell. 
 
 
 
 
 
 
 
 
 
 
 
Figure 37 Fluorescent Scan of SRXHis:SRβΔTMSeMet crystals. Absorbance peak of K-shell 
electrons of Selenium occurs at 12660 eV. 
Integration limits low/high :   1261.17   50632.18 
 First/last data points at   :  12607.80  12706.46 
 Energy scale increment      :      0.315 
 
 |             |   E (eV)   |    f’   |   f’’   | 
 | F’ minimum  |  12656.97  |   -9.8  |   2.8   | 
 | F’’ maximum |  12659.49  |   -7.8  |   4.8   | 
 
Table 10 Statistics of the Selenium K-shell electron peak from the fluorescent scan. 
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The Sr2-1 data set 
The Sr2-1 data set was the best data set collected and processed between 2.45 and 
50.0 Å. An overall completeness of 99.7% was achieved with 100% in the highest 
resolution shell (2.45 – 2.49 Å (Tables 11, 12). The space group was I222 with one 
molecule per asymmetric unit. The overall I/σ was 25.0 (Rsym = 5.7%) and I/σ in the 
highest resolution shell 3.3 (Rsym = 42.4%). In Table 16 all relevant crystallographic 
data are summarised. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shell             Summary of observation redundancies: 
  Lower Upper      % of reflections with given No. of observations 
  limit limit     0     1     2     3     4   5-6   7-8  9-12 13-19   >19  total 
  50.00  6.65   4.8   2.4   4.8   7.7  14.9  18.0  47.3   0.0   0.0   0.0   95.2 
   6.65  5.28   0.2   0.3   2.6   3.3  12.3  18.4  62.9   0.0   0.0   0.0   99.8 
   5.28  4.61   0.4   0.1   1.7   3.8  10.4  21.6  62.0   0.0   0.0   0.0   99.6 
   4.61  4.19   0.0   0.4   2.1   3.5   8.6  22.4  63.1   0.0   0.0   0.0  100.0 
   4.19  3.89   0.0   0.1   1.4   3.7   9.0  19.4  66.3   0.0   0.0   0.0  100.0 
   3.89  3.66   0.0   0.2   1.7   1.9   8.9  20.6  66.7   0.0   0.0   0.0  100.0 
   3.66  3.48   0.0   0.0   1.1   2.2   7.9  21.2  67.6   0.0   0.0   0.0  100.0 
   3.48  3.32   0.0   0.3   1.1   2.9   8.5  21.2  66.0   0.0   0.0   0.0  100.0 
   3.32  3.20   0.0   0.0   0.9   2.6   7.7  21.3  67.6   0.0   0.0   0.0  100.0 
   3.20  3.09   0.0   0.0   1.1   2.9   7.9  20.6  67.5   0.0   0.0   0.0  100.0 
   3.09  2.99   0.0   0.1   0.5   2.9   7.5  21.1  67.9   0.0   0.0   0.0  100.0 
   2.99  2.90   0.0   0.2   0.7   2.3   8.4  21.4  67.0   0.0   0.0   0.0  100.0 
   2.90  2.83   0.1   0.3   0.7   2.6   6.8  20.5  69.0   0.0   0.0   0.0   99.9 
   2.83  2.76   0.0   0.2   0.8   2.3   7.5  23.2  66.0   0.0   0.0   0.0  100.0 
   2.76  2.70   0.0   0.5   0.2   2.2   7.5  22.5  67.1   0.0   0.0   0.0  100.0 
   2.70  2.64   0.0   0.3   0.9   2.3   7.0  22.1  67.4   0.0   0.0   0.0  100.0 
   2.64  2.59   0.0   0.3   0.8   2.7   7.4  22.7  66.2   0.0   0.0   0.0  100.0 
   2.59  2.54   0.0   0.7   1.0   3.0   7.1  20.6  67.6   0.0   0.0   0.0  100.0 
   2.54  2.49   0.0   0.6   0.6   3.1   7.3  22.9  65.3   0.0   0.0   0.0  100.0 
   2.49  2.45   0.0   0.7   2.0   4.6   8.2  25.4  59.1   0.0   0.0   0.0  100.0 
 All hkl        0.3   0.4   1.4   3.1   8.6  21.3  64.9   0.0   0.0   0.0   99.7 
Table 13 Completeness of the Sr2-1 data set in all resolution shells. Overall 
completeness is 99.7% and completeness in the highest resolution shell is 100.0%. 
Shell Lower Upper Average      Average     Norm. Linear Square 
 limit    Angstrom       I   error   stat. Chi**2  R-fac  R-fac 
      50.00   6.65 12521.9   372.0   115.1  0.906  0.034  0.040 
       6.65   5.28  5851.7   159.5    38.8  0.970  0.037  0.041 
       5.28   4.61  8622.3   230.1    50.6  0.981  0.037  0.042 
       4.61   4.19  8712.1   253.2    58.7  0.939  0.038  0.042 
       4.19   3.89  6042.6   177.8    49.0  1.016  0.042  0.045 
       3.89   3.66  4646.7   156.4    43.6  0.935  0.046  0.047 
       3.66   3.48  3740.2   142.5    42.1  0.905  0.049  0.047 
       3.48   3.32  2478.0   110.4    39.4  0.954  0.061  0.059 
       3.32   3.20  2045.9    93.9    38.8  1.033  0.069  0.061 
       3.20   3.09  1489.2    82.0    38.1  1.022  0.084  0.073 
       3.09   2.99  1107.1    70.0    37.6  1.024  0.105  0.096 
       2.99   2.90   913.5    72.3    37.8  0.983  0.122  0.107 
       2.90   2.83   706.9    69.5    37.8  1.065  0.158  0.128 
       2.83   2.76   613.4    71.1    38.7  1.022  0.180  0.142 
       2.76   2.70   479.2    68.2    38.8  1.108  0.235  0.191 
       2.70   2.64   401.5    69.0    39.1  1.055  0.277  0.221 
       2.64   2.59   338.0    69.4    39.5  1.021  0.319  0.242 
       2.59   2.54   279.9    68.3    40.1  1.020  0.391  0.318 
       2.54   2.49   279.3    73.0    40.7  0.958  0.395  0.311 
       2.49   2.45   243.6    74.4    42.3  0.940  0.424  0.335 
  All reflections   3131.9   125.4    45.5  0.994  0.057  0.046 
 
Table 12 Processing Statistics of the Sr2-1 data set. Information is given about signal 
intensity (I, error) and reliability of the data (chi2, linear R-factor, square R-factor). 
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2.3.3 Structure Determination by Molecular Replacement  
The structure was solved by molecular replacement (MR) using the yeast homologue 
of SRβΔTM (PDB accession code 1NRJ) as a search model and the Srax3-2 data 
set. The model build from the MR solution was refined to a R-factor of 38.0% and a 
free R-factor 47.5%. Further improvement of the model was not possible due to high 
model bias and low resolution data. Here, the structure determination using the 
Srax3-2 data set is described. 
In total, over 150 runs of the programs AMoRe (Navaza, 1994) and Molrep 
(Collaborative Computing  Project, 1994) from the CCP4 suite (Collaborative 
Computing  Project, 1994) were used for MR. Search models were generated from 
the yeast homologue of the heterodimeric SRXHis:βΔTM-GTP complex (PDB 
accession code: 1NRJ). The sequence identities of SRβΔTM and SRX2 to their yeast 
homologues are 26.5% and 15.7%, respectively. Therefore the yeast SRXHis:βΔTM 
complex, SRβΔTM and models with deleted loops were chosen as a search models. 
The possible solutions were evaluated according to the R-factor (expected to be < 
50%), variations between correlation factors, the fitting of symmetry related 
molecules and importantly whether the R-factor decreased in the first refinement 
step. 
The proper solution was found by using the yeast homologue of SRβΔTM 
(Schwartz and Blobel, 2003) as a search model. The molecular replacement result is 
shown in Table 14 and is characterised by an unusually high R-factor (58.5%) and a 
slightly higher correlation coefficient (Score) compared to the next best solution. This 
is likely due to the fact that yeast SRβΔTM as search model covers only 54% of the 
total molecular mass of SRX2His:βΔTM-GTP.  
After molecular replacement, symmetry related molecules of the rotated and 
translated model were inspected using O (Jones et al., 1991). Only minor clashes 
caused by the C-terminus of the long helix α4 could be observed as shown in Figure 
38 (illustrated by PyMOL (DeLano, 2002)). Later, it was determined that the clashing 
helix α4 was shorter in SRβΔTM than in yeast (see below) (Schwartz and Blobel, 
2003).  
Results 
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2.3.4 Refinement  
The molecular replacement model (yeast SRβΔTM, 1NRJ) was refined with the 
Srax3-2 data set at 2.9 Å using the CNS package (Otwinowski and Minor, 1997) to 
verify the solution and generate the first electron density map. The free R-factor 
decreased only slightly from 52.3% to 52.1% but the R-factor was reduced from 
53.8% to 45.8% confirming the solution. The first electron density map included only 
phase information from the model of the yeast homologue of SRβΔTM (Schwartz and 
Blobel, 2003) and is shown for SRβΔTM in Fig. 39. Electron density from the SRXHis 
subunit was weakly visible. The SRXHis helix α1 could be identified as shown in 
Figure 39.  
The model could not be refined to a R-factor better than 38.0% (free R-factor 
47.3%; Table 14). Therefore, two strategies were performed in order to build a better 
 S_ RF TF     theta      phi    chi     tx     ty     tz    TFcnt  Rfac   Scor 
  
 S__20__8   1   30.84 -155.65  115.00  0.212  0.491  0.182   4.23  0.585  0.245 
 S__30_10   2   30.26 -179.35  120.79  0.931  0.404  0.666   2.65  0.582  0.235 
 S__25__1   3  130.37 -173.01  122.87  0.205  0.942  0.369   1.65  0.592  0.231 
Table 14 Proper solution of the phase determination by molecular replacement. The proper 
solution is labelled with “S__20__8”, the next best solutions are found below. The proper solution 
is characterised in this case by an R-factor (Rfac) of 0.585 and a slightly higher correlation 
coefficient expressed here as score value (Scor). The rotation angles (theta, phi, chi) and 
translation values (tx, ty, tz) of the solutions are given. 
Figure 38 Examination of the rotated and translated yeast SRβΔTM molecule (Schwartz and 
Blobel, 2003) from the proper molecular replacement solution (red). Symmetry related molecules 
are in green. Minor clashes of the long helix α4 are highlighted by black circles. It was found later 
that this helix is shorter in mammalian SRβ. In A crystal contacts can be observed, B is rotated 
90°. The space between the molecular layers was later found to be filled with SRX (not shown 
since it was not in the search model).  
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molecular model: 1. Trial for a higher resolution native data set; 2. expression, 
purification and crystallisation of seleno-L-methionine substituted protein and 
successive phase determination by a SAD experiment. 
The SAD experiment was not successful but a higher resolution native data 
could be obtained (2.45 Å, Sr2-1 data set). In the data sets Srax3-2 and Sr2-1, the 
space group was identical (I222) and unit cell parameters were very similar. Rigid 
body refinement was used to fit the model obtained from the Srax3-2 data set to the 
Sr2-1 data. To improve the model, the auto-build function of Arp/wARP (Perrakis et 
al., 2001) was used to track the SRXHis:βΔTM-GTP main chain. The model was 
refined to a R-factor of 19.3% and a free R-factor of 23.2%. Detailed data collection 
and refinement statistics of the final model are shown in Table 16. The Improvement 
of the 2mFo-DFc electron density map from the first to the last refinement step is 
illustrated in Fig. 40.  
 
 
 
 
Figure 39 First electron density map of SRβΔTM and SRXHis with the model of the yeast 
homologue (red). A View into the GTP binding pocket formed by P loop (contour level 1.5 σ), 
switch I and switch II. The prominent α4 helix is also clearly visible. The arrow points at the break 
in the electron density indicating that the α4 helix is shorter in mammals than in yeast. B View of 
the central β-sheet (contour level 1.5 σ). The β-strand topology follows the typical Rossmann fold. 
C First density (contour level 1.0 σ) of the SRXHis helix α1 (highlighted in green) calculated from 
phases only achieved from SRβΔTM. This SRX α1 helix is derived from a neighbouring 
SRXHis:βΔTM heterodimer (see below).  
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Data Collection 
Wavelength (Å) 0.933                    
Resolution range (Å) 50 – 2.8 
Completeness (%) 99.8 (100.0, 99.9) 
Rsym (%) 6.4 (64.0, 50.4) 
<I/σ> 13.8 (1.5, 2) 
Molecules per asymmetric unit 1 
Refinement Statistics 
Space group I222 
Cell parameters a = 68.3 Å, b = 118.9 Å, c = 120.6 Å  
Resolution range (Å) 20 - 2.9 
Total reflections 10097 
  Working set 9581 
  Test set 516 
Number of refined atoms  
  Protein 2344 
  GTP 32 
  Water molecules 0 
Matthews coefficient (Å3/Da) 2.85 
Solvent Content (%) 56.8 
B-factor (Å2) 64.7 
R-factor (%)§ 38.0 
Rfree (%)§ 47.3 
rmsd bond length (Å) 0.011 
rmsd bond angle (°) 1.85 
Estimated standard deviations (ESDs)  
  From Luzzati plot (Å) 0.66 
  From SigmaA (Å) 0.71 
Table 15 Crystallographic data from the Srax3-2 data set of SRXHis:βΔTM summarised. *: first 
values in parentheses are for the highest resolution shell: 2.90 – 2.83 Å, second values are for the 
second highest resolution shell: 2.97 – 2.90 Å. §: R = Σ||Fobs| - |Fcalc||/Σh|Fobs|; R-factor and Rfree 
were calculated from the working and test reflection sets, respectively. Rfree was calculated with 
5% of the data. 
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Data Collection 
Wavelength (Å) 0.979 
Resolution range (Å) 50 – 2.45 
Completeness (%) 99.7 (100.0) 
Rsym (%) 5.7 (42.4) 
<I/σ> 25.0 (3.3) 
Molecules per asymmetric unit 1 
Refinement Statistics 
Space group I222 
Cell parameters a = 68.1 Å, b = 118.3 Å, c = 120.4 Å  
Resolution range (Å) 20 - 2.45 
Total reflections 18124 
  Working set 17202 
  Test set 922 
Number of refined atoms  
  Protein 2500 
  Mg2+GTP 35 
  Water molecules 104 
Matthews coefficient (Å3/Da) 2.70 
Solvent Content (%) 54.5 
B-factor (Å2) 56.4 
R-factor (%)§ 19.3 
Rfree (%)§ 23.2 
rmsd bond length (Å) 0.011 
rmsd bond angle (°) 1.50 
Estimated standard deviations (ESDs)  
  From Luzzati plot (Å) 0.27 
  From SigmaA (Å) 0.30 
Ramachandran plot (%)  
  Most favoured region 90.9 
  Additionally allowed region 8.8 
  Generously allowed region 0.4 
  Disallowed region 0.0 
Table 16 Crystallographic data from the best data set (Sr2-1) for the SRXHis:βΔTM-GTP model 
summarised. *: values in parentheses are for the highest resolution shell: 2.49 – 2.45 Å. §: R = 
Σ||Fobs| - |Fcalc||/Σh|Fobs|; R-factor and Rfree were calculated from the working and test reflection 
sets, respectively. Rfree was calculated with 5% of the data. 
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Figure 40 Improvement of the 2mFo-DFc electron density map. 2mFo-DFc electron density maps 
(blue wire) are contoured at 1σ above the average mean density level and superimposed on the 
final model (in sticks). Electron density maps after the first refinement cycle are shown in the left 
panels, and from the last in the right panels. Two sections of the molecule were selected (A, B). 
SRX is in green, SRβΔTM in cyan. The electron density maps were calculated from the Sr2-1 data 
set. 
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2.4 The Structure of SRXHis:βΔTM-GTP 
2.4.1 Overall Structure 
 
In this section the final model of SRXHis:βΔTM-GTP is presented. To distinguish 
between SRβΔTM and SRX the subscript letters B and X are used, respectively. The 
overall structure of the refined SRXHis:βΔTM-GTP model is depicted in Fig. 41. SRβ is 
a typical small GTPase and features a classical Rossmann fold with a central six-
stranded (β1B-β6B) mixed β-sheet packed in between five helices. In the 
SRXHis:βΔTM-GTP complex SRβ is in a state not competent for GTP hydrolysis as 
the catalytic histidine residue (His119B) points away from the active site (see below).  
The SRX domain (Figs. 41 and 42) belongs to the mixed α/β class proteins 
sharing topology (ββαβββαα) and fold of the SNARE-like protein superfamily 
(http://scop.mrc-lmb.cam.ac.uk/scop/) including the N-terminal domains of non-
syntaxin SNAREs (longin domains).  
 
 
Figure 41 The structure of the mammalian SRXHis:βΔTM-GTP 'monomer' is shown as a ribbon 
diagram with SRβΔTM in cyan, SRXHis in green, and Mg2+GTP as ball-and-stick model. The 
termini and secondary structure elements are labelled. Disordered parts of the complex are 
indicated by dashed lines. 
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The fold is defined by a three-layer architecture with a central five-stranded 
antiparallel β-sheet packed 
against helix α1X on the concave 
side of the β-sheet and two C-
terminal anti-parallel helices α2X 
and α3X on the other side 
(secondary structure numbering 
is according to the SCOP 
nomenclature which is different to 
the nomenclature used for the 
yeast structure). At the N-
terminus the two anti-parallel β-
strands β1X-β2X are connected 
by a conserved β-hairpin. Helix 
α1X locates almost perpendicular 
to the β-strands on the concave 
side and connects the peripheral β-strands of the β-sheet (β2X and β3X). The helix 
flanking loop regions are not conserved and only partially visible in the structure. 
Strands β3X, β4X and β5X are connected by short β-hairpin structures. The central 
strand β5X is followed by the long helix α2X, the α2X-α3X loop in the plane of the β-
sheet, and the C-terminal helix α3X running anti-parallel to helix α2X. Helix α2X is 
kinked and wraps around the convex side of the β-sheet like a clamp and helix αLX is 
inserted in the α2X-α3X loop. 
   
2.4.2 The SRXHis:βΔTM-GTP Homodimer 
The mammalian SRXHis:βΔTM-GTP complex forms a 'dimer' in the crystal  due 
to an interaction of the SRX domains, which is stabilised by a domain swap of helix 
α1X (~50° rotation around helical N-terminus) and the formation of a continuous trans 
β-sheet (Fig. 43). Here, strands β3X-β4X of one 'monomer' merge and align anti-
parallel across the 'dimer' interface. Dimerisation leads to an additional buried 
interface of approximately 1000 Å2 between the two SRXHis:βΔTM-GTP 'monomers'.  
 
Figure 42 SRX topology. Secondary structure 
elements are shown in green (β-strands) and magenta 
(α-helices). The termini and secondary structures are 
labelled. 
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In order to analyse the oligomerisation state of mammalian SRXHis:βΔTM-GTP in 
solution, analytical ultra centrifugation was performed by Karsten Rippe and Jacek 
Mazurkiewicz (Kirchhoff Institut für Physik, Heidelberg) and a KD of 270 µM for the 
'dimer' was determined (see Fig. 43). The SRXHis:βΔTM-GTP complex showed a 
tendency for aggregation. Therefore, the KD of the SRXHis:βΔTM-GTP complex could 
not be determined. and the physiological relevance for the dimerisation of 
SRXHis:βΔTM-GTP is not yet clear. Comparison with the yeast structure ('monomer', 
see below) showed that the domain-swapped helix α1X of the second SRX molecule 
of the mammalian receptor superposes with its corresponding position in the yeast 
'monomer' (see Discussion, section 3.1.3). Therefore, a 'monomeric' mammalian 
receptor complex is used for further analysis. 
 
Figure 43 The SRXHis:βΔTM-GTP 'dimer'. The 'dimer' formed by the SRX domains of two
SRX:SRβ-GTP complexes as observed in the crystal structure reveals a domain swap of helix α1X
(rotation is indicated) and the formation of a trans β-sheet between the merged β3x-β4x strands. 
The two-fold axis between two 'monomers' is highlighted in cyan. For clarity SRβΔTM is not 
included in this figure. 
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Figure 44 Analytical equilibrium ultracentrifugation of SRXHis:βΔTM-GTP. (A) Percentage of 
‘monomer’ (green) and ‘dimer’ (yellow) vs. protein concentration. The KD is 270 µM in a 
‘monomer’-’dimer’ equilibrium. (B) Statistics of the data obtained from the experiment. 
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2.4.3 The GTP-binding pocket  
Within the family of small Ras-like GTPases, SRβΔTM is a rare case because it it 
contains GTP in its native active site as shown by an electron density map of 
Mg2+GTP at a contour level of 2σ (mFo-DFc Mg2+GTP omit map, Fig. 45). Normally 
GDP or a non-hydrolysable GTP analogue is crystallised in complex with the native 
small Ras-like GTPase.  
 In Fig. 45 interactions between GTP, important water molecules and residues 
of the nucleotide binding pocket are shown in detail. Asp72B, Ser73B, G74B, Lys75B 
and Thr76B from the P loop (G1) establish polar main chain contacts to the β-
phosphate of the GTP. Side chain contacts from the P loop to GTP involve the 
Lys75B forming salt bridges to the β- and γ-phosphate of GTP and the Thr76B 
hydroxyl group binding Mg2+.  
From the switch I region (G2) Thr90B binds with the side chain hydroxyl group 
the α-phosphate. Ser93B coordinates with the main chain carbonyl group the Mg2+, 
with the main chain amide nitrogen the γ-phosphate. Ser93B forms a hydrogen bond 
with its side chain hydroxyl group to a water molecule (H2Ocat) that is suggested to 
be polarised by the catalytic residue from the switch II region (His119B; homologous 
to Gln51 in Ras) for GTP hydrolysis. 
 
Figure 45 mFo-DFc electron density omit map of Mg2+GTP in the active site of SRβ (cyan). The 
mFo-DFc omit map was calculated by excluding Mg2+GTP from the refinement of the model, 
highlighted in green, contoured at 2σ above the average mean density level and superimposed on 
the final model. SRβΔTM (cyan) is in cartoon representation, secondary structural elements are 
labelled in cyan, side chains of selected conserved residues are in sticks and labelled in black. 
Mg2+ (grey) is depicted as sphere.  
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In the switch II region, the main chain amide groups of His119B and the 
neighbouring Gly118B interact with the H2Ocat and the γ-phosphate, respectively. 
Asp115B forms with its carbonyl group a hydrogen bond to one of the two water 
molecules belonging to the coordination sphere of the Mg2+.  
The octahedral coordination sphere of Mg2+ consists of two water molecules, 
the main chain carbonyl group of the Ser93B, the Thr76B side chain hydroxyl group 
and the β- and γ-phosphate groups of the GTP.  
The P loop, switch I and switch II regions bind to the three phosphate groups. 
In contrast, the G4- and G5 regions interact with the guanine base. The G4 region is 
known to be important for substrate selectivity. An Asp181BAsn mutation in the G4 
region alters the nucleotide binding to favour XTP over GTP (Legate et al., 2000). 
The guanine base establishes two polar contacts to the carboxyl group of Asp181B 
and one to the side chain amide group of Asn178B. The GTP-binding pocket is 
completed by the G5 region (‘closing loop’) from where only one main chain 
interaction of the Ala264B amide nitrogen with the guanine base can be observed. 
 
 
 
 
 
 
 
Figure 46 Interactions of the SRβΔTM active site with GTP. GTP is bound by amino acids (in 
sticks, labelled in black) of all five consensus motifs (labelled in cyan) and complexed to Mg2+
(grey). SRβΔTM (cyan) is in ribbon representation and GTP in sticks with its guanine base 
carbons in magenta. Water molecules are in green, the water molecule suggested to be polarised 
for hydrolysis is indicated with H2Ocat. Side chains and main chains contributing interactions are 
highlighted in sticks. 
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2.4.4 The SRXHis:βΔTM-GTP interface 
The SRXHis:βΔTM-GTP interface involves the predominant effector-binding region of 
Ras-like GTPases (Corbett and Alber, 2001) (Fig. 46). The buried surface between 
SRβΔTM-GTP and SRXHis is 1850 Å2, which is similar to the yeast structure and 
other GTPase-effector complexes (Schwartz and Blobel, 2003). SRβΔTM contributes 
to the interface with its G1 element (P loop, GLCDSGKT), switch I, interswitch, and 
switch II regions. The complete switch I region snugly binds into a hydrophobic 
groove of SRXHis and spans the whole interface. This groove is situated between the 
amphipathic helix α1X and the hydrophobic concave surface of the SRXHis β-sheet. 
Although the protein interface forms a continuous surface, three regions of SRX 
organised in three layers contribute to the interface (Fig. 47, 48): (i) helix α1X, (ii) the 
β-hairpin between strands β1X and β2X and (iii) the α2X-α3X loop including the short 
helix αLX. 
 
 
 
Figure 47 The SRXHis:βΔTM-GTP interface. The interface is divided into three layers (top, centre, 
and bottom). Prominent features of the interface are: top, salt bridge between Arg34X and Asp72B; 
top-centre, hydrogen bonds between helix α1x and switch I; centre, Ile94B in a hydrophobic groove 
of SRX that is schematically denoted by black lines, and the conserved Gly12X (green sphere) at 
the tip of the β1X-β2X hairpin in the centre of the interface; bottom, hydrophobic interactions (black 
lines) and hydrogen bond between Asn101x and Ser98B. Hydrogen bonds involving main chain 
atoms are not shown.  
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 In the top layer, the amphipathic helix α1X binds the switch I and II regions and 
the P loop of SRβ. The side chain of the conserved Asn30X forms hydrogen bonds to 
the side chain Gln91B (not conserved) and the main chain of Thr92B in switch I. One 
helical turn further, Arg34X forms a salt bridge to Asp72B in the P loop bridging the 
active site and forming a hydrogen bond to the side chain of Thr92B. Three residues 
of helix α1X (Ile33X, Leu37X, and Leu38X) are part of a hydrophobic pocket which 
accommodates Ile94B and the aliphatic part of Gln91B in the centre of the interface. 
Leu38X forms an additional hydrophobic interaction with Leu122B of switch II.  
In the central layer, SRXHis exclusively interacts with the switch I region of 
SRβΔTM. The central hydrophobic pocket is completed by Val14X and the aliphatic 
part of Lys10X. The conserved β-hairpin between β1X and β2X contributes a number 
of hydrophilic interactions which are surrounded by a hydrophobic rim. All hydrophilic 
interactions are established by main chain atoms of the β-hairpin, which contains a 
conserved glycine (Gly12X) at the tip. The carbonyl oxygen of Lys10X forms a 
hydrogen bond to the amide nitrogen of Ile94B. The carbonyl oxygen of Gly11X 
approaches the Mg2+ binding site in SRβ and forms a hydrogen bond with the side 
chain of Ser93B which is essential for Mg2+ coordination. Residues Gly12X to Val14X 
form a short stretch of an anti-parallel trans β-sheet with residues Gln91B to Asp89B 
of switch I. 
In the third layer, SRXHis binds to the switch I and interswitch regions of 
SRβΔTM. Interactions are formed by the α2X-α3X loop including the short helix αLX. 
Three hydrophobic side chains (Ala103X, Leu104X and Leu107X) from helix αLX 
interact with residues Phe79B, Val80B, Leu83B and the hydrophobic methyl group of 
Thr84B from switch I as well as with Ala99B and Ile100B from the interswitch region. 
Hydrophilic interactions are established by main chain atoms of Ala103X and 
Leu107X, which hydrogen bond to the main chain of Ser98B and the guanidinium 
group of Arg88B, respectively. The layer is completed by the interaction of the side 
chains of Asn101X and Ser98B. 
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Figure 48 Detailed stereo views of the SRXHis:βΔTM-GTP interface. Detailed stereo views of the 
SRX:SRβ-GTP interface. SRβΔTM is shown in cyan and SRXHis in green. Residues discussed in 
the text are highlighted in sticks. Polar interactions are represented by dashed lines. The three 
layers (top, centre and bottom, see also Fig. 3) are separated in the figure. The top layer includes 
interactions to helix α1X. The centre involves the interactions of the SRβ switch I region with the 
β1X-β2X loop. The bottom layer completes the interface by αLX binding to the switch I and 
interswitch regions of SRβΔTM. 
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2.5 Characterisation of Interactions with SR and Components of 
the SRP Cycle 
2.5.1 SRβΔTM Translocon Interaction  
In previous experiments Sec61β has been proposed as a GEF for SRβ (Helmers et 
al., 2003) and the cytosolic loops L6 and L8 of Sec61α were shown to be important 
for different steps in protein translocation (Cheng et al., 2005) Therefore, the aim was 
to analyse the interaction of SRβ and SR with the Sec61 complex in more detail. An 
immobilised peptide library representing the cytosolic loops of Sec61α and 
Sec61β was created. Due to the high sequence conservation within the translocon 
family, the cytosolic loops of human Sec61 could be defined from the structure of the 
M. jannaschii homolog (Cheng et al., 2005; Van den Berg et al., 2004).  
Human Sec61αβ and M. janaschii YG sequences were aligned with ClustalW 
(Thompson et al., 1994) and cytosolic loop regions were defined from the M. 
jannaschii SecYEG structure (Cheng et al., 2005; Van den Berg et al., 2004). The 
immobilised peptide library covered the sequences as shown in Fig. 49 including the 
N-terminus of human Sec61α (amino acids 2-34), loop 2 (amino acids 90-116), loop 
4 163-184), loop 6 (253-193), loop 8 (375-425), the C-terminus (454-476) and full 
length Sec61β. 
The peptide library contained the hydrophobic transmembrane anchor of 
Sec61β as a control for unspecific hydrophobic interactions. No signal was obtained 
with these peptides. In addition, when SRβ-apo had gone through a freezing and 
thawing cycle it did not give any signals (as in Fig. 50B), whereas fresh protein (Fig. 
50A) gave reproducible signals indicating that the native protein conformation or 
stable protein is essential for the interaction. 
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The library was probed with SRβΔTM-apo or SRβΔTM-GTP in complex with 
either SRXHis or SRαHis. Strikingly, heterodimeric SR did not show any interaction 
while several cytosolic loops of Sec61α and the N-terminus of Sec61β were 
recognised by SRβΔTM-apo (Fig. 50). This indicates that the SRβΔTM surface 
required for Sec61αβ binding is the same as observed in the SRXHis:SRβΔTM-GTP 
structure (see 2.4.4).  
In order to test nucleotide specific binding of SRβΔTM to cytosolic Sec61αβ 
loops, cytosolic loops of Sec61αβ have to be tested with SRβΔTM in the apo-form 
and homogeneously loaded SRβΔTM-GDP and SRβΔTM-GTP species. Only 
SRβΔTM-apo could be obtained homogenously from the SRβΔTM preparation. Due 
to the insufficient reloading of SRβΔTM-apo with either GDP or GTP homogeneous 
SRβΔTM-GDP or SRβΔTM-GTP could not be obtained. Therefore, the nucleotide 
dependent binding of SRβΔTM to Sec61αβ could not be tested. Nevertheless, 
peptides from cytosolic Sec61αβ loops were highlighted by the apo form of SRβΔTM, 
but not by SRβΔTM in complex with GTP and either SRXHis or SRαHis (Fig. 50).  
 
Figure 49 Sequence alignment of M. jannaschii SecG and cytosolic loop regions of SecY with the 
respective human Sec61αβ sequences. Numbering of the residues is according to human 
Sec61αβ. Conserved residues are indicated by asterisks and in red, more similar residues by 
colons and in green, less similar residues by single points and in blue. Dissimilar residues are in 
black. Residues in italics are not represented in the M. jannaschii SecYEG model (PDB accession 
code 1RHZ). 
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Since GEFs facilitate the release of GDP from GTPases and stabilise the apo form, 
these observations are in agreement with Sec61αβ acting as GEF for SRβΔTM.  
 
 
 
 
 
 
Figure 50 The interaction between SR and the Sec61α and Sec61β subunits of the translocation 
pore depends on the availability of the switch regions of SRβ. Cytosolic loops of human Sec61α and 
Sec61β are represented by 13-mer peptides with a three amino acids step (Jerini Peptide 
Technology GmbH, Berlin) and were probed with either SRβΔTM-apo (A), SRXHis:SRβΔTM-GTP (B) 
or SRαHis:SRβ-GTP (as B, not shown). The spotted regions are: Sec61α: N-terminus (spots 1-8), L2 
(10-15), L4 (17-20), L6 (22-32), L8 (34-47), C-terminus (49-53); Sec61β (55-83) and follow the 
labels α, L2, L4, L6, L8, C and β respectively. All labels but α were placed on regions void of 
peptides. Spot 1 was never highlighted. The predicted single transmembrane helix of Sec61β is 
labelled. Coloured boxes represent peptides that have been highlighted by the experiment and 
contain spots with an average intensity of more than approximately 1.5 times the background. The 
colour code is the same as in Fig. 51. The nucleotide load was verified by HPLC (not shown). 
 
Figure 51 Translocon sequences covered by the immobilised peptide library aligned with the 
sequence of the M. jannaschii homologue. Sequences were aligned, numbered and labelled as in 
Fig. 50. Sequences found to be positive in the assay are indicated in colours also used in Figs. 50
and 52 and the numbers of the respective spots found in Fig. 50. Only the highlighted sequences of 
L4, L6 and the C-terminus of Sec61α proved to be positive with all successive peptides. Amino 
acids in Sec61β that are not included in the M. jannaschii translocon model (PDB accession number 
1RHZ) are indicated in italics.  
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Above the interaction of SRβΔTM-apo with cytosolic Sec61αβ loops was analysed 
focussing SRβΔTM-apo. Here, the cytosolic loops of Sec61αβ are described.  
The strongest signals were obtained for SRβΔTM-apo and the ‘back’ side of 
the translocon (Figs. 50 and 52). L6 consists of a β-hairpin structure protruding from 
the translocon channel and peptides representing almost the complete loop give 
strong signals (spot numbers 23-32). The C-terminal helix of Sec61α is highlighted 
by a pair of spots with high intensity (spot numbers 49 and 50). The end of helix 4 
and the N-terminus of loop L4 also give a strong signal.  
 Weaker but still significant signals are observed for peptides close to the 
‘front’ side of the translocon including the binding site of the signal peptide (Fig. 52) 
(Van den Berg et al., 2004). SRβΔTM-apo interacts with the N-terminus of Sec61α 
(spot numbers 2, 4, 6-8) and with loop L8 (spot numbers 37, 39, 40, 44). Importantly, 
loop L2 which is close to the channel opening did not give any signals.  
For the small translocon subunit Sec61β, the N-terminus gives weak signals 
(Fig. 50; spot numbers 59, 60, 62, 63) and two spots of different intensity are 
observed closer to the predicted TM (Figs. 50 and 52; spots 71, 72). The N-terminus 
of human Sec61β is 36 residues longer than in the homologous M. jannaschii SecG 
(Kinch et al., 2002); Fig. 51). Secondary structure predictions of the N-termini do not 
show a clear preference for secondary structure (Ouali and King, 2000) and in the 
crystal structure the first 20 residues of SecG are disordered (Van den Berg et al., 
2004). Therefore, a structural interpretation of this interaction site is not possible (see 
discussion). The signal close to the TM is part of a Sec61β motif that is conserved in 
archaeal and eukaryotic SRβ homologues (Kinch et al., 2002). It is predicted to 
include a small β-strand between Trp56 and Thr60 (Ouali and King, 2000), but in the 
crystal structure this region is part of a loop that folds on top of the Sec61α platform 
and points towards the translocation pore (Fig. 52). 
 In summary, SRβΔTM-apo is likely to bind to cytosolic loops of the translocon 
with a surface that is at least partially occupied by SRα or SRX as observed in the 
SRX:βΔTM structure. The data suggest that SRβΔTM−apo binds on top of the 
translocation channel. The intensities of the signals obtained with peptides from the 
‘back’ side of the translocon suggest stronger interactions than with the ‘front’ side. 
Sec61β peptides highlighted by SRβΔTM-apo involve a binding motif that is 
conserved in archeal and eukaryotic SRβ homologues.   
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2.5.2 SR-SRP:RNC Interaction 
Another important interaction partner of the SR is the SRP:RNC complex. Binding of 
the SR to the SRP:RNC leads to the formation of the docking complex and 
represents a crucial step in cotranslational targeting. During the course of this study, 
the SRP:RNC complex was determined at 12 Å by cryo-EM (Halic et al., 2004) and 
the structural rearrangements upon complex formation were analysed in detail (Wild 
et al., 2004a). As a logical next step, cryo-EM analysis of the complete mammalian 
docking complex was an important goal. In collaboration with Beckmann and co-
workers, the SRαHis:βΔTM complex was employed in the reconstitution of the 
mammalian docking complex. Cryo-EM analysis led to the determination of this 
complex at 8 Å (Halic et al., 2006) shown in Fig. 53. SRαHis:βΔTM was only partially  
ordered. Determination of the SRXHis:SRβΔTM X-ray structure presented in this 
thesis allowed to fit the mammalian SRXHis:βΔTM model into the cryo-EM electron 
density.  
  
 
Figure 52 Mapping of the observed interaction sites on the structure of the M. jannaschii SecYEG 
complex. Peptides from Sec61α and Sec61β recognised in the interaction assay are mapped on 
the structure of the M. jannaschii homolog (PDB accession number 1RHZ). Colours of the 
interacting peptides correspond to the colours in Fig. 51. Translocon subunits, the 'front' and 'back' 
side, as well as the cytosolic loops are labelled. (A) Top view of the translocon as seen from the 
cytosol. (B) Same as (A) rotated by 90°. ER membrane borders are indicated by black lines. The 
platform for SRβ binding is provided by the N-terminal half of SecY (left side), while the C-terminal 
half including the long cytoplasmic loops forms a wall-like arrangement (right side). 
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Figure 53 The SR interacting with the SRP:RNC. Components are labelled, SR corresponds to 
the SRX:βΔTM complex. B is turned 90° relative to A. Image is taken from (Halic et al., 2006). 
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3 DISCUSSION 
The eukaryotic signal recognition particle (SRP) and its receptor (SR) play a central 
role in co-translational targeting of secretory and membrane proteins to the 
endoplasmic reticulum (Keenan et al., 2001,Egea, 2005 #1078). SR is known to bind 
SRP in presence of GTP (Rapiejko and Gilmore, 1992). The SR is a heterodimeric 
complex assembled by the two GTPases SRα and SRβ (Tajima et al., 1986), 
whereas SRβ anchors SRα to the ER membrane (Miller et al., 1995). In vitro the 
eukaryotic SR lacking its transmembrane anchor is fully functional (Abell et al., 2004; 
Fulga et al., 2001; Ogg et al., 1998). SRα is tethered by its N-terminal part to SRβ 
(Young et al., 1995). The binding of nucleotide to SRβ is required for complex 
formation with SRα (Legate et al., 2000; Ogg et al., 1998).  
 
Here, three important topics are discussed: 
1.) The structure of the N-terminal domain of SRα in complex with a soluble form 
of SRβ (SRXHis:βΔTM) as prototype for the interaction of small GTPases with 
longin domains. 
2.) SRβΔTM binds in its nucleotide-free form to the translocon with the surface 
known from the SRXHis:βΔTM X-ray structure. 
3.) Cryo-EM structure of the mammalian docking complex carried out in 
collaboration with Beckmann and co-workers. 
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3.1 The Structure of the Mammalian SRP Receptor: SRXHis:βΔTM 
SRβ reveals highest similarity to the GTP-bound structures of Sar1 in complex with 
Sec23/Sec24 (Bi et al., 2002) (rmsd: 1.30 Å over 143 Cα-positions) and Arf1 (Shiba 
et al., 2003) (rmsd of 1.50 Å over 150 Cα-positions) reflecting their evolutionary 
neighbourhood (Jekely, 2003). Besides the N-terminal membrane anchoring regions, 
the most striking structural difference between SRβ and Arf or Sar1 is an insertion 
between helix α4B and strand β6B (37 residues compared to Sar1). Helix α4B is 
extended by two turns and protrudes from the protein core as described earlier 
(Schwartz and Blobel, 2003). The insertion is partially disordered and no particular 
function has been attributed to it so far.  
The SRX domain (see Figs. 41, 42) belongs to the mixed α/β class proteins 
sharing topology (ββαβββαα) and fold of the SNARE-like protein superfamily 
(http://scop.mrc-lmb.cam.ac.uk/scop) including the N-terminal domains of non-
syntaxin SNAREs (longin domains). Helix α1X flanking loop regions are not 
conserved and only partially visible in the structure. The buried surface between 
SRβ-GTP and SRX is 1850 Å2, which is similar to the yeast structure and other 
GTPase-effector complexes (Schwartz and Blobel, 2003). 
3.1.1 The SRXHis:βΔTM-GTP ‘Dimer’  
The mammalian SRXHis:SRβΔTM-GTP complex forms a crystallographic 
'dimer' due to an interaction of the SRX domains involving a domain swap of helix 
α1X  and the formation of a continuous trans β-sheet (see Fig. 43). Considering that 
α1X satisfies the hydrophobic core in the 'monomeric' and 'dimeric' state, this buried 
surface can not be taken into account to reflect the stability of the 'dimer'. Therefore, 
dimerisation leads to an additional buried interface of approximately 1000 Å2 between 
the two SRXHis:SRβΔTM-GTP 'monomers'. This reflects a complex that is much more 
labile than SRX associated to SRβΔTM. In fact, in solution a KD of 270 µM was 
determined for the 'dimer' (Jacek Mazurkiecz and Karsten Rippe from the Kirchhoff 
Institut fur Physik, Heidelberg). The low KD is also reflected by the fact that crystals 
took usually four weeks to grow and that the ‘dimer’ was not observed meanwhile 
size exclusion chromatography of the protein. This can be explained by the dilution of 
the protein over the column, reducing the amount of ‘dimer’ below the level of 
detection.  
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We cannot directly conclude from this result in solution to the state of the 
complete SR complex at the membrane since full length SRαβ is anchored to the 
membrane in vivo. It is considerable that the membrane anchored receptor occurs in 
locally elevated concentrations increasing the likelihood of homodimerisation. The 
‘dimer’ has not been reported before. Therefore, the physiological relevance for the 
dimerisation of SRXHis:SRβΔTM-GTP is not clear. The 'dimer' might be as well 
enforced by crystal packing. It is not clear whether the crystal symmetry favours the 
domain swap of the flexibly linked helix α1 (see below) due to steric hindrance or, 
more likely, the dimer selects this crystal symmetry. The simultaneous formation of 
the trans β-sheet stabilises oligomerisation by main chain hydrogen bonding. 
Still, a potential homodimeric form is unlikely existing when the SR is 
complexed to SRP54 because of sterical hindrances. Therefore, one could think of 
the homodimeric state as a stabilisation of the SR, especially SRα with its floppy 
linker region between X domain and NG domain, in its inactive state when it is not 
complexed to SRP54. The low affinity between two SRs could be useful in vivo in 
order to allow a fast release of the monomeric form on demand. 
Interestingly, the comparison with the yeast structure ('monomer', see below) 
showed that the domain-swapped helix α1X of the second SRX molecule of the 
mammalian receptor superimposes with its corresponding position in the yeast 
'monomer'. Therefore, a 'monomeric' mammalian receptor complex was used for 
analysis. 
3.1.2 Comparison with SRX:SRβΔTM-GTP from Yeast 
The structures of mammalian and yeast SRβΔTM-GTP (Schwartz and Blobel, 2003) 
are conserved (rmsd of 1.16 Å over 158 Cα-positions, yeast is distinguished in the 
following by a 'y' subscript). Differences include the lengths of the β-strands β2Β and 
β3B that are almost twice as long in mammals and helix α4B that is two turns shorter 
(Fig. 54).  
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In contrast, there are significant differences in SRX (rmsd of 1.81 Å over 75 
Cα-positions) (Fig. 54). In the yeast structure there is no helix swap leading to a 
SRXHis:SRβΔTM-GTP 'dimer'. Instead, the central β-sheet of SRXy is extended by 
one strand (β3Xy) between helix α1Xy and strand β4Xy (β4Xy corresponds to strand β3X 
in our structure), which apparently stabilises the position of helix α1X and thereby 
prevents 'dimer' formation. While helix α1X and the β1X-β2X hairpin in the interface 
superimpose very well, the central β-sheet and the connected helices α2X and α3X do 
not. Differences increase with distance from the SRXHis:SRβΔTM interface.  
 
 
Figure 54 Comparison of mammalian and yeast SRβ-GTP:SRX complexes. Superposition of the 
mammalian and yeast SRβ-GTP:SRX complexes based on SRβ. The yeast structure (PDB code: 
1NRJ) is shown in grey, yeast insertions in black, and mammalian insertions in blue. Insertions 
mentioned in the text are labelled. 
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Yeast SRX shows two major insertions (Figs. 54, 55). A 20 residue insertion 
elongates the central β-sheet by introducing the sixth β-strand (β3Xy: Glu46Xy to 
Ala49Xy) and a loop touching helix α2Xy on the convex side of the β-sheet. A 15 
residue insertion changes the conformation of the loop between helices α2X and α3X 
and the herein inserted helix αLX is not present. The C-terminal helices (α4Xy and 
α3X) do not align which might be due to a truncation of this helix in the yeast 
structure. With its insertions, yeast SRX is unusual compared to other SRX domains. 
The observed structural differences between mammalian and yeast SRX are 
reflected by the low degree of conservation on the sequence level (14.2% identity, 
Fig. 55). Low sequence conservation is a general feature of the SRX family 
(Schwartz and Blobel, 2003). One functionally important exception is the conserved 
Gly12X in the β1X-β2X hairpin (Figs. 54, 55). It facilitates the β-hairpin turn and a bulky 
side chain would sterically interfere with binding of SRβ. Position and amphipathic 
Figure 55 Alignment of longin domain sequences. The alignment is based on structures (bold 
sequences) or secondary structure predictions (regular). Known structures include human and yeast 
SRX, mouse Sec22b (PDB code: 1IFQ, chain A), yeast Ykt6 (1H8M), mouse SEDL (1H3Q), human 
AP2-σ2 (1GW5, chain S) and AP2-Nµ2 (1GW5, chain M). The structures of ζ-COP (hCOPZ), δ-COP 
(hCOPD), and the SNARE hVamp7 are not known. Sequence numbering and secondary structure 
assignment are shown for human SRX above the aligned sequences (β-strands in yellow, α-helices in 
orange). The secondary structure is indicated in all sequences. The conserved glycine in the β1X-β2X
loop is marked in red. The residue causing a conserved anomaly in strand β2X is indicated in green, 
and the critical polar position in α1X hydrogen bonding to the P loop in SRβ is highlighted in blue. 
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character of the important helix α1X are conserved. Asn30X is conserved between 
human and yeast and interacts with SRβ by hydrogen bonding to the switch I region. 
 
 
A polar residue one turn further appears to occupy a crucial position within helix α1X. 
Arg34X forms a salt bridge with Asp72B in the P loop and thereby influences the 
position of the catalytic histidine (His119B) with respect to the active site of SRβ (Fig. 
56). Although this salt bridge is not conserved, a polar interaction is observed in the 
yeast structure between Ser35Xy and Gln47By within the P loop, suggesting a similar 
role. 
 
3.1.3 SRX as Effector for SRβ 
SRX occupies large parts of a typical GAP binding site (Corbett and Alber, 2001) as it 
interacts with the P loop and the switch regions of SRβ-GTP resulting in the 
stabilisation of switch II. However, in the SRX:SRβΔTM-GTP complex the catalytic 
histidine (His119B) in switch II of SRβ (Gln61 in Ras, Gln71 in Arf) is in a 'resting' 
position pointing away from the active site (Fig. 56), the characteristic arginine finger 
of a GAP (Scheffzek et al., 1998) is not present, and the complex is stable when 
bound to GTP. Therefore, the SRX:SRβΔTM-GTP complex is not a GTPase:GAP 
complex and for the stimulation of GTP hydrolysis an additional binding partner is 
needed. The RNC has been shown to stimulate GTP hydrolysis of SRX:SRβΔTM-
 
 
Figure 56 Comparison of mammalian and yeast SRβ-GTP:SRX complexes. Close up of the 
superposition showing the active site of SRβ. The interaction between the P loop and helix α1X is 
indicated. The catalytic histidine is pointing away from the active site and hydrogen bonded to the 
switch II region in both structures. 
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GTP (Bacher et al., 1999). However, the RNC does not act as GAP for SRβΔTM-
GTP alone (Legate and Andrews, 2003). Therefore, the SRX domain can be 
assigned as co-GAP for SRβ which fulfils one part of the GAP function by stabilising 
switch II. Examples for a split GAP function have been reported before. The GAP for 
the α-subunit of a heterotrimeric G protein (Giα1) also stabilises the switch regions, 
but the arginine finger is supplied in cis by an additional domain of the GTPase 
(Tesmer et al., 1997). A unique feature of the Arf1:ArfGAP1 structure is the exclusive 
stabilisation of the switch II region (Goldberg, 1999). The switch I region is 
recognised by the heptameric coat protein complex (COPI) (Zhao et al., 1999), which 
is found to stimulate GTP hydrolysis (Goldberg, 1999). Most likely an arginine finger 
is needed to trigger GTP hydrolysis in Arf1 (Goldberg, 1999), which might be the 
case as well in SRβ.  
The co-GAP function can be explained by a comparison of SRX:SRβ-GTP 
with the structure of the Ras-GDP-AlF3:RasGAP transition-state complex (Scheffzek 
et al., 1997). When SRβ is superimposed on Ras, the loop of RasGAP containing the 
arginine finger (Arg789RasGAP) fits between SRβ and SRX (Fig. 57). The only sterical 
clash concerns the arginine finger itself, which would interfere with the salt bridge 
between Arg34X and Asp72B. In addition, the Ras-GDP-AlF3:RasGAP complex 
contains a second arginine (Arg903RasGAP) in close proximity to Arg34X (Fig. 57). 
Arg903RasGAP forms a salt bridge to Glu63Ras in the switch II region of Ras thereby 
stabilising the switch II region. In SRX:SRβ-GTP the catalytic residue His119B is 
hydrogen bonded to the corresponding residue of Glu63Ras (Ser121B) (Fig. 57B).  
The comparison of SRX:SRβ-GTP with the Ras-GDP-AlF3:RasGAP complex 
suggests that upon the insertion of an arginine finger into the GTP binding pocket the 
salt bridge between Arg34X and Asp72B can be disrupted. The liberated Arg34X may 
then swing from the P loop towards Ser121B in switch II forming a hydrogen bond 
(Fig. 57C). His119B would therefore be released, the catalytic water can be 
positioned and hydrolysis occurs. Mutants in which the salt bridge is disrupted 
(Asp72BGly and an Arg34XAla) still form the SRX:SRβ-GTP complex (data not 
shown) indicating that the missing GAP is essential to stimulate GTP hydrolysis. The 
large conformational changes that are typically observed in the effector region upon 
GTP hydrolysis are expected to disrupt the SRX:SRβ interface and lead to the 
dissociation of the SR complex (Schwartz and Blobel, 2003). 
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3.1.4 Longin Domains 
SRX belongs to the superfamily of SNARE-like proteins with the longin domain fold 
(Filippini et al., 2001). Sequence homology within the superfamily is low (Fig. 55), but 
the structural homology is high (Fig. 59) as illustrated by the comparison of SRX with 
SEDL (Jang et al., 2002), with the SNAREs Sec22b (Gonzalez et al., 2001) and Ykt6 
(Tochio et al., 2001), and the μ2 (N-terminal domain) and σ2 adaptins (Collins et al., 
2002). 
 In order to determine conserved elements within the longin domain fold we 
prepared a structure based sequence alignment of structurally known longin domains 
and of important longin domain candidates (ζ-COPI, Nδ-COPI, VAMP7; Fig. 55). 
Among longin domains with known structures, SRXy reveals specific insertions like 
 
 
Figure 57 Split GAP model for SRβ activation. The model is based on the superposition of the 
respective GTPases within SRX:SRβ-GTP and the Ras-GDP-AlF3:RasGAP complex (grey, PDB code: 
1WQ1). (A) SRX:SRβ-GTP is shown together with the finger loop of RasGAP containing  the arginine 
finger Arg789RasGAP. The loop fits between SRβ and SRX and the arginine finger interrupts the Arg34X-
Asp72B salt bridge. (B) Superposition of the active sites. Arg903RasGAP occupies a similar position as 
Arg34X. In the activated Ras:RasGAP complex, the arginine binds to Glu63Ras (position Ser121X in 
SRX) and the catalytic Gln61Ras is bound to the nucleophilic water in the active site. (C) Model of GAP-
activated SRX:SRβ-GTP. Arg34X could bind to Ser121B in a similar way as Arg903RasGAP to Glu63Ras. 
His119B is rotated into the active site. The arginine finger could be provided by the RNC-SRP 
complex. 
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strand β3Xy whereas the mammalian structure is closer to other members of the 
superfamily. Longin domains share the ββαβββαα topology as described for SRX 
(Fig. 55). The glycine residue (Gly12X in SRX) in the β1-β2 hairpin is highly 
conserved (Fig. 55), and the hairpin adopts a similar conformation in all longin 
domain structures. Only in SEDL this glycine is exchanged for an aspartate and the 
change is compensated by adjustments in the adjacent β-strands. Ykt6 comprises a 
unique insertion of three residues. Helix α1 is an essential component of the longin 
domains (see below). The amphipathicity of helix α1 is highly conserved, while there 
is no conservation on the sequence level and the length ranges from three (SRX) to 
six turns (Ykt6). The orientation of helix α1 with respect to the central β-sheet varies 
in the different longin domains (Fig. 59). Flexibility is reflected by elevated 
temperature factors in the loops connecting helix α1 to the β-sheet (not shown) and 
in the SRX structure the flexibility is responsible for 'dimer' formation by the swap of 
helix α1X. 
 A conserved β-sheet anomaly (down-up-up-down) is the insertion of a bulky 
hydrophobic residue (Leu15X in SRX, Fig. 5) within strand β2. It seems to be 
important for stabilising the protein core and indicates an evolutionary relationship 
between the longin domains. The C-terminal helix α3 differs in length and orientation 
between the individual structures and superimposes best for Sec22b, SEDL and 
SRX. Helix α3 is truncated in the longin domains of the AP2-complex (Nμ2, σ2), 
which according to secondary structure predictions is also the case in other AP 
complexes and the COPI-complex (Nδ-, ζ-COPI) (Fig. 55). Here, the longin domain 
fold is extended by a β-hairpin structure followed by another helix forming a fourth 
layer in the back of the longin domain fold (not shown). The length and the 
conformation of the loop regions vary significantly (Fig. 59). 
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3.1.5 GTPase: Longin Domain Complexes at Endomembranes 
The localisation of longin domains at the endomembrane system correlates with the 
presence of small membrane-associated GTPases like the Arf and Sar1 proteins 
which are the closest relatives of SRβ. The structural conservation and the co-
localisation strongly suggest that other GTPase:longin domain interactions may exist. 
Two hydrophobic patches flanking helix α1 were noticed previously in longin domain 
structures and were proposed as protein-protein interaction surfaces (Gonzalez et al., 
2001; Jang et al., 2002; Tochio et al., 2001). Interestingly, these patches are 
conserved in structurally determined longin domains (Fig. 59). In the SRXHis:SRβΔTM 
complex, SRβ binds to this interaction surface. SRβΔTM intercalates its switch I 
region between helix α1X and the SRX β-sheet, one of the helix flanking hydrophobic 
patches is extended and forms a hydrophobic groove (Figs. 59, 60). In free longin 
domain structures the hydrophobic groove is absent (Fig. 59). The opening of the 
groove can be envisaged by rolling the conserved amphipathic helix α1 onto the 
second hydrophobic surface patch on the other side of the helix. The flexibility of 
helix α1 is therefore a prerequisite for the interaction of longin domains with their 
respective GTPase. 
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Figure 59 Comparison of longin domains and flexibility of helix α1. Longin domain structures are 
depicted in ribbon and surface representations (PDB codes are given). SRX is oriented to show 
the surface interacting with SRβ. All structures are oriented accordingly. The structures of longin 
domains other than SRX have been determined as monomers or in context of the AP-2 'trunc' 
(Nµ2 and σ2). Colour code corresponds to hydropathicity (Kyte and Doolittle, 1982). The different 
orientations of helix α1 are indicated by a grey line. The hydrophobic grooves in SRX and SRXy
are marked by black arrows. Hydrophobic patches are shown by blue and white arrows, 
respectively. Previously described hydrophobic patches are boxed (SEDL (Jang et al., 2002); 
Sec22b (Gonzalez et al., 2001); Ykt6 (Tochio et al., 2001)). The rmsd values of all longin domains 
in respect to SRX are given. 
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While the conservation of the hydrophobic patches suggests a similar mode of 
GTPase:longin domain interaction, the low degree of conservation reflects the special 
adaptations of the individual systems. For example, in all known longin domains the 
equivalent position of Arg34X within helix α1X (Figs. 47, 48 and 56) seems to be 
occupied by a charged or polar residue (Fig. 58). In the respective GTPases the 
same is true for the residue at the position equivalent or adjacent to Asp72B in the P 
loop. Therefore, a polar contact between helix α1 and the P loop might be present in 
all GTPase:longin domain interactions. As discussed for the co-GAP function of SRX 
(see above), the residues corresponding to Arg34X could also participate in the 
stabilisation of the switch II regions of the respective GTPases. The mammalian 
SRXHis:SRβΔTM complex can thus be regarded as a structural prototype for a 
GTPase:longin domain interaction. Although there is no direct experimental proof, to 
our knowledge this idea does not contradict any previous data. 
Structures of longin domains other than SRX have been determined as 
monomers (Sec22b, Ykt6, SEDL) or in context of the AP adaptin 'trunc' complex. All 
clathrin adaptor complexes (AP-1,-2,-3,-4) and COPI share a tetrameric 'trunc' 
organisation that consists of two large, a medium and a small subunit (McMahon and 
Mills, 2004). COPI- and AP-complexes contain two copies of longin domains (Nδ- 
and ζ-COPI, and AP-Nµ and -σ, respectively). In the structure of the AP-2 complex 
Figure 60 An adjustable hydrophobic surface within longin domains. SRβ-bound SRX and free 
SEDL are shown in the same orientation with semi-transparent surfaces. Helix α1 and the β1-β2 
hairpin are labelled. Colours are according to hydropathicity and hydrophobic groove and patches 
are indicated. SRX surface as prototype for a GTPase-bound longin domain (to the left). The 
switch I region of SRβ (blue ribbon) binds into the hydrophobic groove created by the 'packing' 
defect of helix α1X and the central SRX β-sheet. Ile94B is inserted into a pocket in the centre of the 
interface. SEDL as an example for a free longin domain (to the right). The hydrophobic groove is 
not present. 
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(Collins et al., 2002), the two longin domains form the core of the 'trunc' with the 
respective α1 helices being in close proximity. Therefore, a tandem GTPase:longin 
domain interaction might be an important feature in all these complexes. 
  
3.1.3 A molecular Explanation for a Genetic Disease  
The GTPase:longin domain concept offers a structural explanation for the occurrence 
of spondyloepiphyseal dysplasia tarda (SEDT), an X-linked skeletal disorder 
characterised by a short trunk (MacKenzie et al., 1996). Point mutations in the human 
SEDL protein seem to be involved in a defect in cartilage transport from the ER to the 
Golgi apparatus (Sacher, 2003). The yeast homologue of SEDL (Trs20p) has been 
shown to be part of the highly conserved transport protein particle I (TRAPP I) that is 
required to tether ER-derived vesicles to the Golgi (Sacher et al., 1998) and consists 
of ten subunits (Wang et al., 2000). 
When the structure of SEDL is superimposed with SRX in the SRXHis:SRβΔTM 
complex (Fig. 61), the pathogenic Asp47Tyr mutation in human SEDL would be 
located on the protein surface within helix α1X in close proximity to the catalytic 
residue His119B and the interacting Ser121B of SRβ (see Fig. 56). There is no 
structure of the corresponding SEDL:GTPase complex, however Ypt1p has been 
shown as the TRAPP interacting GTPase (Jones et al., 2000; Sacher et al., 2001; 
Wang et al., 2000) and according to our model Gln67 and Arg69 in Ypt1p could form 
a favourable interaction with Asp47SEDL. Thus, the mutation most likely disturbs the 
GTPase regulation by interfering with the positioning of the catalytic residue.  
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3.2 Analysis of Interactions with SR and Components of the SRP 
Cycle  
3.2.1 SRβΔTM Binds in its Nucleotide-free Form to the Translocon 
Data obtained from this work suggest interactions between a binding surface of 
SRβΔTM-apo which binds to SRX in the SRXHis:SRβΔTM complex. Additionally, there 
is indication that SRβΔTM-apo interacts with defined regions of both Sec61α and 
Sec61β.  
The Sec61β homolog in yeast (Sbh) has been previously proposed to act as 
GEF for SRβ (Helmers et al., 2003). Since GEFs facilitate the release of GDP from 
GTPases and stabilise the empty form, it seems likely that SRβΔTM-GDP interacts 
with the translocon similar to the apo-form. These data localise the GTPase-effector 
interaction to cytosolic loop regions in Sec61α and β. For the yeast translocation pore 
sequence alignments show a homology of the Sec61β and the Sec7 protein family 
(Helmers et al., 2003; Jackson and Casanova, 2000; Mossessova et al., 1998). Sec7 
acts as GEF for Arf proteins and the structure of the Sec7/Arf complex shows the 
relevant interactions (Mossessova et al., 2003; Renault et al., 2003). However, the 
homology between Sec61β and Sec7 is very low, important residues are missing in 
 
 
Figure 61 Superposition of SRX and SEDL. SRX is shown in green and SEDL in magenta. 
Secondary structure assignment is given for human SRX. The pathogenic point mutation 
(Asp47SEDLTyr) within helix α1 at the protein surface is indicated. 
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Sec61β, and the secondary structure is not conserved. The Sec7 domain consists of 
200 residues, whereas the cytosolic domain of Sec61β is much shorter (66 residues 
for human SRβ) and shows only low conservation (Kinch et al., 2002). Since 
structural information is missing, it is still possible that the signals obtained here for 
Sec61β correspond to an interaction surface like in the Arf/Sec7 complex (Helmers et 
al., 2003). 
So far, a precise role of the Sec61α subunit for SRβ binding has not been 
described. Recent studies showed that L6 was not involved in ribosome binding, and 
the binding partner of L6 was not identified. However, L6 seems to be important in 
co-translational translocation, and an interaction of L6 with the SR was recently 
proposed based on pulse labelled protein translocation experiments in yeast (Cheng 
et al., 2005). Our data suggest that almost the complete loop L6 is an important 
component of the interaction with SRβ-apo and SRβ-GDP. Since in addition to loop 
L6 a number cytosolic loop regions also contribute to SRβ binding, Sec61α might act 
as a binding platform for SRβ. 
The structure of Sec61α shows a pseudo-two-fold symmetry which divides it in 
two halves comprising TMs 1-5 and TMs 6-10 (Fig. 52) (Van den Berg et al., 2004). 
Cytoplasmic loops of the C-terminal half (L6, L8, and C-terminus) of Sec61α protrude 
significantly into the cytosol (Fig. 52). Since almost the complete cytoplasmic surface 
is involved in SRβ binding, the following model for the SRβ-Sec61α complex is 
proposed: The β-hairpin structure of L6 forms a β-sheet in trans with SRβ as it is 
known to occur in the interaction between other Ras-like GTPases and their effectors 
(Corbett and Alber, 2001). Taking the Arf-Sec7 complex as a model (Mossessova et 
al., 2003; Renault et al., 2003), the L6 β-hairpin could even insert between the so-
called interswitch region and the central β-sheet of SRβ (not shown). This interaction 
would still leave room for Sec61β to bind to the adjacent switch I and II regions of the 
GTPase as observed in the Arf-Sec7 crystal structure and thereby to act as a GEF. If 
Sec61α contributes to the GEF function remains to be seen. 
Taking into account the structural information on Sec61 and the small size of 
the small GTPase SRβ the contribution of all regions of Sec61 that interact with SRβ 
according to our data suggests that SRβ binds on top of the translocation channel 
(Fig. 52). The N-terminal half of Sec61α with its short loop regions might form a 
binding platform, whereas the C-terminal half including loop L6 acts as a docking 
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station (Figs. 52 and 62). Although the intensity of the signals obtained with peptides 
from the ‘back’ side of the translocon suggests stronger interactions than the ‘front’ 
side, detailed binding experiments with isolated peptides have to be performed to 
confirm the preferred binding site. The most prominent signal in the assay (spot 
number 17) includes significant parts of helix α4. As the following peptide (shifted by 
three residues towards the L4 loop) does not give a signal, helix integrity might play a 
role for stable SRβ docking. 
Since the strong signals obtained with SRβ-apo are completely lost when the 
SRXHis:SRβΔTM or SRαHis:SRβΔTM complexes are used, the surface of SRβΔTM-
GTP binding to SRX, as known from the structure of the SRXHis:SRβΔTM-GTP 
complex, must at least partially overlap with the surface of SRβΔTM-apo generating 
signals in this assay. Since a GEF would facilitate GDP release from a GTPase and 
stabilise the apo form, this data supports previous data indicating a GEF function of 
the translocon (Helmers et al., 2003). A nucleotide-dependent model of the 
translocon SRβ interaction can be envisaged as follows: While SRβ-apo is likely to 
block the translocation pore, in its GTP bound form it might swing aside to bind SRα 
leaving the translocon accessible for an incoming RNC-SRP complex (Fig. 62).  
 
 
 
Figure 62 Model for nucleotide dependent interactions of SRβ in the context of SRα and the 
translocon. SRα is shown in green, SRβ in blue, the translocon in magenta and the positions 
of SRX and Sec61α loop L6 are indicated. SRβ-apo binds mainly to L6 and blocks access to 
the translocon on the cytosolic surface. In the GTP-bound state, SRβ detaches from the 
translocon and binds to the SRX domain of SRα with its effector region that was part of the 
interface with the translocon before. The translocon is left for free access of the RNC-SRP 
complex and SR is ready to access SRP.  
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This model is consistent with GTP binding to SRβ being necessary for efficient 
protein translocation (Fulga et al., 2001). It is not known, whether GTP hydrolysis in 
SRβ occurs in each SRP cycle and which would likely lead to the dissociation of SR. 
The location of the transmembrane helix of SRβ with respect to the transmembrane 
helices of the translocon is not known. With the extensive contacts between the SRβ 
GTPase and the cytosolic loops of the translocon it seems possible that the TM of 
SRβ attaches to the translocon within the membrane. Interestingly, the bacterial 
Sec61β homolog SecG comprises two TMs and cryo-EM data (Breyton et al., 2002) 
place them side-by-side on the SecY surface. Bacteria do not code for SRβ, which 
makes it tempting to speculate that the TM of SRβ might have replaced the extra TM 
of the SecG protein and could therefore be located in direct neighbourhood of the 
Sec61β TM. 
The translocation pore is known to form oligomers in the membrane, but 
despite a high resolution crystal structure (Van den Berg et al., 2004) the architecture 
in the membrane is still under debate (Beckmann et al., 1997; Beckmann et al., 2001; 
Breyton et al., 2002; Manting et al., 2000; Menetret et al., 2000; Mitra et al., 2005; 
Mori et al., 2003). One model suggests a back-to-back associated dimer of SecY 
complexes derived from a 2D-crystal structure (Breyton et al., 2002) while another 
one suggests a front-to-front arrangement derived from cryo electron microscopy 
(Mitra et al., 2005). A third model prefers a tetrameric arrangement (Manting et al., 
2000). A back-to-back arrangement could merge with a tetrameric assembly into an 
assembly of two dimers side-by-side (Van den Berg et al., 2004). Crosslink data 
support an oligomeric SecY complex assembly but neither go along with a front-to-
front nor back-to-back orientation of the monomers (Veenendaal et al., 2001). The 
implications of translocon oligomerisation for the co-translational targeting process 
are not clear (Dobberstein and Sinning, 2004; Mitra et al., 2005; Van den Berg et al., 
2004). In principle, one SRβ subunit could bind stoichiometrically to a single 
translocon complex. From cryo-EM data (Beckmann et al., 2001; Mitra et al., 2005) it 
is evident that only one translating ribosome can be bound to an oligomeric 
translocon, and therefore only one SRβ would be necessary to support SRP 
dependent targeting. However, several SRP receptors bound to a translocon 
oligomer could be advantageous for efficient co-translational targeting as it has been 
suggested for the recruitment of enzymes required for modification of the synthesised 
protein (Dobberstein and Sinning, 2004). 
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 Taken together, this data support the idea of an interaction of SRβ with the 
translocon depending on the nucleotide load of SRβ. It is suggestive that the surface 
of SRβΔTM participating in the SRXHis:SRβΔTM complex at least partially overlaps 
with the surface of SRβΔTM-apo highlighting to the cytosolic translocon loops. 
SRβΔTM binds in its nucleotide-free form, but not when in complex with GTP and 
either SRX or SRα, to the translocon, supporting data that the translocon acts as a 
GEF for SRβ. SRβΔTM-apo binds to the Sec61α and Sec61β subunits. The observed 
signals are best explained by a model in which Sec61α functions as a binding 
platform for SRβ with an important contribution by the cytosolic loop L6. Therefore, 
Sec61α might contribute to the GEF function which was previously attributed to 
Sec61β.  
3.2.2 Analysis of the SR Interacting with the SRP:RNC Complex 
 
Comparing the structures of the SRP:RNC complex and the docking complex, it is 
interesting to note, that the SRP54NG and the SRαNG domains can not be localised 
(Fig. 63A), implying a high flexibility of these domains upon docking complex 
formation. It is interesting to note that in previous cross-linking studies (Pool et al., 
2002) SRP54 could be cross-linked to two ribosomal proteins. However, in the 
presence of SR one of these cross-links was lost. While a more detailed 
 
Figure 63 Delocalisation of the NG domains and exposure of the translocon binding site in the 
docking complex. The SR is in green, the SRP in red, the large ribosomal subunit in blue and the 
small ribosomal subunit in yellow. The image is modified from (Halic et al., 2006). The top panel 
shows the SRP:RNC complex (Halic et al., 2004), the lower panel the docking complex (Halic et 
al., 2006) from the same perspective. In A, the view is on the SRP S domain, in B the view is on 
the ribosomal exit site (indicated by an asterisk). The translocon and its ribosomal connections are 
indicated by a white contour. 
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interpretation of this observation was not possible before, the cryo-EM data put it now 
on a structural basis. With the observed delocalisation of the NG domains, an 
important part of the ribosomal translocon binding site is exposed (Beckmann et al., 
2001)  
So far, it is not clear whether a monomeric or oligomeric translocon 
arrangement binds to the SRP:RNC complex. The oligomerisation state of the 
translocon or the translocon:ribosome complex has been analysed before by different 
techniques. A homodimeric covalently linked SecYEG complex was shown to form a 
functional translocon by complementation assays (Duong, 2003). Homodimers are 
also proposed from analysis of two-dimensional crystals (Breyton et al., 2002). 
Fluorescence resonance energy transfer (FRET) experiments suggest that two or 
more SecYE complexes associate in the lipid bilayer (Mori et al., 2003). Functional 
assays, negative stain EM data and mass measurements with the scanning 
transmission microscope point towards a tetrameric translocon assembly (Manting et 
al., 2000). Also, EM data of detergent treated yeast and mammalian translocons 
reveal homotrimeric to homotetrameric translocon complexes (Hanein et al., 1996). 
Cryo-EM data showed before that a translocating ribosome can bind either to a 
homotrimeric translocon (Beckmann et al., 2001) or an unusual homodimeric 
assembly (Mitra et al., 2005). Although the latter one seems questionable, it is still 
under debate. 
The relatively small spatial rearrangements occurring upon docking complex 
formation (Fig. 63) (Halic et al., 2006) suggest now that a monomeric translocon 
could bind to the docking complex. This would be in agreement with the X-ray 
structure of a monomeric SecYEG complex suggesting that a single translocon forms 
a functional translocation unit (Van den Berg et al., 2004). This proposal is supported 
by immunoprecipitation experiments showing that no co-immunoprecipitation was 
found between translocation complexes assembled from HA-tagged and wild-type 
SecE (Yahr and Wickner, 2000).  
In summary, the cryo-EM docking complex structure (Halic et al., 2006) 
highlights the flexibility of the NG:NG complex which leads to the exposure of an 
important translocon binding site at the ribosome. Whether the translocon binds as a 
monomer or as an oligomer remains to be shown.   
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4 Outlook 
The data presented here emphasises the importance of the interaction between 
longin domains and small GTPases at the endomembrane system of eukaryotic cells. 
As a next step the interaction between Ypt1p and SEDL could be further examined in 
vitro and in vivo in order to explain one of the mutations in SEDL leading to the 
disease SEDT. Another interesting result is the suggestion of a functional interaction 
between Arf1 and ζ-COPI or Nδ-COPI. Binding studies should give further insights in 
the assembly of COPI vesicles. 
SRβ binds in its nucleotide-free and likely GDP state to the translocon. This is 
in agreement with the translocon acting as a GEF for SRβ. Peptides that were 
highlighted in the binding assay by SRβΔTM-apo could be used in isothermal 
calorimetry or fluorescence spectroscopy experiments. This would allow to further 
narrow down and determine crucial SRβ translocon interactions. 
The reconstitution of a part of the mammalian SRP S domain was the basis for 
further structural characterisation. Crystallisation experiments have to be continued 
for SRP and the SRP:SR complexes. Mutants of SRP and SR proteins will 
characterise the kinetics of complex formation of the SRP:SR complex. SRP68 and 
SRP72 are poorly characterised. Reconstitution experiments of the complete S 
domain with the SR could analyse the functional role of SRP68 and SRP72 in more 
detail.    
In collaboration it was shown that binding of the SR to the SRP:RNC complex 
leads to the exposure of an important translocon binding site on the ribosome. Cryo-
EM analysis of the SRP:RNC:SR complex with translocon proteins will answer the 
question whether a monomeric or an oligomeric translocon contacts the ribosome. 
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5 MATERIALS AND METHODS 
 
5.1 CHEMICALS, ENZYMES AND CLONING KITS 
 
Chemicals were bought from Sigma-Aldrich Chemie GmbH (Germany) and Merck 
(Germany). Columns and resins for protein purification were obtained from 
Pharmacia, Sweden. Restriction enzymes and buffers were obtained from NEB (New 
England Biolabs, USA). Nucleotides and nucleotide analogues were bought from 
Sigma-Aldrich Chemie GmbH (Germany). Protease inhibitor tablets Complete were 
EDTA free and purchased from Boehringer (Germany). Blotting membranes were 
purchased from Schleicher and Schuell (Germany). Immobilised peptide libraries 
were synthesised on a PepSPOT membrane from Jerini, Germany. Crystallisation 
kits from the following companies were used: Emerald BioSystems (USA), Hampton 
Research (USA).  
Standard Mini-, Midi- and Maxi-Prep Kits from Qiagen (Germany) were used to 
prepare DNA according to the manual. Kits for the purification of DNA (QIAquick PCR 
purification kit and QIAquick Gel Extraction Kit) were obtained from Qiagen 
(Germany) and used according to manufacturer’s instructions. The following cell lines 
were used for plasmid preparation and cloning purposes: XL1-Blue (Stratagene, 
USA), DH5α (Invitrogen, USA) and NovaBlue (Novagen, USA). In general, either 
Pfu-Polymerase (Stratagene) or HighFidelity DNA Polymerase (Merck, Germany) 
was used for PCR. For site-directed mutagenesis the Stratagene QuickChange site-
directed mutagenesis kit was used according to manufacturer’s instruction. Primers 
were purchased from MWG Biotech AG (Germany). All constructs were verified by 
sequencing. Constructs were sequenced by MWG Biotech AG (Germany). 
 
Remark 
If not stated differently all experiments involving proteins were performed at 4°C. 
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5.2 Cloning, Expression and Purification of SR- and SRP Proteins 
5.2.1 SRαHis:βΔTM 
Expression was performed in E. coli BL21 (DE3) Arg cells that are based on BL21 
(DE3) cells (Novagen, USA) and contain λlysogen under the lacUV5 promotor and 
tRNA genes for two rare codons in E.coli (AGG/AGA). Cells were grown at 37°C in 3 
– 6 l LB medium up to a density of 0.3 – 0.4, then temperature was reduced to 18°C. 
Cells were induced with 0.5mM IPTG at an optical density of 0.6 – 0.8, grown ON 
and harvested by centrifugation at 5300 g for 30 min. Cells were washed in 1 x PBS 
at 4°C and transferred to 50 ml Falcon tubes. Cells were flash frozen in liquid 
nitrogen and stored at -80°C. For protein preparation, cells from 3 l cell pellet were 
resuspended in 50 ml lysis buffer (Lαβ).  
The cells were lysed using a sonicator followed by emulsiflex disruption. The 
cell debris was removed by centrifugation at 120000 g for 1 hour and the supernatant 
was filtered through a 0.22 µm sterile low protein binding filter (Millipore, USA). 
Subsequently, the protein was bound to Chelating Sepharose Fast Flow resin loaded 
with Ni2+ and washed with resuspension buffer lacking Triton X-100 (ANi(αβ)) until 
baseline was reached. The protein was eluted usually in a single step at 300mM 
imidazole (BNi(αβ)). Successively, two ion exchange purification steps were 
performed. The protein was prepared by dialysis ON into the ion exchange buffer 
(Q(αβ)).  
The protein solution was then applied on a column with Q-Sepharose Fast 
Flow resin equilibrated in the ion exchange buffer. The flow-through was collected 
since the positively charged complex (theoretical pI: 9.25) does not bind to a strong 
anion exchanger. In the next step the protein was purified via a strong cation 
exchanger (SP-Sepharose Fast Flow resin) equilibrated with the buffer ASP(αβ). The 
protein was washed with this buffer until baseline was reached and eluted with the 
buffer BSP(αβ). Last purification step was size exclusion chromatography via a 
Superdex 200 (26/60) column in the buffer GF(αβ). The bicistronic SRαHis:βΔTM 
construct includes human full length SRα with an N-terminal His-tag and mouse SRβ 
lacking the predicted transmembrane spanning anchor in a pet16b vector (N-
terminus Δ57; (Fulga et al., 2001)). For cloning details see (Fulga et al., 2001). The 
expression and purification protocol has been modified from (Fulga et al., 2001). 
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5.2.2 Cloning of SRα:βΔTM 
The bicistronic insert for this construct was excised from the SRαHis:βΔTM construct 
(Fig. 64) and ligated into pET21d vector. Both were restricted with NcoI and BamHI 
for two hours at 37°C in NEB restriction buffer 2. Both digestions were separated via 
agarose gel electrophesis (1 % gel). The SRα:βΔTM insert and the pET21d were 
purified via QIAquick Gel Extraction Kit and ligated via NEB Quick Ligation Kit 
according to manufacturers’ instructions.  
 
 
Figure 64 Map of SRα:βΔTM cloned in vector pET21d. The map was generated using the program 
Vector NTI. 
 
5.2.3 SRX2His:βΔTM 
SRX2His:βΔTM was over-expressed and cells were harvested as described for 
SRαHis:βΔTM. Pellets from 3 l expressed cell culture were disrupted in 50 ml lysis 
buffer (L(X2β)). In the first purification step (affinity purification) the same buffer 
without protease inhibitor (ANi(X2β)) was used to equilibrate the Fast Flow Chelating 
resin loaded with Nickel. Buffer (BNi(X2β)) corresponds to buffer ANi(X2β) but 
included 500 mM imidazole. The protein was eluted via a gradient from 10 to 500mM 
imidazole. The eluted protein was collected and dialysed over night against buffer 
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Q(X2β). Fast Flow Q-resin from Pharmacia was also equilibrated in buffer Q(X2β), 
and the flow-through was collected. SP Fast Flow resin equilibrated with ASP(X2β)-
buffer was used next. The protein was eluted via a salt gradient from 150 to 1000 mM 
NaCl (BSP(X2β)). Before the last purification step the protein was dialysed against the 
buffer used for size exclusion chromatography column GF(X2β). The bicistronic 
pSRX2His:βΔTM construct includes the N-terminal 176 amino acids of human SRα 
with an N-terminal His-tag and mouse SRβ lacking the predicted transmembrane 
spanning anchor in a pet16b vector (Fulga et al., 2001). For cloning details see also 
(Fulga et al., 2001). 
 
5.2.4 Seleno-L-Methionine Substituted Expression and Purification of 
SRX2His:βΔTMSeMet 
 
In order to perform a seleno-L-methionine (SeMet) substituted expression an 
expression cell strain had to be chosen that is methionine auxotroph (B834 (DE3)). 
Additionally, it is very important to degas the buffers in order to prevent oxidation of 
SeMet (4 R-SeH + O2 → 2 R-Se-Se-R + 2 H2O). This protocol is based on a protocol 
available on the homepage of Venki Ramakrishnan (http://alf1.mrc-
lmb.cam.ac.uk/~ramak/madms/segrowth.html).  For the cell growth, the medium 
GM(SeMet) is used. 
Pre-cultures were grown on plates, using 1/3 plate per litre of growth medium. 
SRX2His:βΔTM was induced at OD 0.6 with 400 µl 1 M IPTG and expressed ON at 
18°C.  The preparation was performed as described above for SRX2His:βΔTM. 
Buffers were slightly changed. The names of the respective buffers are also termed 
L, ANi, BNi, Q, ASP, BSP and GF, but with the index ‘SeMet’. The buffer GF(SeMet) was 
also used for crystallisation experiments. 
 
5.2.5 SRX2His:βΔTM / SRαHis:βΔTM mutants 
All mutations but SRαR524Q are based on our SRXHis:βΔTM-GTP structure. The 
mutation R524Q was introduced in order to prevent GTP hydrolysis in SRα (Rapiejko 
and Gilmore, 1992). The mutations αR34A, βD72G and βH119A were introduced in 
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the bicistronic plasmids of SRX2His:βΔTM and SRαHis:βΔTM. Table 17 shows names, 
locations and probable features of the mutations.  
Site-directed mutagenesis was performed according to the manufacturer’s 
instructions in order to generate the outlined mutations.  
 
Mutation Location Feature 
SRα R524Q SRα, G-3 (switch II)  Should prevent GTP hydrolysis, but keep 
nucleotide binding of the wild-type. 
SRα R34A Helix α1 in SRα/SRX, 
interface to P loop of SRβ 
Disrupts the interface from the side of 
SRα/SRX and eliminates a possible 
further function of R34  
SRβ D72G P loop of SRβ, interface to 
helix α1 from SRα/SRX 
Disrupts the interface from the side of 
SRβ 
SRβ H119A Catalytic residue in the 
switch II region of SRβ 
Should completely rule out GTP-
hydrolysis. Similar mutation (Q71L) has 
also been used for Arf1 to prevent GTP 
hydrolysis (Shiba et al., 2003) 
Table 17 SRα/SRX2 mutants. Location and probable features of the mutant proteins. 
 
5.2.6 SRαNGHis (SRαNΔ314-NtermHis) 
Cloning of SRαNGHis 
The NG-domain of human SRα was cloned into a pET16b vector. The vector is 
derived from the SRαHis:βΔTM construct. The construct contains an N-terminal His-
tag and starts with MSHHHHHHSM N-terminally in front of the NG-domain that 
begins with GTLGG. Cleavage Sites are NcoI (N-terminally, located at the second 
methionine) and BamHI (C-terminally) (Fig. 65). 
 
Template: SRαHis:βΔTM, primer: SRαNG-Forward, SRαNG-Reverse 
PCR: 1 min 95°C -> 25 cycles (30s 95°C, 30s 45°C, 50s 72°C) -> 5 min 72°C -> 4°C 
 
The PCR product was purified via QIAquick PCR purification kit. Successively, the 
sample was digested by NcoI and BamHI restriction endonucleases for 2 h at 37°C in 
NEB restriction buffer 2. The restricted DNA was separated via agarose gel 
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electrophoresis on a 1 % agarose gel and the anticipated insert of 983 bp was 
excised. The gel was removed via QIAquick Gel Extraction Kit. The insert was cloned 
into the vector of the SRαHis:βΔTM construct, which was digested the same way as 
SRαNGHis. To separate it from and SRα:βΔTM, the digested vector was run on a 1 % 
TAE gel. The cleaved vector was excised and purified via QIAquick Gel Extraction 
Kit. Finally, cleaved insert and vector were set up for ligation using New England 
Biolabs’ Quick Ligation Kit according to manufacturer’s instructions.  
 
Preparation of SRαNGHis 
Test expression 
The construct was test-expressed in Rosetta (DE3), C43 (DE3), BL21 (DE3), Rosetta 
(DE3) pLysS and BL21 (DE3). Cells were grown until OD 0.6 at 37°C and induced 
with 0.5 mM IPTG over night at 16°C. Cells were lysed in the buffer L(αNG), lysed via 
Emusiflex (3 passes at 10000-15000 psi) in a volume of 50 ml buffer ANi(αNG) (see 
below) and loaded on dripping columns filled with 1 ml Pharmacia Fast Chelating 
resin saturated with Ni2+.  
Columns were washed with buffer ANi(αNG) until the protein concentration was 
minimal and visibly not changing anymore (detected via Bradford Reagent) and 
eluted in a step using buffer BNi(αNG). 
 
Figure 65 Map of SRαNGHis cloned in vector pET16b. The map was generated using the program 
Vector NTI. 
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Standard preparation  
Two litres of BL21 (DE3) cell culture were grown as described in the test-expression 
above and lysed in 50 ml buffer L(αNG). Cells were sonicated (6 min, power 6, 70 % 
duty cycle) and further disrupted via Emusiflex (3 passes at 10000 – 15000 psi).  
Centrifugation was performed according to the description of SRαHis:βΔTM. For 
affinity purification protein was applied on a column filled with Fast Chelating Flow 
resin that was saturated with Ni2+. The column was washed with buffer ANi(αNG) until 
baseline was reached and eluted via gradient from 10 – 500 mM imidazole using 
buffer ANi(αNG) and BNi(αNG).    
 
5.2.7 SRβΔTM 
Here, the construct was used, in which SRβ lacking the N-terminal 57 amino acids 
was cloned into a pHAT2 vector. The protein was expressed in BL21 (DE3) Arg cells, 
purified via affinity purification (Fast Flow Chelating Sepharose resin saturated with 
Ni2+) and analysed via size exclusion chromatography (Superdex 75 (10/30)). The 
protein was eluted from the affinity chromatography column in two steps. A 100 mM 
step led to SRβΔTM with a nucleotide-free and GTP-loaded SRβ, meanwhile a 300 
mM step eluted only the nucleotide-free form as observed from HPLC analysis (Fulga 
et al., 2001). The nucleotide-free form of SRβΔTM is much more sensitive to 
aggregation and precipitation than the nucleotide loaded SRβΔTM and could be 
stabilised at 1 mg / ml in a buffer containing 50 mM Tris pH 8, 500 mM NaCl, 10 mM 
MgCl2, 100 mM imidazole and 20 % glycerol. For further information of cloning and 
purification see (Fulga et al., 2001). 
 
5.2.8 SRP54D (SRP54CtermΔ68) 
SRP54D is a construct derived from canine SRP54 DNA. Canine SRP54 is on the 
DNA level not equal to human but on the protein level both sequences are identical. 
The C-terminus of the construct refers to the length of the E. coli SRP54 M-domain, 
which is visible in the crystal structure of the Ffh:RNA complex published by Jennifer 
Doudna in 2000 (Batey et al., 2000) and is therefore called SRP54D. The constructs 
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with N-terminal and C-terminal His-tags are called SRP54DNHis SRP54DCHis, 
respectively. In cases where a method is applicable to SRP54DNHis or SRP54DCHis, 
the term SRP54DHis is used. 
 
Cloning of SRP54DNHis and SRP54DCHis 
The length of the insert coding for SRP54D is 1340 bp, which corresponds to a 
molecular weight of 49.25 kD. The insert was cloned between the NcoI and XhoI 
restriction sites into pET24d (Fig. 66). For SRP54DNHis the forward primer contained 
a hexa-histidine tag (MGHHHHHH), for SRP54DCHis the reverse primer contained the 
hexa-histidine tag and stop codon. The C-terminal amino acids of SRP54D are 
KKMGG-436. Amino acid one is counted from the methionine coding the SRP54 
sequence not including the tag. As a template, the full length SRP54 gene in a viral 
vector was used, kindly provided by Mark Brooks (laboratory of Stephen Cusack, 
EMBL Grenoble, France). 
  
Template: Full length SRP54 in viral vector, Primers: SRP54DN-Forward, SRP54DN-
Reverse or SRP54DC-forward, SRP54DC-Reverse, respectively. 
PCR: 1 min 95°C -> 25 cycles (30s 95°C, 30s 50°C, 60s 72°C) -> 5 min 72°C -> 4°C 
 
SRP54DNHis and SRP54DCHis were cloned according to the description below. The 
PCR product was ligated into the TOPO vector (SRP54D-TOPO) using the TOPO 
cloning kit (Invitrogen, Germany) according to manufacturer’s instructions. 
SRP54DHis-TOPO and pet24d vector were cleaved for 2 h at 37°C with NcoI and 
XhoI in NEB restriction buffer 2. Both restriction setups were applied on a 1 % TAE 
gel and the bands of the cleaved pet24d vector (5213 bp) and the SRP54DHis insert 
(1340 bp) were excised. The gel was removed via QIAquick Gel Extraction Kit. 
Finally, cleaved insert and vector were set up for ligation using New England Biolabs’ 
Quick Ligation Kit according to manufacturer’s instructions.  
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Figure 66 Map of SRP54DHis cloned in vector pET24d. The map was generated using the program 
Vector NTI. 
 
Preparation of SRP54DHis 
Test expression 
This construct was test-expressed in BL21 (DE3) pLysS, C43 (DE3), BL21 (DE3), 
Rosetta (DE3) pLysS. Cells were grown until OD 0.6 at 37°C and induced with 0.5 
mM IPTG over night at 18°C. Cells were harvested as described for SRαHis:βΔTM, 
lysed via Emusiflex (3 passes at 10000-15000 psi) in a volume of 50 ml buffer 
L(54Dt). Successively, the lysed cells were loaded on dripping columns filled with 1 
ml Fast Chelating resin saturated with Ni2+.  
The protein was washed on the column with buffer ANi(54Dt) until the protein 
concentration was minimal and visibly not changing anymore (detected via Bradford 
Reagent) and eluted in a step using buffer BNi(54Dt). 
 
Complete preparation  
Two litres of C43 (DE3) cell culture were grown as described as in the test-
expression above and lysed in 50 ml buffer L(54D) (see below) supplemented with 
one tablet of protease inhibitor. Cells were disrupted via Emusiflex (3 passes at 
10000-15000 psi). Protein harvested as described for SRαHis:βΔTM, washed with 
buffer ANi(54D) until baseline was reached and eluted in a step using buffer BNi(54D). 
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For cation exchange chromatography the sample was dialysed against buffer 
ASP(54D) ON. The protein was then loaded on a column filled with SP-Sepharose 
Fast Flow resin equilibrated with buffer ASP(54D). The column was washed with 
buffer ASP until baseline and eluted in a step with buffer BSP(54D). The protein was 
successively dialysed against the size exclusion chromatography buffer (GF(54D)), 
concentrated and loaded on the gel filtration column (Superdex 75 (26/60)).  
 
5.2.9 SRP54NG (SRP54CtermΔ208) 
The SRP54NG construct comprises the NG-domain of SRP54, lacking the C-terminal 
M-domain. The protein is truncated C-terminally in the linker between NG- and M-
domain after LG from the sequence LGMGD. The amino acid sequence of the protein 
ends with SKLLG-296. It contains 940 bp with a corresponding mass of the translated 
protein of 33.47 kD. The constructs with N-terminal and C-terminal His-tags are 
named SRP54NGNHis SRP54NGCHis, respectively. In cases where a method is 
applicable to SRP54NGNHis or SRP54NGCHis, the term SRP54NGHis is used.  
 
Cloning of SRP54NGNHis  
The construct (Fig. 67) is derived from the SRP54DNHis construct (see above) by 
inserting a stop codon via site-directed mutagenesis between Gly296 and Met297. 
Site-directed mutagenesis was performed according to manufacturers’ instructions.  
        
Materials and Methods 
 100
 
Figure 67 Map of SRP54NGNHis cloned in vector pET24d. The map was generated using the program 
Vector NTI. 
 
Test Expression of SRP54NGNHis 
Test-expressions were performed for 3h at 30°C and ON at 16°C. The plasmid was 
tested with BL21 (DE3) Arg, Rosetta (DE3), C43 (DE3), BL21 (DE3) pLysS and 
Rosetta (DE3) pLysS cells. Rosetta (DE3) pLysS cells over-expressed SRP54NGNHis 
in highest amounts followed by C43 (DE3).  
 
Preparation of SRP54NGHis 
Rosetta (DE3) pLysS cells were grown until OD 0.6 and induced with 0.5mM IPTG at 
16°C ON. Cells were disrupted using an Emulsiflex and ultra-centrifuged for 45 min 
@ 40000 rpm 120000 g in order to separate the lysate from the cell debris. The 
protein was loaded on Fast Chelating Resin saturated with Ni2+ equilibrated with 
buffer L(54NG). The protein was washed with buffer ANi(54NG) until baseline and 
eluted in a step with 18 % BNi(54NG) (115 mM imidazole). In order to deplete DNA 
from the sample a Q-column can be used. The sample was dialysed ON against 
buffer Q(54NG) (see below) and purified next day via anion exchange 
chromatography (Q-Sepharose Fast Flow resin). The protein was in the flow-through 
but the DNA was bound to the resin due to a higher negative charge. Finally, the 
protein was dialysed against GF buffer (GF(54NG)) and purified using size exclusion 
chromatography via a Superdex 75 (26/60) column. 
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Cloning of SRP54NGCHis 
The SRP54NGCHis construct (Fig. 68) correlates to SRP54NGNHis but differs in the 
position of the hexa-histidine tag which is located C-terminally. The protein sequence 
ends with SKLLG(296)HHHHHH. SRP54DCHis was used as template for the 
SRP54NGCHis PCR, primers were SPR54NGC-Forward and SRP54NGC-Reverse. 
PCR: 1 min 95°C -> 30 cycles (30s 95°C, 30s 45°C, 75s 72°C) -> 7 min 72°C -> 4°C 
 
 
Figure 68 Map of SRP54NGCHis cloned into pET24d. 
 
 
5.3 Complex Formation Studies 
5.3.1 Trimeric Complex: SRαHis:βΔTM:SRP54DHis 
Proteins were over-expressed and purified as described in sections 5.2.1 and 5.2.8. 
The proteins were dialysed ON into the complex formation buffer (CF(T.)) and 
SRP54DHis was added to SRαHis:βΔTM with SRP54DHis in excess in presence of 2 
mM GMPPNP. Depending on the amount of SRP54DHis available, the 
SRαHis:βΔTM:SRP54DHis ratios varied from 1:1.25 to 1:2. Final concentrations of 
SRαHis:βΔTM varied between 23 and 30 µM. The complex was formed within 1 h at 
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37°C. An addition of glycerol (10% final concentration) to the sample before warmed 
up to 37°C did not affect the ability of complex formation but decreased aggregation.  
The trimeric complex is purified via size exclusion chromatography (Superdex 
200 (26/60)) using the complex formation buffer without GMPPNP and glycerol 
(GF(T)). Fractions containing the complex were stabilised immediately by the addition 
of GMPPNP (0.1 mM). Fractions were analysed via polyacrylamide gel 
electrophoresis and further staining with Coomassie Brilliant Blue. Since SRα:βΔTM 
could not be separated from the trimeric complex, only fractions were pooled for 
successive pentameric complex formation or crystallisation that contained 
stoichiometric amounts of SRαHis:βΔTM and SRP54DHis. The stoichiometry was 
examined by eye according to the Coomassie Brilliant Blue staining intensity of the 
respective bands.  
 
5.3.2 Pentameric Complex Formation: 
SRαHis:βΔTM:SRP54DHis:SRP19:RNA104 
In parallel to the formation of the trimeric complex the complex of SRP19 and RNA is 
formed. SRP19 and RNA104 and the SRP19:RNA104 complex have been kindly 
provided by Klemens Wild. In principle, the dimeric complex was assembled by pre-
treating the RNA104 with urea, heating it up to 70°C briefly and snap-cooling on ice. 
SRP19 was added in excess and in a 20-fold larger volume in order to dilute the 
urea. The mixture was incubated for 30 min on ice in order to allow the complex to be 
formed and subsequently concentrated. The complex was isolated via anion 
exchange chromatography.   
Dimeric (SRP19:RNA104) and trimeric (SRαHis:βΔTM:SRP54DHis) complex 
were mixed in equimolar concentrations (0.7 µM) and GMPPNP was added to a 
concentration of 0.1 mM. This setup was incubated on ice for one hour and 
concentrated for the final purification step via size exclusion chromatography 
(Superdex 200 (26/60)) using buffer GF(P).  
The fractions were analysed on a 12 % polyacrylacrylamide gel, stained with 
Coomassie Brilliant Blue and eventually by silver staining with SilverXpress silver 
stain kit (Invitrogen, Germany) according to manufacturers’ instructions. In contrast to 
Coomassie Brilliant Blue dying, silver-staining allows to stain RNA which can be 
recognised due to its orange colour. Fractions containing the complex were 
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immediately stabilised by the addition of GMPPNP (to 0.1 mM) and concentrated. 
Finally, at protein concentrations of 4 mg/ml or higher GMPPNP was added (up to 2 
mM) and the protein was set up for crystallisation. The complex was also crystallised 
in 96-well plates using the sitting drop method performed by a crystallisation robot 
(Cartesian) at Aventis, Frankfurt (Germany) and EMBL (Heidelberg). 
 
5.3.3 Trimeric Complex Formation Pull-Down: SRα:βΔTM:SRP54NGCHis 
Purification of the trimeric complex includes a methodical difficulty in the last 
purification step (size exclusion chromatography): Free SRα:βΔTM (92 kD) can not 
be separated from the whole complex (125 kD) because both molecular weights are 
too similar. This is also true for the SRα:βΔTM:SRP54DHis complex purification. Here, 
one approach was examined that took advantage of the fact that just SRP54NGHis 
was tagged with a hexa-his tag. A pull-out experiment via Ni2+-affinity 
chromatography would allow unbound SRα:βΔTM to flow through meanwhile the 
complex and free SRP54NGCHis would bind to the Fast Flow Chelating resin. Non-
complexed SRP54NGHis could be easily separated from the approximately 4-fold 
larger complex via size-exclusion chromatography (Superdex 200).  
SRα:βΔTM was expressed as pointed out before for SRα:βΔTM. In order to 
pre-purify SRα:βΔTM anion exchange chromatography was applied directly after lysis 
using buffer L(αβ2). Fast Flow SP-Sepharose was equilibrated with buffer SPA(αβ2) 
(see below), the loaded protein was washed until baseline and eluted with buffer 
SPB(αβ2) (see below). SRP54NGCHis was purified as described above. Both 
components were diluted into the complex formation buffer (CF2). A 3-fold molar 
excess of SRP54NGCHis was incubated with SRα:βΔTM in presence of 2 mM 
GMPPNP ON on ice.  
Successively, Fast Flow Chelating resin saturated with Ni2+ was equilibrated 
with buffer ANi(T2), the resin with loaded protein was washed until baseline and 
eluted over a gradient from 15 to 500 mM imidazole using buffers ANi(T2) and 
BNi(T2). 
Finally, the complex was purified via size exclusion chromatography 
(Superdex 200 (26/60)) in buffer GF(T2). 
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5.3.4 Analysis of SR:SRP Complex Formation 
These studies have been performed using SRP19His:RNA104 complex kindly provided 
by Klemens Wild and SRP54D kindly provided by Mark Brooks (EMBL Grenoble, 
Stephen Cusack group). Mark Brooks expressed the protein in insect cells and used 
a heparin resin procedure for purification. This experiment examines the difference in 
complex formation rate comparing the trimeric SRα:βΔTM:SRP54DHis and the 
pentameric SRαHis:βΔTM:SRP54DHis:SRP19His:RNA104 complexes. 
250 µl of SRαHis:βΔTM at 8 mg/ml (21 nmol) in buffer SR in were added to 750 
µl SRP54DHis at 1.4 mg/ml (21.7 nmol) in buffer B54. Before GMPPNP was added a 
sample (250 µl) was taken resembling the starting point. Then GMPPNP was added 
to a final concentration of 2 mM. In parallel a second setup was prepared like this one 
but SRP19His:RNA104 was added stoichiometrically (21 nmol) in a volume of 200 µl 
(5.2 mg/ml in the buffer B19RNA). Both setups were stored on ice. After the addition 
of GMPPNP samples were taken from the trimeric complex formation setup after one, 
four and seven hours and from the pentameric complex formation setup after 1 h 20 
min, 4 h 30 min, 7 h 30 min and 10 h 30 min. All samples were run immediately on a 
Superdex 200 (10/30) column equilibrated with buffer GF(5). 
 
5.4 Crystallisation and Structure Determination of SRαX2His:βΔTM 
5.4.1 Crystallisation of SRαX2His:βΔTM 
All crystallisation experiments were performed using the hanging drop method in a 
24-well plate. First crystals of SRαX2His:βΔTM appeared after 3 months at 20°C using 
100 µl of 2 M ammonium sulphate as precipitant buffered by 0.1 M sodium citrate at 
pH 5.5 in the reservoir (WIZARD sparse matrix screen, Emerald Biosciences, USA). 
One µl of protein solution at 14 mg/ml in the buffer Cryst was mixed with one µl of the 
reservoir.  The initial successful condition was 2 M (NH4)2SO4, 0.1 M sodium citrate 
pH 5.5 (buffer Res1). 
After trying different grid screens altering buffers, pH-values, salt 
concentrations, protein concentrations, and additives, the finally best diffracting 
crystals were obtained using the same method as the one used for the initial 
condition supplemented with 100 mM guanidinium hydrochloride (buffer Res2) mixed 
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with a protein solution at 12 mg/ml. In general, crystals appeared after four to six 
weeks, rarely earlier. 
 
5.4.2 Freezing and Mounting  
As a cryo-buffer (BCryo), 20% glycrol was added to 2M (NH4)2SO4, 0.1 M sodium 
citrate pH 5.5 and 100 mM guanidinium hydrochloride was used. The cryo-protectant 
is used in order to prevent the formation of ice crystals. 20% glycerol was added as 
cryoprotectant to the freezing buffer. Crystals were transferred with a loop 
(CryoLoops, Hampton Research, USA) to a drop containing the buffer Cryo. 
Successively, the crystals were flash frozen in liquid nitrogen and then either stored 
in liquid nitrogen or mounted immediately in the cryo-stream of the X-ray source. 
5.4.3 Data Collection 
Crystals were exposed X-rays at beamline ID 14.4 at European Synchroton Radiation 
Facility (ESRF), Grenoble (France) with the parameters from Table 18. First, a single 
exposure (test) allowed the determination of the space group. The image could be 
examined using the software MOSFLM (Leslie, 1992) in order to determine the 
oscillation start. The data were indexed, scaled and merged using the HKL program 
package (Otwinowski and Minor, 1997). 
 
X-ray wavelength (Ǻ) 0.979 
Detector-dependent theoretical max. resolution (Ǻ) 2.50  
Frame number to start  1 
Oscillation start (°) 70 
Oscillation range (°) 1 
Overlap between frames   - 
Exposure time per frame (s) 0.9  
Number of passes per frame 3 
Number of frames to collect 180 
Table 18 Parameters of the data collection for the final data set (Sr 2.1) for the SRXHis:βΔTM-GTP X-
ray structure . 
 
5.4.4 Structure Determination and Model Refinement 
The structure was determined by molecular replacement using the program AMoRe 
implemented in the CCP4 program suite (Collaborative Computing  Project, 1994) 
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and the SRβΔTM-subunit of the yeast homolog (PDB accession code 1NRJ, 
(Schwartz and Blobel, 2003)). The model for refinement was created with the auto-
build function of Arp/wArp (Perrakis et al., 1999) implemented in the CCP4 program 
suite (Collaborative Computing  Project, 1994) run in warpNtrace-mode. The model 
was refined with the program CNS (Brunger et al., 1998) using the input files 
generate.inp and refine.inp. In this way simulated annealing, energy minimization, B-
factor refinement, and map calculation were combined. GTP and Mg2+ were added to 
the model. For CNS refinement GTP and Mg2+ topology and parameter files were 
obtained from the Hetero-compound Information Centre - Uppsala (HIC-Up; 
(Kleywegt and Jones, 1998)). Cycles of model building and refinement 
(‘bootstrapping’) were performed in order to generate the final model. Water 
molecules were added using CNS with the file water_pick.inp as a template (Brunger 
et al., 1998) and were manually checked for correctness. The model building was 
performed with the program O (Jones et al., 1991). The model was analysed for 
correctness of various parameters with the help of the programs PROCHECK (Morris 
et al., 1992) and WHATCHECK (Hooft et al., 1996). 
 
5.4.5 Determination of the Selenium K-shell absorbance peak 
Data of the performed Single Anomalous Dispersion (SAD) experiment were neither 
included in structure determination of SRXHis:βΔTM nor refinement of its model 
because the refinement process went on very well after molecular replacement and 
ArpWarp (Perrakis et al., 1999) autobuilding in the warpNtrace mode. Still, the 
absorbance of Selenium K-shell electrons was measured at beamline ID 14.4 at 
ESRF (Grenoble, France) in a Fluorescent Scan experiment. Hereby, the X-ray 
energy is varied in the range of the absorption of Selenium K-shell electrons leading 
typically to an absorbance edge of 12632 eV for a wavelength of 0.9797 Å. 
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5.5 Immobilised Peptide Library Scan 
5.5.1 Probing the SRβ:Sec61p interaction by an immobilised peptide 
library 
This technique was applied in order to find out whether mammalian SRαHis:βΔTM, 
SRαX2His:βΔTM or SRβΔTM interact with cytosolic loops of the human translocon. 
Therefore, the sequences of the translocons from Homo sapiens and Methanococcus 
jannaschii were aligned with ClustalW (Chenna et al., 2003) and cytosolic loop 
regions were deduced from the M. jannaschii SecYEG structure. The sequence 
chosen for each cytosolic loop included one helix turn of transmembrane helix 
sequence. A 13-mer peptide library was synthesised with a three amino acids step 
(Jerini Peptide Technology GmbH, Berlin). Each spot carried approximately 5 nmol 
peptide covalently bound via the C-terminus to a cellulose PEG-membrane. The 
predicted Sec61β transmembrane helix was included as an internal control to detect 
unspecific hydrophobic interaction. The immobilized peptide library covered the 
following sequences: 
N-terminus of human Sec61α (spots 1-8):  2-
AIKFLEVIKPFCVILPEIQKPERKIQFKEKVLW-34 
Loop 2 (TM2-TM3, spots 10-15): 90-IMQLLAGAKIIEVGDTPKDRALFNGAQ-116 
Loop 4 (TM4-TM5, spots 17-20): 163-LLLDELLQKGYGLGSGISLFIA-184 
Loop 6 (TM6-TM7, spots 22-32): 253-
AVVIYFQGFRVDLPIKSARYRGQYNTYPIKLFYTSNIPIIL-293  
Loop 8 (TM8-TM9, spots 34-47): 375-
FSKTWIEVSGSSAKDVAKQLKEQQMVMRGHRETSMVHELNRYIPTAAAFGG-425 
C-terminus (spots 49-53): 454-IYQYFEIFVKEQSEVGSMGALLF-476  
Sec61β (full length, spots 55-83): 
MPGPTPSGTNVGSSGRSPSKAVAARAAGSTVRQRKNASCGTRSAGRTTSAGTGG
MWRFYTEDSPGLKVGPVPVLVMSLLFIASVFMLHIWGKYTRS 
 
Membranes were prepared according to Jerini PepSPOT manual and blocked in 
blocking buffer (buffer BLK) for 1h.  
SRβΔTM-apo, SRXHis:βΔTM-GTP and SRαHis:βΔTM-GTP were probed over 
night at 4°C at 400nM in the same buffer. Due to the high affinity of SRβΔTM for GTP 
and incomplete reloading of SRβΔTM-apo with GDP (not shown), populations of 
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homogenously loaded SRβΔTM-GTP and SRβΔTM-GDP could not be included in this 
assay. The membrane was washed briefly with blocking buffer lacking BSA and 
blotted at 2 mA/cm2 membrane for 30 min in blotting buffer BLT onto 0.2 µm PVDF 
membranes (Schleicher & Schuell, Immobilon) with the spots facing the cathode. 
After blocking for one hour with PMT (see below), proteins were decorated 
with an anti-pentahis/mouse antibody (Qiagen) diluted in PMT for one hour at RT, 
followed by an anti-mouse horseradish peroxidase-coupled secondary antibody for 
one hour at RT and ECL detection. PepSPOT membranes were regenerated 
according to Jerini Regeneration Protocol I.   
 
5.5.2 Probing the SRβ ribosome interaction by an immobilised peptide 
library  
The sequences of the subunits L23a and L35 of the human ribosome were mapped 
on an immobilised peptide library in 13mers with a step size of three synthesised by 
Jerini Peptide Technology GmbH, Berlin. These studies were performed as described 
above with the only difference that the protein concentrations were reduced to 100 
nM in order to reduce unspecific interactions with the membrane. 
 
5.6  HPLC analysis 
The nucleotide load of SRαHis:βΔTM, SRX2:βΔTM and SRβΔTM was verified by 
HPLC on Waters Delta 600 Multisolvent Delivery System equipped with a 2487 dual 
lambda absorbance detector and a Vydac protein & peptide C18 column. 
Measurements were performed at 280 nm. A phosphate buffer with tetra-n-
butylammonium bromide (TBAB) (buffer HP) was used (see below) for analysis and 
an isocratic flow of 1.8 ml/min. TBAB binds due to its positive charge the more to the 
negatively charged nucleotides the higher they are charged. In this way the highest 
charged nucleotides are neutralised most, resulting in an increased affinity to the 
hydrophobic C18 column. Therefore for example, GTP is expected to elute after 
GDP. 
20µl of 70 µM nucleotide solutions were used in order to calibrate the system 
and 20 µl of 100 to 150 µM protein solutions were used for the protein experiments. 
The experiments were analysed with the program MASSLYNX. 
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5.7 Programs used for Figures in the Text 
All three-dimensional pictures of molecules were created with PyMol (DeLano, 2002). 
Superpositions of molecules were performed using either PyMol or O (Jones et al., 
1991). Figures have been edited using COREL Photopaint®. The image of the Ewald 
sphere construction was created with the help of the program XRayView 
(Open_Software_Foundation, 1991). 
 
5.8 Crystallographic Background 
 
In order to resolve an object, the wavelength of the light used for the examination of 
the object can roughly not be larger than the size of the object. Carbon-carbon bonds 
have a length of about 1.5 Å (1.5 x 10-10 m or 0.15 nm). Therefore electromagnetic 
waves (X-rays) are required for structural analysis of biological material. Since X-rays 
are three dimensional electromagnetic waves, they can be described by the common 
features of waves and photons. The exact knowledge of the X-ray waves that 
generated the diffraction from a crystal is essential for the determination of the 3D 
structure of the molecule in the crystal.  
5.8.1 Crystal Systems and Bravais Lattices 
Crystals are organised by lattices which are Bravais lattices. They are setup by a set 
of points generated by discrete translation operations. The crystal is composed of 
molecules that are repeated at every lattice point. When viewed from any of the 
lattice points, the crystal looks the same. The basic building brick of a crystal is the 
unit cell which is repeated to form the crystal. The axes of the unit cell are noted as a, 
b, c, its angles are α, β, γ. The symmetry of the unit cell is described by its space 
group which is expressed in a term including information about the lattice centring 
and symmetry operations that can be applied on the unit cell without changing its 
appearance (e.g. I222, where I describe the lattice centring explained below and the 
numbers describe symmetry operations). There are 230 space groups of which 65 
are possible for chiral objects such as proteins and 14 Bravais lattices organised in 
seven crystal systems (Table 19). The smallest unit required for the reconstruction of 
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the crystal is the asymmetric unit which excludes the presence of any further 
crystallographic symmetry operations.  
 
Different lattice centrings: 
P: Primitive; lattice points in the corners of the unit cell. 
I: Body centred; lattice points in the corners and an additional lattice point in the 
   centre of the unit cell. 
F: Face centred; lattice points in the corners and an additional lattice point in the 
    centre of each of the faces of the unit cell.  
A, B, C: Centring on single faces; lattice points in the corners and an additional lattice  
   point at one of the faces of the unit cell. 
Crystal System Bravais Lattices 
triclinic 
 
     P 
monoclinic 
  
      P              C 
orthorhombic 
 
      P                C               I                 F 
tetragonal 
 
      P                 I 
rhombohedral 
(trigonal) 
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        P 
Hexagonal 
 
         P 
cubic 
 
        P                     I                     F 
Table 19 The seven crystal systems and 14 relevant Bravais lattices. Bravais lattices are sorted 
according the crystal system they belong to. P, I and F describes the molecule centring in the unit cell 
where P means primitive, I body centred and F face centred (see above). Images are taken from 
http://en.wikipedia.org/. 
 
5.8.2 Bragg’s Law 
Crystals can be thought of molecules organised in planes with certain lattice spacing 
(d). The condition at which ordered molecules amplify the signal of scattered waves 
with a wavelength λ is described by Bragg’s law. 
 
     BC/d = sin θ     (see Fig. 69) 
=> BC = d sin θ   //  2BC = n λ  (the distance 2BC must be an integer multiple of λ)  
=> n λ = 2d sin θ  (Bragg’s law) 
 
When two rays hit a crystal lattice (Fig. 69) in phase and the first is diffracted by one 
molecule and the second by another molecule in a neighbouring plane, then the 
second beam travels an additional distance between the planes (2BC) which is 
dependent on the lattice spacing d. When 2BC equals an integer multiple of the 
wavelength λ, then the second beam can amplify the first one. 
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5.8.3 Data Collection and Reciprocal Lattice 
For a crystallographic experiment a crystal positioned on a goniometer (‘mounted’) is 
exposed to an X-ray beam and diffracted X-rays are recorded. Usually prior to a 
crystallographic experiment, crystals are frozen in liquid nitrogen (100 K) and 
meanwhile the experiment exposed to a stream of gaseous nitrogen in order to 
reduce radiation damage, thermal vibrations and conformational disorder. Diffracted 
X-rays are recorded using an image plate detector or Charge-Coupled Device (CCD). 
All electrons of the crystallised molecules contribute to the signals that are recorded. 
For structure determination, a three dimensional reconstruction of the recorded signal 
is used. The result of the experiment is the representation of the electron distribution 
(‘electron density map’) for the crystallised molecule. 
Diffracted X-rays generate reflections on the image plate detector which can 
be compared to light in the plane of a lens leading to images produced by visible light 
(400 – 700 nm) (Fig. 70).  
 
 
Figure 69 Requirement for an amplified diffracted ray. The upper incident beam is in phase with 
the lower beam and hits a molecule (black circle) with the angle θ relative to the lattice plane. The 
lower beam must travel the extra distance 2 BC. When 2BC is an integer multiple of the 
wavelength λ then the lower beam can amplify the upper beam. d is the lattice spacing. 
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 The lattice of the examined crystal (the ‘object’, see Fig 70) leads to diffracted 
X-rays forming a virtual lattice with inverted lattice spacing which is therefore called 
reciprocal lattice. The axes of the unit cell in real space are a, b, c and the 
corresponding axes of the unit cell in the inverted lattice in reciprocal space are a*, 
b*, c*. Coordinates in real space are defined as xyz values, the corresponding 
coordinates in reciprocal space are noted as hkl values (Miller indices).  
In order to employ a graphical representation of Bragg’s law, the Ewald 
construction can be used. X-rays diffracted from the crystal, passing through points of 
the reciprocal lattice in a distance of 1/λ can be recorded as reflections (Fig. 71). The 
sphere with the radius 1/λ around the crystal is deduced from Bragg’s law and called 
according to the German physicist Peter Ewald (Ewald sphere). The borders of the 
reciprocal lattice are described by the ‘limiting sphere’ that is originating in the centre 
of the reciprocal lattice with a radius of the inverse of the maximal resolution (r = 
1/Dmax.[Å]). Therefore, a crystal leading to high resolution data creates a larger 
limiting sphere and more reflections than a crystal generating lower resolution data. 
The aim of data collection is to record every unique reflection at least once. 
One image of the diffraction pattern of the crystal is sufficient to estimate the space 
group. In order to generate data for the three dimensional representation of the 
electron density, more images are required which are taken from different angles. 
 
Figure 70 Image produced by a simple lens compared to structural analysis by X-ray 
crystallography. A The central straight ray is equivalent to the optical axis of the lens and therefore 
not altered in direction. Rays diffracted by an object are refracted by the lens producing an 
enlarged image of the object in an inverted orientation. B Comparing the generation of a 
photographing image to structural analysis by X-ray crystallography, the crystal corresponds to the 
object, the refraction plane of the lens to the image detector recording reflections and the image to 
the electron density map. The result is not a photographic image but an electron density map 
generated with the help of a computer. 
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The crystal is rotated on the goniometer and for example after every turn of a degree, 
a diffraction pattern is recorded. In this way the (reciprocal) crystal lattice is 
examined. Due to symmetry in the diffraction pattern (Friedel symmetry: hkl = -h -k -l) 
images covering 180° of a native crystal are enough to generate a complete data set. 
An additional symmetry of the space group can reduce the oscillation range for a 
complete data set (e.g. 60° rotation for a trigonal space group due to 3-fold 
symmetry). In general, the amount of data collected depends on the symmetry of the 
space group and its position relative to the X-ray beam. 
 
 
 
5.8.4 The Phase Problem and Electron Density Calculation 
Every wave has three basic parameters: Wavelength (λ or frequency (f) which is 1/λ), 
amplitude (A) and phase (α) (Fig. 72). In order to determine an electron density map, 
the waves that generate the reflections must be defined. The amplitude is 
proportional to the square root of the reflection intensity ((Ihkl)1/2); the wave length is 
equal to the one from the X-ray source. The phase (α) plays a major role in the 
process of structure determination because it is the parameter that is not directly 
 
Figure 71 Ewald sphere construction. The crystal is mounted on a goniometer and can 
therefore be freely rotated. The Ewald sphere measures r = 1/λ with the crystal in the center. 
The border of the Ewald sphere describes diffracted X-rays following Bragg’s law. X-rays 
leading to reflections originate from the crystal and cross intersections of the Ewald sphere with 
the limiting sphere (r = 1 / max. resolution [Å]) of the reciprocal lattice. 
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measurable from the data collection experiment but requires further expertise. This 
circumstance is known as the “phase problem”. 
 
The X-ray generating a reflection is a complex three dimensional wave. The French 
mathematician Jean Baptiste Joseph Fourier described 1822 that any periodic 
function can be described by a series of terms of simpler periodic functions (Fourier 
series). The resulting function is a Fourier transform. The X-ray leading to a reflection 
can therefore be described as a Fourier transform of the ordered molecules in the 
crystal with the crucial variable of the phase. 
Every recorded X-ray can be considered as the reflection of an infinitesimal 
small volume element of the dissected molecule and is fully described by a structure 
factor equation, often only called structure factor (Fhkl). For a complete data set, all 
structure factors recorded can be interpreted as contour map of the electron density 
(ρx,y,z) for the examined molecule. ρx,y,z can be calculated by the following Fourier 
transform of the structure factors: 
)(2( )1),,( lzkyhxiihkl
h k l
eeF
V
zyx hkl ++−∑∑∑= παρ  
ρ: value of the electron density at xyz 
F: structure factor at the reflection at hkl 
α: phase of the reflection at hkl  
 
Figure 72 A periodic wave described by three essential parameters. The wave is described by the 
wavelength (λ), the amplitude and the phase (α). The phase (α) determines the location of a point 
of a periodic wave relative to a reference point. A wave shifted by Δα (here Δα = π correlating to 
180°) is indicated in cyan. 
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5.8.5 Molecular Replacement 
Molecular replacement is a method to generate phases in order to determine a 
structure. Structurally determined proteins that are supposed to have a similar fold as 
the undetermined protein are used as search models and applied on the 
experimental data. Basically, the search model is rotated and translated in order to fit 
the experimental data. Disadvantage of the method is phase bias from the probe 
model. 
 Since the fold of the protein of interest is not determined, functionally 
homologous proteins with a similar size can be used as probe models. A protein with 
a sequence identity of 50% or more is most likely a good search model since, at this 
high sequence identity level, examined and probe protein should be structurally very 
similar. Molecular replacement is usually performed with data between 3.5 and 10 Å 
resolutions because higher resolutions include conformational information that is very 
specific for the probe model and lower resolution data contains information that is too 
much dependent on the packing of the molecule. 
 For the understanding of the evaluation of the rotation function it is important 
to define the Patterson map. Patterson maps are achieved by Fourier synthesis of 
the squared amplitudes (F•F*) resulting in a phase angle of 0.0 and centre of 
symmetry. The Patterson coordinate system is noted as uvw. Importantly, phases are 
not considered in Patterson maps. A Patterson map contains vectors between atoms 
in the unit cell without specification of the absolute positions of the atoms. For 
molecular replacement the Patterson map of the search model is placed at the origin 
of a virtual unit cell with primitive centring (P1) and rotated for a maximum correlation 
with the Patterson map of the desired protein.  
 Successively, a translation search is performed. The search model is placed 
on a grid and the position is altered. During the search, the structure factor 
amplitudes of the search model are compared to the amplitudes of the protein of 
interest until the so called reliability factor (R-factor) is minimal. R-factors in molecular 
replacement can be high (exceed 0.6) but still represent a proper solution. This 
depends importantly also on how complete the search model is compared to the 
protein of interest. Searching a heterodimer with a monomer might result an R-factor 
of above 0.5 but still indicate the solution. The R-factor is defined in the following 
formula: 
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R: R-Factor 
 Fobs: observed structure factor 
 Fcalc: calculated structure factor 
 
Another, more robust method to observe the success of the translation search is the 
calculation of a correlation function because scaling errors are avoided. The higher 
the correlation coefficient the better is the result. A relatively large difference between 
the highest and second best correlation coefficient might indicate that the top score is 
the solution. 
 Molecular replacement represents today a very powerful method because of 
an enormous pool of structural information and sufficiently fast computers to execute 
large numbers of rotation and translation operations within a very short time. The 
major disadvantage of molecular replacement is the bias from the phase information 
of the search model. 
 
5.8.6 Anomalous Dispersion 
Single anomalous dispersion (SAD) and multiple anomalous dispersion (MAD) are 
methods used to obtain phases relying on the crystallisation of proteins including 
anomalous scatterers in their structure. For SAD a single and for MAD a multiple 
wavelength approach is used.  
For anomalous scattering the symmetry given by Friedel’s law (reflections with 
identical intensities at hkl and -h-k-l and αhkl = -α-h-k-l) is broken down (Fig. 73). The 
two reflections at hkl and -h-k-l are called Friedel pair. Anomalous scatterer generate 
Friedel pairs that are not equivalent in amplitude and inverse in phase due to the fact 
that electrons from these atoms interact in a resonant manner with the incident X-ray 
used for the experiment. The resonant interaction occurs around a certain 
wavelength as a sharp peak (absorption peak) characteristic for the anomalous 
scatterer but also dependent on its chemical environment.  
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In general, SAD or MAD phase determination depends on an accessible 
absorption peak from K-, L- or M-shell electrons. In models for X-ray scattering in 
matter, excitations are thought to occur localised on single electrons ('independent 
particle approximations'). A commonly used anomalous scatterer is Selenium, where 
a K-shell electron is promoted. Selenium can be introduced into proteins by seleno-L-
methionine substituting methionine during over-expression. In order to estimate 
whether anomalous dispersion gives rise to a signal sufficient for structure 
determination, there should be at least about one anomalous scatterer per 80 amino 
acids. 
 Normal scattering of X-ray photons is elastic scattering; no energy is 
transferred to the atom. When the energy of X-rays is close to the absorption edge of 
an (anomalous scattering) atom the following scattering effects occur: 
1. Partial normal scattering. 
2. Absorption leading to fluorescence. The photon is absorbed by an electron 
and emitted with lower energy (lower wavelength) and altered phase. 
3. The X-ray photon hits a K-, L- or M-shell electron, no energy is absorbed but 
the electron is emitted with altered phase (strong coupling to absorbance edge 
energy).   
4. Retardation of the photon causing the phase shift generates an imaginary 
(negative) component to the absorption term in the atomic form factor 
calculation. 
 
Figure 73 Breakdown of Friedel’s law. Structure factors are shown as vectors with the length 
representing the amplitude and the angle the phase. FP(+) and FP(-) indicate structure factors 
following Friedel’s law, FPH(+) and FPH(-) those where Friedel’s law is broken down (anomalous 
scatterer). FH(+) and FH(-) indicate difference vectors. The anomalous scatterer generates Friedel 
pairs with different amplitude and the phases α (FPH(+)) ≠ - α (FPH(-)). Image taken from (Drenth, 
1994). 
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Atomic form factors (f(θ,λ)) consider the normal scattering (f0(θ)), the dispersive 
(f’(λ)) and the imaginary (if’’(λ)) contribution to the scattering in order to predict 
diffraction, scattering and attenuation processes of light through matter.  
( ) ( ) ( )λλθλθ '''),( 0 iffff ++=  
 f(θ,λ): atomic scattering factor | θ: Bragg angle, λ: wave length 
 f0(θ): normal scattering term  
 f’(λ): dispersive term, matches the change in the real part of the scattering 
 f’’(λ): absorption term (negative since it describes an energy absorption), 
equals the change in the imaginary part of the scattering  
 
f’ and f’’ are determined in a fluorescence scan. The dispersive term is 90° 
advanced in phase compared to the normal term also stating the breakdown of 
Friedel’s law (Fig. 74). 
The experimental wavelength giving the largest signal is close to the 
wavelength of largest absorption (‘absorption edge’; f’’(λ) = maximal) where the 
dispersive term (f’(λ)) has its maximum reflecting the largest amplitude difference of 
the two structure factors of the Friedel pair. In total, for a MAD experiment three 
wavelengths are measured: one at the absorption edge (‘inflection’) for the largest 
dispersive difference of the Friedel pair, one to optimise anomalous differences 
(‘peak’ or ‘white line’), and one at a wavelength remote from the absorption (Fig. 74).  
 The phase information of the anomalous scatterer is extracted from the 
difference of the anomalous reflections of the Friedel pair. Consequently, a 
substructure including only the anomalous scatterers can be calculated which gives 
the first phases for the electron density map of the protein containing the anomalous 
scatterer. If the anomalous scatterer is present due to substitution (e.g. for 
selenomethionine crystals), phases for the native data set can be achieved by 
molecular replacement using the structure of the non-native protein as a search 
model for the native data set.  
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5.8.7 Isomorphous Replacement 
 Other methods using anomalous scatterers are called isomorphous 
replacement. Here, interpretation of the anomalous signal is possible but not 
required. The goal of an isomorphous replacement experiment is to alter the structure 
factor of a native protein of interest, without modifying crystal form or unit cell 
dimensions, upon addition of an intensively scattering atom (such as Pd, Ag, Gd, Pt, 
Au, Hg, Pb or U). After successful soaking, information about the structure factor of 
the native protein (FP) can be achieved by the knowledge of the structure factors of 
the derivatised protein (FPH) and the derivative itself (FH): 
 
FP = FPH - FH 
 
The heavy atom is added to the crystallisation buffer and incorporated into the 
mature crystal (‘soaking’). Since the scattering intensity per atom is correlated to the 
square of the number of electrons per atom, only one heavy atom per 20 kD of 
protein can generate a signal sufficient for the determination of FPH and FH. The small 
number of heavy atoms required for the generation of a measurable signal allows to 
easily deconvoluting a Patterson map in order to determine a substructure for the 
hetero atoms.  
 
Figure 74 Selenium fluorescence scan of the A. fulgidus hjc enzyme performed for a SAD 
experiment. Anomalous scattering factors are plotted versus X-ray energy. The energies of the 
absorption edge (inflection) and peak (white band) are noted and highlighted in cyan and red, 
respectively. A possible remote X-ray energy is highlighted as dashed black line. The image is 
modified from (Biertümpfel, 2005). 
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In single isomorphous replacement (SIR) one type of heavy atom derivative is 
applied to determine FPH and FH, in multiple isomorphous replacement (MIR) more 
heavy atom derivatives are included. In contrast to MIR, phase determination using 
SIR is not sufficient to determine a de novo structure without further phase 
information.    
The dispersive effects in isomorphous replacement are the same as for 
anomalous dispersion. For additional phase information, the anomalous signal of one 
or more heavy atoms can be analysed giving rise to SIRAS (single isomorphous 
replacement with anomalous scattering) or MIRAS (multiple isomorphous 
replacement with anomalous scattering). 
The important difference between isomorphous replacement and SAD/MAD is 
that for isomorphous replacement the introduced hetero atom is not part of the 
protein and might also alter or destroy the crystal package. SAD and MAD have the 
advantage to be ‘automatically’ isomorphous since the anomalous scatterer is part of 
the protein. 
 
5.8.8 Data Processing 
Data processing prepares the collected data for the refinement which leads to the 
generation of the electron density map. For data processing, first the space group is 
determined from a single image recorded and different parameters of data collection 
are adjusted such as distance from crystal to X-ray source. Then reflections are 
indexed (‘indexing’) on all images recorded in order to determine unique reflections 
and outliers are filtered out. Successively, the data is scaled which means that 
identical intensities are assigned to reflections with the same index. Then reflections 
with common indices are put together (‘merging’). This step generates the 
redundancy of the data set. The accuracy of the processed data can be evaluated by 
a value called Rsym which compares the variance of symmetry-related reflections. 
Overall Rsym values below 0.05 can be considered to be good and values up to 0.10 
are probably useable. In comparison, processed random data might give an overall 
Rsym value of up to 0.35. 
5.8.9 Refinement and Evaluation of the Model 
With the information of the wavelength, the structure factor amplitudes from data 
processing and the preliminary phase information (e.g. from molecular replacement), 
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the first electron density map can be calculated. Meanwhile the refinement process 
the model is improved to better fit the experimental data. Iterative steps of calculation 
and model building (‘bootstrapping’) lead to enhanced phases and therefore a better 
electron density map.  
 The first density map calculated is called Fo because it was generated with a 
Fourier transform from only the observed structure factor amplitudes. When the figure 
of merit (FOM) is taken into account, describing the quality of the map, the map is 
termed mFo map. An electron density map reflecting the structure factor amplitudes 
expected from the current model is called Fc map (‘Fourier calculated’). Considering 
the average coordinate error of the model (Luzzati, 1952), the map is named DFc 
map (see blelow).  
 In the first refinement cycle, a model from a molecular replacement solution 
can be evaluated via the R-factor (see below) which states the difference between 
the calculated and observed structure factor amplitudes. An R-factor of 0.45 – 0.50 
indicates that the correlation is not random.  
 The model can be evaluated according to different parameters: 
 
R-factor / Free R-factor 
For a correct solution the R-factor drops during the bootstrapping process. It reflects 
how well the current model reflects the entire data set. The model can also bias the 
successively calculated electron density. Therefore, a randomly chosen small part of 
the reflections (about 5%) is excluded from the refinement process (‘test set’) and 
gives rise to the free R-factor (Rfree), stating how well the model corresponds to the 
test set. Since reflections of the test set are not used for refining the model, the Rfree 
value is higher than the R-factor and less biased from the model. During 
bootstrapping a dropping Rfree value indicates a true improvement on the model. 
 
Ramachandran Plot 
The Ramachandran Plot allows evaluating the correctness of the main chain 
stereochemistry of the model. Here, the psi (Ψ) angle is plotted against the phi (Φ) 
angle (Fig. 75). Both main chain angles are also known as dihedral angles. Regions 
are indicated where a phi-psi combination is most favoured, additionally allowed, 
generously allowed and disallowed. In secondary structural elements, the ranges of 
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dihedral angles are restrained. Therefore, dihedral angles assigned to amino acids in 
secondary structural elements can be easily verified by the Ramachandran plot.  
 
 
 
Coordinate Error 
The model can be validated by determining the average coordinate error of the 
model by Luzzati (Kleywegt et al., 1994; Kleywegt and Brunger, 1996; Luzzati, 1952) 
and SigmaA (Read, 1986) analysis. The Luzzati coordinate error is determined by 
plotting the crystallographic R-factor versus resolution (Luzzati plot) assuming a 
Gaussian error distribution. The program SIGMAA (Read, 1986) combines calculated 
with previously determined phase information using phase probability profiles. Phase 
information calculated from a model structure or the combination of phase 
probabilities, from experimental phases with those from one or model structures, 
allows the calculation of weighted Fourier coefficients. The program calculates 
iteratively the SigmaA value as defined by (Srinivasan, 1966). For each reflection, the 
 
Figure 75 Ramachandran plot. The backbone angles psi (Ψ) and phi (Φ) are plotted against each 
other. Areas of most favoured combinations of dihedral angles are in red, additionally allowed in 
yellow, generously allowed in light yellow and disallowed regions are white. Areas of dihedral 
angle combinations favoured by β-sheets (β), right-handed helices (αR) and left-handed helices 
(αL) are labelled.   
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figure of merit m, describing the quality of the map, and the estimate of the error in 
the partial structure from coordinate errors D (Luzzati, 1952) are determined. 
Consequently, SigmaA weighted electron density maps are termed e.g. mFo – DFc 
when a SigmaA weighted Fo – Fc electron density map is calculated. In this work the 
program CNS (Brunger et al., 1998) was used to generate SigmaA weighted electron 
density maps for model building refinement.   
 
Other Evaluation Parameters 
For the evaluation of the model it is important to confirm that the interatom distances 
are proper. In general, interatom distances should be at least the radii of their Van 
der Waals radii minus 0.4 Å. Bond lengths and angles should be within a range as 
stated by Engh and Huber (Engh and Huber, 1991). Important non-covalent bonds 
are hydrogen bonds which can vary in length between 1.6 and 2.4 Å with the O-H 
bond vector pointing directly at the acceptor ion pair.  
Torsion angles can be compared to torsion angles of well refined structures in 
the protein data bank and scored by the program WHATCHECK (Hooft et al., 1996). 
WHATCHECK (Hooft et al., 1996) can also compare rotamers of side chains to a 
database of proper rotamer conformations. Unusual conformations are reported 
accordingly. It is further important to inspect the planarity of rings in side chains 
where e.g. aromatic rings (in Phe, Tyr, Trp) are flat. Additionally, water molecules 
integrated into the atomic model should be bound to the protein.  
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5.9   List of Buffers 
5.9.1 SRαHis:βΔTM 
 
Name Buffer 
L(αβ) 50 mM Tris-HCl pH 8.0, 500 mM NaCl, 5mM MgCl2, 10 mM imidazole, 
0.1%, Triton X-100, 0.02% MTG and one tablet of protease inhibitor 
ANi(αβ) 50 mM Tris-HCl pH 8.0, 500 mM NaCl, 5mM MgCl2, 10 mM imidazole, 
0.1%, 0.02% MTG 
BNi(αβ) 50 mM Tris-HCl pH 8.0, 500 mM NaCl, 5 mM MgCl2, 300 mM imidazole, 
0.1%, 0.02% MTG 
Q(αβ) 20 mM Tris-HCl pH 7, 200 mM NaCl, 5 mM MgCl2, 0.02% MTG 
ASP(αβ) 20 mM Tris-HCl pH 7, 200 mM NaCl, 5 mM MgCl2, 0.02% MTG 
BSP(αβ) 20 mM Tris-HCl pH 7, 350 mM NaCl, 5 mM MgCl2, 0.02% MTG 
GF(αβ) 10 – 50 mM Tris pH 8, 500 mM NaCl, 5 mM MgCl2 and 0.02 % MTG 
 
 
5.9.2 SRX2His:βΔTM 
 
Name Buffer 
L(X2β) 50mM Tris pH 8.0, 500 mM NaCl, 5 mM MgCl2, 10 mM imidazole, 0.01% 
MTG, supplemented with one tablet of protease inhibitor 
ANi(X2β) 50mM Tris pH 8.0, 500 mM NaCl, 5 mM MgCl2, 10 mM imidazole, 0.01% 
MTG 
BNi(X2β) 50mM Tris pH 8.0, 500 mM NaCl, 5 mM MgCl2, 500 mM imidazole, 
0.01% MTG 
Q(X2β) 20mM HEPES pH=7, 150 mM NaCl, 5 mM MgCl2, 0.02 % MTG 
ASP(X2β) 20mM HEPES pH=7, 150 mM NaCl, 5 mM MgCl2, 0.02 % MTG 
BSP(X2β) 20mM HEPES pH=7, 1 M NaCl, 5 mM MgCl2, 0.02 % MTG 
GF(X2β) 10 mM Tris pH 8, 150 mM NaCl, 5 mM MgCl2, 0.02% MTG 
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5.9.3 SRX2His:βΔTMSeMet 
 
GM(SeMet): 
Added per litre 
of medium 
Name Contents 
2 ml MgSO4 1 M MgSO4 * 
65 ml M9 (20X) 0.375 mM NH4Cl, 2.265 M KH2PO4, 2.1 M 
Na2HPO4x2H20 * 
10 ml Amino acid mix I All amino acids but Met, Tyr, Trp, Phe at 4 
mg/ml ** 
10 ml Amino acid mix II Tyr, Trp, Phe at 4 mg/ml, stirred slowly ON at 
RT, not all dissolves ** 
20ml Glucose 20 % Glucose * 
1 ml Vitamin mix  Niacinamide, pyridoxine monochloride, 
thiamine at 1mg/ml ** 
1 ml Riboflavin 1 mg / ml Riboflavin in 0.1 % acetic acid, 
stirred 6 h at RT, not all dissolves ** 
40 mg Selenomethionine Added directly 
*: autoclaved, **: filtered sterile 
 
Name Buffer 
L(SeMet) 50 mM Tris pH 7.4 (measured at 4°C), 500 mM NaCl, 30 mM 
imidazole, 10 mM MgCl2, 0.02% MTG , supplemented with one tablet of 
protease inhibitor 
ANi(SeMet) 50 mM Tris pH 7.4 (measured at 4°C), 500 mM NaCl, 30 mM 
imidazole, 10 mM MgCl2, 0.02 % MTG 
BNi(SeMet) 50 mM Tris pH 7.4 (measured at 4°C), 500 mM NaCl, 500 mM 
imidazole, 10 mM MgCl2, 0.02% MTG 
Q(SeMet) 20 mM HEPES pH7, 150 mM NaCl, 5 mM MgCl2, 1 mM DTT 
ASP(SeMet) 20 mM HEPES pH 7, 150 mM NaCl, 5 mM MgCl2, 1 mM DTT 
BSP(SeMet) 20 mM HEPES pH 7, 1 M NaCl, 5 mM MgCl2, 1 mM DTT 
GF(SeMet) 10 mM Tris pH 8.0, 150mM NaCl, 5 mM MgCl2, 1 mM DTT  
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5.9.4 SRαNGHis 
 
Name Buffer 
L(αNG) 50 mM Tris-HCl pH 8.0, 500 mM NaCl, 5mM MgCl2, 10 mM imidazole, 
0.1%, Triton X-100, 0.02% MTG and one tablet of protease inhibitor 
ANi (αNG) 50 mM BisTris pH 7, 300 mM NaCl, 10 mM imidazole, 5 mM MgCl2, 
0.02% MTG 
BNi (αNG) 50 mM BisTris pH 7, 300 mM NaCl, 500 mM imidazole, 5 mM MgCl2, 
0.02% MTG 
 
5.9.5 SRP54DHis 
 
Test expression 
Name Buffer 
L(54Dt) 50 mM Tris pH 8, 500 mM NaCl, 5 mM MgCl2, 0.02% MTG and one 
tablet of protease inhibitor 
ANi(54Dt) 50 mM Tris pH 8, 500 mM NaCl, 5 mM MgCl2, 0.02 % MTG 
BNi(54Dt) 50 mM Tris pH 8, 500 mM NaCl, 5 mM MgCl2, 0.02 % MTG 
 
Standard Preparation 
Name Buffer 
L(54D) 50 mM Tris pH 7.3, 500 mM NaCl, 5 mM MgCl2, 0.02% MTG, 
supplemented with one tablet of protease inhibitor 
ANi(54D) 50 mM Tris pH 7.3, 500 mM NaCl, 5 mM MgCl2, 0.02% MTG 
BNi(54D) 50 mM Tris pH 7.3, 500 mM NaCl, 5 mM MgCl2, 0.02% MTG 
ASP(54D) 50 mM BisTris pH 6, 120 mM NaCl, 5 mM MgCl2, 0.02% MTG 
BSP(54D) 50 mM BisTris pH 6, 500 mM NaCl, 5 mM MgCl2, 0.02% MTG 
GF(54D) 10 mM Tris pH 8, 250 mM NaCl, 5 mM MgCl2, 0.02% MTG 
 
5.9.6 SRP54NGHis 
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Name Buffer 
L(54NG) 50 mM BisTris pH 7, 150 mM NaCl, 5 mM MgCl2, 30 mM imidazole, 
0.02% MTG, supplemented with one tablet of protease inhibitor 
ANi (54NG) 50 mM BisTris pH 7, 150 mM NaCl, 5 mM MgCl2, 30 mM imidazole, 
0.02% MTG 
BNi(54NG) 50 mM BisTris pH 7, 150 mM NaCl, 5 mM MgCl2, 500 mM imidazole, 
0.02% MTG 
Q(54NG) 25 mM BisTris pH 6, 150 mM NaCl, 5 mM MgCl2, 0.02% MTG 
GF(54NG) 20 mM Tris pH 7.5, 350 mM NaCl, 2 mM MgCl2, 0.02% MTG 
 
5.9.7 Trimeric Complex: SRαHis:βΔTM:SRP54DHis 
 
Name Buffer 
CF(T) 20 mM Tris/HCl pH 8, 10% glycerol, 250 mM NaCl, 5 mM MgCl2, 0.02% 
MTG, 2mM GMPPNP 
GF(T) 20 mM Tris/HCl pH 8, 250 mM NaCl, 5 mM MgCl2, 0.02% MTG 
 
5.9.8 Pentameric Complex Formation: 
SRαHis:βΔTM:SRP54DHis:SRP19:RNA104 
 
Name Buffer 
GF(P) 20 mM Tris pH 8, 250 mM NaCl, 10 mM KCl, 10 mM MgCl2, 0.02% MTG 
 
5.9.9 Trimeric Complex Formation Pull-Down: SRα:βΔTM:SRP54NGCHis 
Name Buffer 
L(αβ2) 50 mM BisTris pH 7, 150 mM NaCl, 5 mM MgCl2, 0.01% Triton X-100, 
0.02 % MTG, supplemented with one tablet of protease inhibitor  
ASP(αβ2) 50 mM BisTris pH 7, 150 mM NaCl, 5 mM MgCl2, 0.02% MTG 
BSP(αβ2) 50 mM BisTris pH 7, 350 mM NaCl, 5 mM MgCl2, 0.02% MTG 
CF2 25 mM BisTris pH 7, 150 mM NaCl, 5 mM MgCl2, 15 mM imidazole, 
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0.02% MTG, 2 mM GMPPNP 
ANi(T2) 50 mM BisTris pH 7, 150 mM NaCl, 15 mM imidazole, 0.02% MTG 
BNi(T2) 50 mM BisTris pH 7, 150 mM NaCl, 500 mM imidazole, 0.02 % MTG 
GF(T2) 10 mM BisTris pH 7, 150 mM NaCl, 5 mM MgCl2, 0.02 % MTG 
 
5.9.10 Analysis of SR:SRP Complex Formation 
 
Name Buffer 
SR 10 mM Tris pH 8, 250 mM NaCl, 10 mM MgCl2, 0.02 % MTG 
B54 50 mM HEPES pH 7.5, 200 mM NaCl, 10 % glycerol, 5 mM MgCl2 
B19RNA 20 mM Tris pH 8, 400 mM NaCl, 10 mM KCl, 10 mM MgCl2 
GF(5) 10 mM Tris pH 8, 250 mM NaCl, 10 mM MgCl2, 0.02 % MTG 
 
5.9.11 Immobilised Peptide Library Scan 
 
Name Buffer 
BLK 50 mM HEPES pH 7.5, 150 mM KOAc, 5mM MgCl2, 0.2 % BSA 
BLT 30 mM Tris, 20 % methanol 
PMT PBS, 0.5 % milkpowder, 0.05 % Tween-20 
 
5.9.12 Buffer for HPLC analysis 
 
Name Buffer 
HP 50mM K2H/KH2PO4 pH 6.3, 10 mM TBAB, 6 % acetonirile 
 
5.9.13 Crystallisation and Structure Determination of SRαX2His:βΔTM 
 
Name Buffer 
Cryst 10 mM Tris pH 8, 150 mM NaCl, 5 mM MgCl2, 1 mM DTT 
Res1 2 M (NH4)2SO4, 0.1 M sodium citrate pH 5.5 
Res2 2 M (NH4SO4)2, 0.1 M sodium citrate pH 5.5, 100 mM guanidinium 
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hydrochloride 
BCryo 2 M (NH4)2SO4, 0.1 M sodium citrate pH 5.5, 100 mM guanidinium 
hydrochloride, 20% glycerol 
 
5.10   List of Primers 
5.10.1 SRX2His:βΔTM / SRαHis:βΔTM mutants 
 
Mutation Sequence (5’-3’) 
SRα R524Q Forward (-Fo): ggtggacacggcaggcCAGatgcaagacaatgcccc 
Reverse (-Re): ggggcattgtcttgcatCTGgcctgccgtgtccacc 
SRα R34A Forward (_f): cccgttaacgcgttgattGCTtccgtgctgctgcagg 
Reverse (_r): cctgcagcagcacggaAGCaatcaacgcgttaacggg 
SRα D72G Forward (_f): ctcttcgttggtctctgtGGAtctgggaaaacgttgctg 
Reverse (_r):cagcaacgttttcccagaTCCacagagaccaacgaagag 
SRβ H119A Forward (_f): gatcgacctccccgggGCTgagagcttgaggtttcagc 
Reverse (_r): gctgaaacctcaagctctcAGCcccggggaggtcgatc 
Sequences coding for mutated amino acids are highlighted in capital and bold letters. 
 
5.10.2 SRαNGHis 
 
Name Sequence (5’-3’) 
SRαNG-Forward CATCACTCCATGGGAACACTGGGTGGCATG 
SRαNG-Reverse AGTGTGGGATCCTCATTAAGCCTTCATGAGGGCAGCCAC 
 
 
5.10.3 SRP54DHis 
 
Name Sequence (5’-3’) 
SRP54DN- 
Forward 
GTCAGTACCATGGGACACCACCACCACCACCACATGGTACTAGCAG 
ACCTTGGAAGAAAAATAACATCAGC 
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SRP54DN- 
Reverse 
GGGTGACCTCGAGTCATTAACCTCCCATCTTTTTTACCATCTG 
SRP54DC- 
Forward 
GTCAGTACCATGGTACTAGCAGACCTTGGAAGAAAAATAACATCA 
GC 
SRP54DN- 
Reverse 
GGGTGACCTCGAGTTATCAGTGGTGGTGGTGGTGGTGACCTCCCAT 
CTTTTTTACCATCTGTGCAAATTTGG 
 
5.10.4 SRP54NGHis 
 
Name Sequence (5’-3’) 
SRP54NGN-
Forward 
cagcaagcttcttggtTGAatgggtgacatcgaag 
SRP54NGN-
Reverse 
cttcgatgtcacccatTCAaccaagaagcttgctg 
SRP54NGC-
Forward 
GTCAGTACCATGGTACTAGCAGACCTTGGAAGAAAAATAACATCAAGC 
SRP54NGC-
Reverse 
TACTCGCCTCGAGTTACTAATGGTGATGGTGATGGTGACCAAGAAGCTTGC
TGATAAAAGGCTGTGTTTTGAAAGG 
Bold and capital letters indicate the inserted stop codon. 
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